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ABSTRACT
Studies were undertaken to examine the factors influencing 
the development of Type I respiratory allergy in the rat, 
with a view to providing an animal model for assessing the 
potential of inhaled materials to induce respiratory allergy.
Differences between the Brown Norway (BN) and PVG rat 
strains in relation to their ability to produce reaginic 
antibody following inhalation exposure, and differences in 
lung cell populations following inhalation challenge, 
underlined the importance of genetic constitution of the 
selected experimental animal. Following pre-treatment with 
the adjuvant carrageenan it was possible to induce sustained 
reaginic antibody responses to inhaled ovalbumin in the BN 
rat, which could be re-elicited upon subsequent exposure. 
Inhalation challenge of sensitised animals produced a 
characteristic "notching" breathing pattern associated with 
respiratory sensitivity in the rat, which was considered 
indicative of a positive respiratory response.
Aspects of atmosphere generation were investigated with 
regard to their influence on immune recognition. Several 
factors were found to influence the range of particle sizes 
generated, these included choice of generating system, nature 
and concentration of test material and use of diluting air.
Intraperitoneal administration of material together with 
carrageenan was employed to assess the allergenicity
11
of various low molecular weight materials, which were 
administered conjugated to either rat serum albumin or 
ovalbumin. Hexyl isocyanate, penicillin G and eight reactive 
dyes were assessed both in terms of induction of reaginic 
antibody and elicitation of respiratory responses during 
inhalation challenge using either BSA-conjugated or free 
material.
Using this system differing allergenic potencies were 
revealed, which for the reactive dyes was related both to 
their ability to bind to protein and the hapten density of 
the dye-protein conjugates produced. In addition, the use of 
computer graphic molecular modelling of two reactive dyes 
showed some correlation between the chemical structure of the 
dyes and their allergenic potential.
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GLOSSARY
Adjuvant: A substance which non specifically enhances or
modifies the response of the immune system to an antigen. 
Allergy: Originally defined as an altered reactivity on
second contact with antigen; now usually refers to a type I 
hypersensitivity. J
Antibody: An immunoglobulin molecule produced by animals in
response to antigen which has the particular property of 
combining specifically with antigëh^th^ induced its formation
Antigen: A molecule that induces the formation of antibody.
Apnoea: Temporary cessation of respiration.
Atopy: The clinical manifestation of Type I hypersensitivity
reactions including eczema, asthma and rhinitis.
Cytokines: A generic term for soluble molecules which
mediate interactions between cells.
Dendritic cells: Antigen presenting cells present in lymph
nodes, spleen and at low levels in the blood, which are 
particulary active in stimulating T cells during the primary 
phase of an immune response.
Dyspnoea: Shortness of breath, difficulty in breathing during 
a forced expiration.
Fc: Portion of the antibody molecule containing heavy chain
only, which designate the class of antibody.
FEV: Volume of gas expired over a given time interval.
Hapten: A small molecule which will combine with antibody
but which is not capable of evoking an antibody response when 
injected alone.
XX
Helper T cells (CD4): A functional subclass of T cells which
can help to generate cytotoxic T cells and cooperate with B 
cells in production of antibody responses. Helper cells 
recognise antigen in association with class II MHC molecules. 
Hypersensitivity reaction: A heightened immune response
associated with the development of allergy (Coombs and Gell 
1963)
la antigens: Induction of an antigen-specific immune
response requires that the immunising antigen be presented to 
a T cell in association with la antigens (MHC class II 
antigens) on the surface of an accessory cell.
Immune complex: The product of an antigen-antibody reaction
which may also contain components of the complement system. 
Interferon: A group of mediators which increase resistance
of cells to viral infection, and act as cytokines. jlNFy is 
also an important immunological mediator.
Interleukins: A group of molecules involved in signalling
between cells of the immune system.
Isotype: Refers to a genetic variation within a family of
proteins or peptides such that every member of the species 
will have each isotype of the family represented in its 
genome, in this instance the immunoglobulin classes. 
Leukotrienes: Products of arachadonic acid metabolised via
the lipoxygenase pathway, which are potent mediators of 
inflammatory reactions.
Lipopolysaccharide (LPS): A product of some Gram-negative 
bacterial cell walls which can act as a B cell mitogen in 
rodents.
XXI
Major histocompatibility complex (MHC): Encodes for cell
surface molecules, which are involved in the signalling 
between lymphocytes and antigen presenting cells.
Minute volume: The volume of air respired within one minute.
Prostaglandins: Products of arachadonic acid metabolised via
the cycloxygenase pathway, which have regulatory roles in 
immune and inflammatory responses.
Pulmonary compliance: Elasticity of the lung during
breathing.
Pulmonary resistance: Resistance to the flow of air within
the lung.
Reagin: Term for IgE antibody or antibodies of other classes
that possess the property of inducing antibody dependent 
degranulation of mast cells, via binding to these cells 
through Fc receptors.
Residual volume: The volume of air remaining in the lungs
after a forced expiration.
Respiratory rate: The number of breaths an individual takes
in the period of a minute.
Suppressor T cells (CDS): A sub population of T cells which
act to reduce the immune responses of other T cells or B
cells in association with class I MHC molecules.
l air
Tidal volume: The volume of/repeatedly inspired and expired
between the resting inspiration and expiration levels. 
Tolerance: A state of specific immunological
unresponsiveness induced by exposure to antigen.
Vital capacity: Maximum volume measured on expiration after
the deepest inspiration.
XXll
LIST OF ABBREVIATIONS
General abbreviations
ADE = area of dye extravasation
AMP = adenosine monophosphate
BN = Brown Norway
DNP = dinitrophenol
ELISA = enzyme linked immunosorbant assay
FEV = forced expiratory volume
IFNY = gamma interferon
IL-4 = interleukin 4
i.p. = intraperitoneal
LPS = lipopolysaccharide
LT = leukotriene
MBP = major basic protein
OD = optical density
PBS = phosphate buffered saline (0.15 M)
PCA = Passive cutaneous anaphylaxis assay
PEG = polyethylene glycol
PG = prostaglandin
RAST = radioallergosorbent test
RM = Respiratory monitoring
TDI = toluene diisocyanate
TLV = threshold limit value
TMA = trimeltitic anhydride
TNBS = trinitrobenzene sulphonic acid
Materials used for sensitisation
Protein
OA = Ovalbumin
XXlll
BSA = Bovine serum albumin
HSA = Human serum albumin
RS = Rat serum
SSA = Sheep serum albumin
Dves
R014 = Reactive orange 14
R04 = Reactive orange 4
R013 = Reactive orange 13
RB4 = Reactive blue 4
RB2 = Reactive blue 2
LB3R = Lanasol blue 3R
LR5B = Lanasol red 5B
LY4G = Lanasol yellow 4G
Other materials
CGN = Carrageenan
Pen = Penicillin G
HIC = Hexylisocyanate
Hapten protein conjugates
R014-0A = Reactive orange 14-ovalbumin
R014-BSA = Reactive orange 14-bovine serum albumin
R014-HSA = Reactive orange 14-human serum albumin
R014-RS = Reactive orange 14-rat serum
R014-SSA = Ractive orange 14-sheep serum albumin
R04-0A = Reactive orange 4-ovalbumin
R04-BSA = Reactive orange 4-bovine serum albumin
R04-RS = Reactive orange 4-rat serum
R013-0A = Reactive orange 13-ovalbumin
R013-BSA = Reactive orange 13-bovine serum albumin
R013-RS = Reactive orange 13-rat serum
XXIV
RB4-0A = Reactive blue 4-ovalbumin
RB4-RS = Reactive blue 4-rat serum
RB2-0A = Reactive blue 2-ovalbumin
RB2-BSA = Reactive blue 2-bovine serum albumin
LB3R-0A = Lanasol blue 3R-ovalbumin
LB3R-BSA = Lanasol blue 3R-bovine serum albumin
LB5R-RS = Lanasol blue 3R-rat serum
LR5B-0A = Lanasol red 5B-ovalbumin
LR5B-BSA = Lanasol red 5B-bovine serum albumin
LR5B-RS = Lanasol red 5B-rat serum
LY4G-0A = Lanasol yellow 4G-ovalbumin
LY4G-BSA = Lanasol yellow 4G-bovine serum albumin
LY4G-RS = Lanasol yellow 4G-rat serum
Pen-OA = Penicillin-ovalbumin
Pen-BSA = Penicillin-bovine serum albumin
Pen-RS = Penicillin-rat serum
Pen-HSA = Penicillin-human serum albumin
HIC-OA = Hexyl isocyanate-ovalbumin
HIC-BSA = Hexyl isocyanate-bovine serum albumin
HIC-RS = Hexyl isocyanate-rat serum
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CHAPTER 1
General introduction
The effects of occupational asthma can range from mild 
irritation to debilitation and death. Not only is there loss 
of quality of life for those affected, but a cost in economic 
terms for both the individual and the industry. Although it 
is considered that occupational asthma is greatly under­
diagnosed, it is thought to represent about 5% of adult onset 
asthma (Burge, 1988). Asthma is usually defined as airway 
narrowing that is reversible over a short period of time 
either spontaneously or as a result of treatment (Newman- 
Taylor, 1988), rather than the permanent impairment of lung 
function present in other lung diseases.
Many dusts and chemicals can be inhaled without 
producing any deleterious effects on the lung, however, 
others are capable of causing inflammatory or immunologically 
mediated adverse reactions, including allergic lung diseases. 
The term allergy and hypersensitivity are used synonymously 
to describe an increased reactivity to antigen rather than 
the development of immune tolerance. The principal 
immunological mechanism involved in occupational asthma is 
the Type I immunoglobulin E (IgE)-mediated hypersensitivity 
response (Section 1.5.1.).
Clearly it would be advantageous to be able to identify 
those materials that act as respiratory sensitisers. Study 
of the factors involved in the development of respiratory 
sensitivity would provide a better understanding of the
- 2 -
phenomena, and may also provide the methodology for 
predicting the allergenicity of inhaled materials.
1.1. HISTORICAL PERSPECTIVE
The condition of asthma has been recognised from ancient
times, however the term was used to describe any condition
associated with dyspnoea (Sakula, 1988). Between the
seventeenth and eighteenth centuries major advances were made
in the understanding of the mechanisms and causes of asthma.
Sir John Floyer published his "treatise on asthma" in 1698,
and was the first to define asthma, clearly separating it
from other pulmonary diseases. He considered the dyspnoea to
be due to bronchoconstriction and was also aware of the
multi-factorial basis of asthma, i.e. the contribution of
heredity, occupation, atmospheric pollution,
hypersensitivity, infection, exercise and physiological
influences (Sakula, 1984).
Although diseases produced through occupational exposure
were well known, it was Bernadino Ramazzini in his "treatise
De Morbus Artificum Diatriba", the diseases of tradesmen
published in 1700, who made the causative connection between
occupation and disease (Sakula, 1983). He described many
diseases observed in individuals employed in a variety of
occupations including grain workers, bakers, potters, glass
[and
makers, painters/ metal diggers. In his chapter on corn 
sifters and measurers Ramazzini showed an understanding of 
the complex composition of grain dust, for it contains a 
diverse mixture of allergens and debris, such as fungi, 
insects, silicon dioxide as well as pigeon and rodent
- 3 -
excreta, that can give rise to a variety of respiratory 
syndromes including those mediated by immune reactions 
(Chang-Yeung and Lam, 1986). Modern technology involving 
mechanised harvesting, bulk storage and movement of grain has 
not eliminated the hazard of this occupational respiratory 
disease, for the symptoms described by Ramazzini are still 
evident in the respiratory impairment recorded in those 
exposed to grain and flour dusts today (Awad El Karim, 1986; 
Chan-Yeung et ai., 1981).
Central to the industrial revolution of the eighteenth 
century was the move from the use of hand-driven to power- 
driven machinery, bringing about major changes in 
manufacturing processes, notably in the textile industry and 
in the production of chemicals required to service that 
industry; for example, dyes, chlorine for bleach and 
sulphuric acid for the manufacture of alkalis for soap (Hill, 
1985). Following these technological advances occupational 
diseases became apparent related to particular industries 
(Salvaggio, 1990). Expansion of the chemical industry in the 
twentieth century and the development and production of 
synthetic materials such as plastics, pesticides, fertilisers 
and explosives, led to a dramatic increase in the number of 
chemicals in use, some of which were capable of causing 
occupational asthma (Newman-Taylor, 1980).
1.2. OCCUPATIONAL ASTHMA
Inhalation of materials during employment can result in a 
variety of lung diseases some of which manifest the symptoms 
of asthma. The term occupational asthma, is generally
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restricted to asthma induced by agents inhaled at work due to 
a specific hypersensitivity reaction, which develops after an 
initial disease-free interval from the first exposure 
(Newman-Taylor 1980). In Britain occupational asthma was 
first prescribed as an industrial disease in 1982 under the 
Department of Health and Social Security Act 1975, Section 
141d (DHSS, 1982a). Prescription was restricted to 
occupations in which workers were exposed to specified 
sensitising agents. Initially seven groups of agents were 
prescribed, a further seven being added in 1986 (DHSS 1986). 
In the 1990 document (DHSS 1990), in addition to specifying a 
further nine materials, a category of any other sensitising 
agent inhaled at work was added, in order to aid the process 
of compensation.
Materials responsible for inducing occupational asthma 
can be vapours, gases or particulates and range from very low 
molecular weight inorganic chemicals to complex organic 
molecules. The main classes of high and low molecular weight 
materials that cause occupational asthma are shown in Tables
1.1 and 1.2 respectively. These have been compiled from 
several sources which show the diversity of materials 
involved, together with the occupations associated with the 
use of these materials, and in some cases the mechanism(s) by 
which the asthma is induced (Newman-Taylor, 1980; Bardana & 
Andrach, 1983; Pepys, 1986; Salvaggio et al., 1986; Chan- 
Yeung & Lam, 1986; Hagmar et al., 1987; Burge, 1988). The 
three main categories that account for 80% of cases of 
occupational asthma in Britain ^re the isocyanates, soldering 
flux, and flour and grain (HSE, 1989). Evidence of specific
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Table 1.1. Types of high molecular weight materials 
causing occupational asthma
Agent Material Occupation/Industry
Animal material
(f) Mammals
Danders and urinary proteins
Laboratory workers, veterinary 
surgeons and animal handlers
(f) Arthropods
Cockroach, locust 
Silkworm larvae
Pesticide research 
Silk producers
(q) Crustaceans and fish 
Crab, oyster.
Prawn
Food processing
(f) Birds
Feathers and excreta 
Plant material
Poultry industry, upholstery and 
bedding workers, pet shop worker
(g) Grain, flour Farmers, grain handlers and 
bakers from barley oats, maize, 
rye and wheat
Gums
Acacia and tragacanth Printing industry
(k)
(1)
Other
Isphagua powder 
Castor bean dust
Laxative manufacture 
Oil industry/dock workers
(m)
(P)
(s)
(t)
(u)
Ipecacuanha 
Henna 
Psyllium 
Soya bean dust 
Tea dust
Green coffee bean dust
Hair dressing 
Laxative manufacture 
Dock workers 
Tea workers 
Food processing
(e) Proteolytic Enzymes
[Bacillus subtilisienzyme 
Bromelian
Plavitase 
Pancreatic enzymes 
Papain 
Pepsin
Detergent industry 
Pineapple processors, meat 
tenderiser
Pharmaceutical meat tenderiser 
Pharmaceutical industry, meat 
tenderiser
( ) DHSS (1990) Agent Listing
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Table 1.2. Types of low molecular weight materials 
causing occupational asthma
Agent Material Occupation/Industry
Drugs
(h) Antibiotics
Penicillins
Cephalosporins
Tetracyclin
Sulphathiazines
Pharmaceuticals and pharmacists
(i)
Other
Phenylglycine acid chloride 
Centimedine
Chemicals
Pharmaceuticals and pharmacists
(c) Acid anhydrides
Tetrachlorophthalic anhydride Hardening agents in plastics, 
rubber, paint workers and 
mould makers
Trimellitic anhydride tl II II II II
Phthalic anhydride Meat wrapper labellers
(n) Azodicarbonamide Plastic and rubber industry
(a) Isocyanates
Toluene diisocyanate 
Diphenylmethane isocyanate 
Hexamethylene diisocyanate
Plastics/polyurethane industries 
Foundries
Automobile paint spraying
(o)
(P)
glutaraldehyde 
persulphates
Hospital staff 
Hairdressers
(r) Reactive dyes
(see Table 7.1)
Textile industry
(j) Wood dust
Tropical hard woods 
(Western red cedar) 
Pilatic acid
Metals
Carpenters, joiners and 
timber workers
(b) Platinum salts 
Nickel salts 
Chromium 
Vanadium
Soldering fluxes
Metal refining, photographic 
Metal plating workers 
Printing
Fuel oil and steel workers
(d)
(V)
Colophony
Aminoethyl ethanolamine
Electronic industry 
Aluminium soldering
( ) DHSS (1990) Agent Listing
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immunological reactions have been established for some of 
those materials listed but not all. This may be due to the 
difficulty in the preparation of antigens for the detection 
of antigen-specific IgE antibody directed against low 
molecular weight materials (Karol, 1986), or that IgE is not 
involved in the pathogenesis of these particular asthmas.
It has been estimated that there are over 10,000 new and 
unique organic chemicals synthesised each year (Hurst, 1982). 
Therefore, although changes in industrial processes, design 
of industrial facilities and industrial hygiene have served 
to reduce the risk of developing occupational asthma, as new 
chemicals are introduced into the working environment the 
proportion of materials likely to cause occupational asthma 
will continue to grow. Therefore, it is important to develop 
screening methods to determine which of these materials 
present such a hazard, so that the requisite safeguards can 
be taken.
Agents causing occupational asthma are usually 
encountered in an industrial setting. Those at risk include 
persons involved in transport and secondary industries as 
well as manufacture. Once occupational asthma has been 
induced, subsequent exposure to very low levels of allergen 
below the recommended threshold limit value (TLV) can be 
sufficient to elicit an asthmatic reaction. This is 
illustrated by the work of Butcher et al. (1979), where 
workers who developed sensitivity to toluene diisocyanate 
(TDl) were found to react to bronchoprovocation exposures at 
concentrations of TDl vapour as low as 0.005 ppm, which is
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far below the TLV of 0.02 ppm recommended for the prevention 
of occupational illness for this material.
Asthma related to industrial activities is not, however, 
always confined to the factory. For example, persons have 
been "sensitised" to TDl through the aspiration of waste TDl 
fumes into the ventilation system of their work place (Pepys, 
1978). Under certain conditions asthma related to the 
distribution of "work" generated allergens can also be 
observed in the general "asthmatic" population presenting a 
broader problem. For instance, in the area surrounding the 
castor bean mills and harbour facilities in Marseilles, 91% 
of those affected were shown to possess castor bean-specific 
IgE antibodies in their serum (Thorpe et al., 1987).
Similarly Anto and Sunyer (1986) pin pointed the harbour as 
the source of outbreaks of asthma in Barcelona. Subsequently 
anti-soya bean IgE antibody was detected in the serum from 
affected individuals, identifying soya bean dust as the 
causative agent (Sunyer et al., 1989).
The symptoms of asthma can also be induced under 
conditions which are not immunologically specific, but due to 
direct effects of a material on the mast cell and smooth 
muscle of the airways. Furthermore, following the 
development of asthma to a specific agent the airways become 
exquisitely sensitive to various non-specific 
pharmacological, chemical and physical stimuli (bronchial 
hyper-reactivity), therefore, they react non-specifically to 
materials unrelated to the causative agent.
Increased sensitivity or bronchial hyper-reactivity in 
response to external stimuli is a characteristic feature of
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asthma, and together with the detection of antigen-specific 
IgE antibody or the development of immediate type skin tests 
can be used as a means of assessing sensitivity (Cockroft et 
al., 1987). In some instances where the above tests are 
inconclusive, the induction of respiratory responses to the 
suspected causative agent, at levels which do not provoke 
irritant reactions, may be considered necessary.
1.3. PREDISPOSING FACTORS
It has been recognised for more than 50 years that certain 
individuals have a tendency to develop hay-fever, asthma and 
eczema, and also to produce reaginic antibody (IgE) to common 
allergens. The genetic profile of an individual is the most 
important factor in determining which type of immune response 
is induced. From the work of Cookson and Hopkin (1988) and 
Hopkin (1989), it has been suggested that IgE responsiveness 
is inherited in a simple autosomal dominant manner and that 
the trait is determined at a single gene locus.
Those individuals that have a predisposition to produce 
IgE and develop immediate type skin tests to mould, pollen, 
house dust, mite and animal dander upon challenge are defined 
as atopic. About 10-20% of the population are considered 
atopic and of these 1-5% have asthmatic symptoms (Turner- 
Warwick, 1982). Therefore, only a proportion of those 
exposed to an allergen will develop asthma. This variation 
in responsiveness of the human population to inhaled 
materials serves to complicate the development of appropriate 
animal models for assessing the allergenicity of inhaled 
materials.
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In addition to a genetic predisposition to produce IgE 
other extraneous factors may also influence the development 
of sensitivity. Factors responsible for an individual's 
susceptibility to develop occupational asthma have been 
investigated in a number of work places. The incidence of 
asthma will depend in part upon the nature of the allergen 
concerned, for example, asthma to laboratory animal allergens 
can vary from 3 to 30% depending upon the particular species 
involved, whilst a 60% incidence has been observed associated 
with the manufacture of bacterial enzymes isolated from B. 
subtilis (Chan-Yeung & Lam, 1986). Similarly for low 
molecular weight materials the incidence of occupational 
asthma varies from levels of 3% for wood dusts to 38 and 57% 
for the isocyanates and platinum industries respectively 
(Chan-Yeung & Lam, 1986).
In some situations smoking has been shown to increase 
the risk of sensitisation, particularly in workers exposed to 
epoxy resin curing agents such as tetrachlorophthalic 
anhydride (Venables et al., 1985) and by platinum salts 
(Venables et al., 1989). In these studies there was found to 
be a stronger correlation with smoking and the development of 
occupational asthma than with atopy. Results from recent 
studies by Finnegan et al. (1991) indicate that smoking 
exerts an enhancing effect on IgE and an inhibitory effect on 
IgG production in adults exposed to novel antigens in the 
work place. This may be related to the observation that 
chemicals within cigarette smoke can act as immunomodulators 
(Francus et al., 1989), or to enhanced uptake of antigen
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across the respiratory mucosa due to damage induced by 
cigarette smoke.
The role of respiratory infections on the development of 
asthma is uncertain. Exposure of mice to aerosols of 
ovalbumin during an acute influenza infection was found not 
to lead to the development of IgE tolerance that would have 
been expected under normal conditions (Holt, 1988).
Bacterial adjuvants such as Freunds complete adjuvant and B. 
pertussis are routinely used as adjuvants, but only the B. 
pertussis directs the immune response toward production of 
the IgE isotype. Therefore the impact of a respiratory 
infection on induction of respiratory allergy may not be 
confined to the changes in the respiratory mucosa, but also 
be dependent on the characteristics of the particular 
organism involved.
1.4 RESPIRATORY IMMUNE SYSTEM
The site of deposition of material within the lung, will 
depend upon the aerodynamic properties of the particles 
within the aerosol and the lung physiology of the 
experimental species, and may prove to be a critical factor 
in determining the nature of the immune response produced 
(Chapter 6). The majority of inhaled particulates impinging 
on the airways of the lung are efficiently removed by normal 
clearance mechanisms, such as mucocilliary transport, 
dissolution of soluble particles and macrophage phagocytosis 
(Schlesinger, 1989), and hence fail to gain access to the 
pulmonary lymphatic drainage. Soluble substances on the 
mucosal surface, such as immunoglobulin A and digestive
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enzymes, bind, neutralise and degrade inhaled materials 
preventing their penetration of the mucosa (Kaltreider,
1984).
The lung associated lymphoid nodes function as effective 
filters to remove particulate antigen cleared from the lower 
respiratory tract via the lymphatics. Antibodies produced in 
these nodes are released into the blood, providing systemic 
immune protection. Lymphoid tissues that do not drain the 
lung are not normally involved in the production of immunity 
after lung immunisation. However, following inhalation 
exposure to large quantities of antigen, antibody producing 
cells can be detected in the spleen (Bice & Shopp, 1988).
The alveolar macrophage plays an important role in 
clearance, uptake and degradation of inhaled particulates 
reaching the alveolar space. Unlike those present at other 
sites the vast majority of alveolar macrophages lack the la 
surface antigen, indicating that they do not perform as 
antigen presenting cells in the induction of immune responses 
(Simecka et ai., 1986). However, pulmonary dendritic cells, 
which are bone marrow derived leukocytes that constitutively 
express la on their surface, have been shown to have potent 
accessory functions (Rochester, 1987). Populations of 
dendritic cells have been identified within the tracheal 
epithelium and alveolar septal wall of rat lung, intimately 
associated with heterogeneous staining populations of 
macrophages (Holt & Schon-Hegrad, 1987). In addition 
populations of lymphocytes were identified within the 
alveolar spaces and parenchyma. Therefore, distributed at 
various sites within the respiratory tract are the cellular
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elements necessary for the development and regulation of 
immune responses to inhaled antigen. The precise 
interactions that may occur between inhaled materials and the 
various populations of cells within the lung are as yet not 
clearly understood.
1.5. MECHANISMS INVOLVED IN THE INDUCTION OF ASTHMA
1.5.1. Immunological mechanisms
The immunological mechanisms involved in the development of 
hypersensitivity responses to allergens have been classified 
into four main types by Coombs & Cell, (1963) and are shown 
in Table 1.3.
Table 1.3. Classification of hypersensitivity reactions according 
to Coombs and Gell (1975) as related to inhaled materials
Type Terminology Mechanism Symptoms
I Anaphylactic 
IgE antibody 
mediated
Degranulation of IgE 
sensitised mast cells
Immediate symptoms occurring 
within minutes, asthma, 
rhinitis and conjunctivitis
II Cytotoxic Antibody directed 
against modified host 
cells, resulting in 
cell damage or 
destruction
Anaemia
,
III Immune complex Immune complexes induce 
inflammation through 
activation of complement 
and platelet aggregation
Delayed asthmatic symptoms 
4-8 hours post exposure 
accompanied by systemic 
symptoms of fever, dysnopea 
chills and malaise
IV Delayed cell 
mediated
Sensitised lymphocytes 
stimulation by antigen 
resulting in tissue 
damage
Presence of sensitised 
lymphocytes demonstrated 
in some asthmas
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Following this classification allergic asthma occurs in 
"sensitised" individuals who possess antigen-specific 
reaginic (IgE) antibodies, and in the lung is characterised 
by immediate-onset asthma following inhalation challenge with 
antigen, and also by a wheal and flare reaction when the 
antigen is inoculated intradermally into the skin.
The IgE antibody binds to specific high affinity epsilon 
Fc receptors present on the surface of mast cells and 
basophils. Mast cells are distributed throughout the 
respiratory tract, and can be found in the alveolar septa and 
in the bronchial lumen, localised in the mucosa and 
connective tissues, beneath the basement membrane of the 
airways, near blood vessels, and scattered throughout the 
muscle bundles (Friedman & Kaliner, 1987).
When "sensitised" mast cells come into contact with 
specific allergen they are stimulated to degranulate, 
resulting in the release of an array of pharmacologically 
active mediators. This reagin-dependent degranulation is 
initiated by bridging or cross-linking of cell bound IgE 
molecules by inter-reaction with specific divalent allergen 
(Ishizaka, 1978). This produces changes within the cell 
membrane which are associated with increased energy dependent 
entry of calcium, alterations in phospholipid metabolism, and 
increases in cyclic AMP. The perigranular membranes fuse 
with each other and then with the cell membrane allowing 
extrusion of the granules (Ishizaka et al., 1987).
Mast cell granules contain preformed low molecular 
weight mediators such as histamine (serotonin also released
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in rodents) that are released immediately following 
stimulation. Newly generated membrane derived mediators such 
as the prostaglandins (PG) are also released immediately, 
whilst the leukotrienes (LT) are released within minutes of 
stimulation (Rock et al., 1990). Airway narrowing is due to 
constriction of the smooth muscle of the airways, oedema of 
the submucosa and occlusion of the lumen of the airways by 
mucus, cells and debris. These mediators are responsible for 
the bronchoconstriction, increases in vascular permeability 
cellular infiltrates and other processes that give rise to 
the symptoms of immediate- and late-onset asthma.
The mediators that correlate with the presence of mast 
cells in bronchoalveolar lavage fluid following antigen 
challenge are histamine and PGDg (Flint et al., 1985), 
suggesting that other mediators present are released, in 
part, by other cell types. Sub-populations of eosinophils, 
neutrophils, macrophages, lymphocytes and platelets have been 
shown to possess low affinity IgE Fc receptors on their 
surfaces (Capron et al., 1986; Spiegelberg et al., 1984), and 
are therefore available to participate in Type I reaginic 
responses. Arachadonic acid derived mediators such as LTC4 
are also produced by inflammatory cells present in the 
bronchial wall in chronic asthma, hence the activities of 
many cells have been implicated in the pathogenesis of 
mucosal inflammation in chronic asthma. However, a 
characteristic of asthma is the presence of eosinophils in 
tissue and in bronchoalveolar lavage samples following 
antigen challenge (Demonchy et al., 1985; Metsger et al., 
1987). Eosinophils produce quantities of LTC^ and other
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leukotrienes, suggesting that they may be associated with the 
late phase respiratory responses. In addition, they also 
contain cationic granular proteins, such as major basic 
protein (MBP) which are involved in tissue damage. Since MBP 
has been demonstrated in tissues and lavage samples from 
asthmatics but not from normal individuals it has been 
proposed that they are directly responsible for the 
epithelial damage observed in asthma (Kay et ai., 1987).
Although the IgE-mediated hypersensitivity response is 
identified as the primary mechanism involved in the induction 
of occupational asthma, inhalation of some materials triggers] 
the development of other types of hypersensitivity responses 
(Table 1.3). These mechanisms are not mutually exclusive, 
for it is unusual to identify IgE antibodies without also 
observing antibodies of other classes, and similarly the 
presence of sensitised T cells is accompanied by the presence 
of antibodies.
1.5.2 Non-immunological mechanisms 
Bronchoconstriction can also be induced by non- 
immunologically specific mechanisms, through either direct 
stimulation of mast cell degranulation, or stimulation of the 
smooth muscle or nerve endings within the respiratory tract. 
Materials that act directly on the mast cell such as the 
complement components C3a and C5a are termed anaphylatoxins. 
Inhalation of materials such as acrolein, formaldehyde, 
sulphur dioxide, sulphuric acid mist and histamine have been 
reported to increase airway resistance in experimental 
animals. Both reflex bronchoconstriction as well as a direct
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effect on the airway smooth muscle have been suggested as 
mechanisms for this response (Alarie, 1973).
Maintenance of bronchial smooth muscle tone is a balance 
between constriction of the airways produced by stimulation 
of the muscarinic cholinergic receptor, the a-adrenoceptor 
and the non-adrenergic non-cholinergic neurokinin receptor, 
and dilation produced through stimulation of the B-adrenergic 
and the vasointestinal peptide receptor on smooth muscle 
(Barnes, 1990). In normal individuals autonomic stimulation 
via the B-adrenergic pathway is balanced by opposing 
a-adrenergic and/or cholinergic responses. In persons with 
asthma this relationship may be disturbed and manifested by 
a-adrenergic or cholinergic hyper-responsiveness, or by 
B-adrenergic ! hypo-responsiveness (Lemanske & Kaliner, 1990), 
and can be demonstrated by the increased responsiveness to 
methacholine. This raises the question as to whether 
bronchial hyper-reactivity is a predisposing factor for 
occupational asthma or whether it occurs as a consequence of 
the disease. However, from the work of Lam et al. (1979) it 
appears that non-specific bronchial irritability develops 
after the airways become sensitive to a specific agent.
In addition to regulation of smooth muscle tone, the 
autonomic nervous system controls many aspects of airway 
function. It is known to influence secretion of mucus from 
submucosal glands, transport of fluid across airway 
epithelium, permeability and blood flow in the bronchial 
circulation and release of mediators from mast cells and 
other inflammatory cells (Barnes, 1990) and therefore may 
play a critical role in the development of asthma.
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It is important that experimental models can clearly 
distinguish between reaginic antibody-mediated asthmatic 
symptoms and those induced by other mechanisms.
1.5.3. Mechanisms involved in induction of some 
occupational asthmas
Agents which induce occupational sensitisation comprise a
diverse group of substances (Tables 1.1 and 1.2) with greatly
differing size and chemical reactivities, which depending
upon the their inherent properties can induce airway
reactivity by a variety of the above mechanisms. The onset
of respiratory symptoms in sensitised individuals can follow
three different patterns, an immediate reaction that occurs
within minutes of exposure to allergen, a late response which
occurs several hours after exposure to the allergen and a
dual reaction where an immediate response precedes a late
reaction (Butcher, 1989).
The presence of immediate and non-immediate
respiratory responses, together with positive skin prick
tests, indicative of a type I hypersensitivity response,
occur following exposure to materials such as the platinum
et al.
salts (Pepys, 1983) and reactive dyes (Docker^ 1987).
Respiratory sensitivity to TDl is confirmed in most
individuals by inhalation challenge which can induce
immediate, late or dual responses. In some studies the
presence of TDI-specific IgE has been demonstrated in a
ft al.
proportion of sensitive individuals (Karol/ 1978a; Cvitanovic
et al., 1989), whereas in others this has not been found to
i  et al.
be the case (Danks( 1981). Therefore, due to the lack of
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correlation between TDI-specific antibody and respiratory 
symptoms it has been suggested that TDl has a direct effect 
on the maintenance of airway tone, which is supported by the 
fact that in vitro studies have demonstrated an alteration in 
B-adrenergic activity (Borm et al., 1989).
Cobalt is one of the major constituents of "hard metal" 
alloys, and some workers with "hard metal" asthma possess 
cobalt-specific IgE antibodies (Shirakawa et al., 1988), 
whilst cobalt-sensitised lymphocytes can be detected in 
others (Kusaka et al., 1989). There are however, individuals 
in whom neither cobalt-specific IgE nor cobalt-sensitised 
lymphocytes can be demonstrated, indicating that other 
underlying mechanisms are active in this asthma.
In other instances, neither the presence of reaginic 
antibody nor the development of positive skin tests can be
established. For example,!bronchoprovocation tests have 
identified the pine resin (colophony) component of non- 
corrosive fluxes as the cause of asthma in the electronics 
industry (Fawcet et al., 1976), yet no colophony-specific 
antibody or skin tests are present (Burge, 1981).
The mechanisms involved in the induction of asthma 
following exposure to highly reactive materials such as 
trimellitic anhydride (TMA) are complex. Apart from a direct 
irritant effect, TMA can give rise to variety of symptoms 
some of which involve elements of more than one 
hypersensitivity response. In addition to antibody-mediated 
Type I and III hypersensitivity reactions, following exposure 
to high levels of material, haemolytic anaemia can develop 
and sensitised lymphocytes have been demonstrated, which are
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indicative of type II and IV hypersensitivity responses 
respectively (Patterson et al., 1984).
Hypersensitivity pneumonitis or allergic alveolitis 
induced by Type III hypersensitivity responses although 
classically associated with diseases such as farmers lung, 
can also be observed in those exposed to materials such as 
the isocyanates, B. subtilis enzymes and cobalt (Sharma,
1987). Allergic alveolitis is mediated through immune 
complexes formed between antigen and precipitating antibody 
(IgG). However, the presence of antigen-specific IgG 
antibody can also be demonstrated in exposed asymptomatic • 
individuals. This situation also occurs following exposure 
to other respiratory allergens such as the reactive dyes, and 
is an indication of exposure to the allergen.
The above examples of occupational asthma illustrate the 
variety and complexity of the mechanisms involved. The 
designing of animal models to encompass all of these aspects 
of respiratory sensitivity pose many difficulties.
1.6 PREVENTIVE MEASURES
It has been suggested that in order to limit the number 
of susceptible workers, that persons are screened for atopy 
before employment. Studies examining this issue have 
concluded that only in those situations where a high rate of 
occupational asthma occurs would such exclusion be justified 
(Slovak & Hill, 1987).
It has been put forward that occupational asthma is a 
potentially preventable disease, for identification of a 
particular agent as a cause of occupational asthma should
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represent a first step toward prevention of this disease 
(Newman-Taylor, 1980). Studies of agents producing 
occupational asthma are of necessity retrospective, making it 
difficult to identify potential respiratory allergens. 
Awareness of the potential of materials to induce 
occupational asthma and the improvement of industrial 
facilities will serve to reduce the problem. Nevertheless, 
it is still important to have a reliable model for screening 
for potential respiratory allergens within the work place and 
for new materials being introduced into the working 
environment. Not only would this be of value with regard to 
risk assessment and determining the requisite safeguards to 
be taken, but also in influencing the choice of materials 
used.
1.7. PREDICTIVE ANIMAL MODELS
Animal models have given an insight into immune regulation of 
respiratory responses and are of importance in generating 
information related to the prevention and treatment of 
asthma. They have the obvious advantages of encompassing the 
effects of environmental manipulations in genetically similar 
individuals, and also allow a sequential analysis of the 
disease process.
At present however, there are no specific tests to 
identify potential respiratory allergens. Under the section 
for Type I hypersensitivity, the DHSS (1982b) regulations do 
not specifically deal with respiratory allergy, other than to 
indicate that inhalation exposure was an option for both 
sensitisation and challenge. The guinea pig was given as the
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animal of choice, although in special cases the rat could be 
used. It was noted that a variety of procedures were 
available, but none was generally accepted. However, the 
Schultz-Dale reaction (challenge of sensitised guinea pig 
ileum) and the passive cutaneous anaphylaxis assay were 
suggested as methods for determining sensitivity. The United 
States Federal Drug Administration, on the other hand, has 
specified the rat as the animal species preferred for testing 
chemicals and drugs for approval and use by humans, and if 
possible it would be advantageous to perform all assays in a 
single species, which would allow a more integrated 
assessment of an overall risk assessment for test compounds.
The mechanisms involved in the allergic response to a 
chemical are complex and the individual biological activity 
of the causative agent are so variable that to design a 
system to encompass all aspects of respiratory sensitivity 
would be both difficult and expensive.
1.7.1. Development of tolerance
The primary problem in the development of animal models for 
assessing the allergenic potential of materials is the lack 
of an appropriate species that represents the state of atopy 
observed in man. In addition, exposure by the mucosal route 
and by inhalation in rodents has been demonstrated to be 
directed toward the development of tolerance rather than 
sensitisation.
A single inhalation exposure to an aerosol of ovalbumin 
was found to induce IgGl but not IgE antibodies in mice, 
subsequent intraperitoneal challenge with antigen
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demonstrated an IgE class-specific suppression (Fox & 
Siraganian, 1981). The use of repeated exposures to 
ovalbumin aerosols, although inducing transient IgE responses 
in mice, also led to the development of antigen-specific IgE 
tolerance following intraperitoneal challenge (Holt, 1981). 
Similar observations were made in BN rats repeatedly exposed 
to aerosols of ovalbumin (Sedgwick & Holt, 1983). Although 
substantial amounts of material were found to be ingested 
during inhalation exposure, it was determined that this did 
not contribute to the development of tolerance following 
inhalation exposure, as the amount of material required to 
induce tolerance by this route was much lower than that by 
the oral route (Holt, 1983).
Comparison of the induction of IgE tolerance following 
inhalation between high and low IgE responder strains of rat 
showed that low responders were exquisitely sensitive, 
requiring only nanogram quantities of allergen to initiate 
tolerance. Nevertheless, once a state of tolerance has been 
induced following inhalation exposure it may not be absolute, 
for under certain circumstances such as the administration of 
the B cell mitogen LPS together with the intraperitoneal 
antigen challenge, IgE responses were seen to be re-elicited 
(Sedgwick & Holt, 1985).
The above studies show that although it is possible to 
induce reaginic antibody via the inhaled route, development 
of a state of tolerance is the normal outcome. Clearly 
exposure regimens designed specifically for the assessment of 
occupational allergens will need to overcome this problem.
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Animal models for occupational immunological disease due 
to inhalation of simple chemicals have been developed with 
specific objectives in mind. Many of these have been 
designed to investigate the asthmatic state or to answer a 
particular problem related to a specific material rather than 
to produce a general model. The usefulness of any model 
however depends upon the questions asked of it.
1.7.2. Animal models
Animal models used in this area fall into two categories, 
those which have been developed to investigate the mechanisms 
involved in the elicitation of Type I hypersensitivity 
following inhalation challenge, and those that have addressed 
problems related to the induction of respiratory sensitivity 
to a particular material.
With the possible exception of dogs and monkeys, 
experimental animal models do not reflect the atopic state. 
Recently Wegner et al. (1991) utilised the naturally 
occurring respiratory sensitivity of cynomolgus monkeys
(Macaca fascicularis) to Ascaris suum, to investigate airway 
responsiveness. They found that in order to increase airway 
responsiveness multiple inhalation exposures to antigen were 
necessary. Mapp at al. (1985), on the other hand, 
selectively bred dogs for sensitivity to ragweed pollen based 
upon responses to skin challenge. These dogs received doses 
of ragweed antigen following inoculations for distemper.
Those that became sensitised to ragweed were observed to 
develop mild atopic dermatitis around the muzzle and eyes 
during the pollen season. At inhalation challenge
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bronchoconstriction was greater in the ragweed-sensitive 
group. This type of model would be suitable for the study of 
asthma with respect to the pathogenesis and treatment of 
asthma. However, the use of a selective breeding programme 
to develop a model for a single allergen, although providing 
a useful system for the assessment of drugs following antigen 
challenge, may not be advantageous when applied to the 
induction of sensitivity to a variety of inhaled allergens.
Cashner et al. (1980) exposed cynomolgus monkeys {Macaca 
mulatta) to bacterial enzymes present in detergents, 
including B. subtilus enzymes, by repeated inhalation 
exposure. Although precipitating antibodies were detected, 
there was no clear evidence for the presence of enzyme- 
specific IgE. The IgG antibody response was found to be 
related to the level of enzyme used for inhalation and to be 
potentiated by the presence of detergent in the enzyme 
mixture. Determining the dose level to be used is a critical 
factor in the development of an IgE response, and Cashner et 
al. (1980) felt that the reason for the lack of IgE responses 
was due to the fact that the dose levels used in their study 
were much higher than those encountered by factory workers.
Patterson et al. (1983) exposed three dogs to 
concentrations of TDI analogous to the human exposure to 
atmospheric concentrations of 0.02 ppm. Antigen specific 
IgG, IgA and IgM were detected in serum samples, and these 
correlated with the development of respiratory responses. 
Alterations in pulmonary function were also detected in the 
initial exposures before sensitivity had developed which
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would suggest some similarities with the responses observed 
in man.
Apart from the problems associated with a reluctance to 
use the dog as an experimental animal, and the importation or 
breeding of primates, both the dog and monkey are large and 
expensive animals to maintain, and not suited for use in a 
routine safety evaluation programme. Of the small laboratory 
animal species, the guinea pig has in the past been 
extensively used for the study of allergy because, as in man, 
histamine is the main mediator released and it also exhibits 
skin sensitivity to dermal challenge. Although the guinea 
pig undergoes an intense anaphylactic bronchcoconstriction 
the response differs from human allergic asthma in that the 
reaginic immunoglobulin involved is of the IgGl class.
1.7.2.1. Guinea pig models
Many models that use the guinea pig to examine Type I 
hypersensitivity reactions following inhalation challenge 
make use of a respiratory index to assess the severity of the 
respiratory response in order to take into account 
respiratory collapse (Karol, 1978b). Other workers have 
sought to protect guinea pigs from anaphylactic death with 
the use of antihistamines during inhalation challenge.
Ishida et al. (1989) used this approach when examining 
pulmonary responses to repeated inhalation challenge for 
examining whether repeated allergen challenge led to 
increased airway hyper-reactivity or eosinophilia. However, 
several guinea pigs died despite the antihistamine treatment.
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With regard to the development of potential assay 
systems for low molecular weight materials, Karol et al. 
(1978b) induced reaginic antibody and respiratory responses 
in guinea pigs repeatedly exposed to aerosols of either p- 
benzo arsenate and p-tolyl monoisocyanate conjugated to 
ovalbumin. Following this Karol et al. (1980) went on to 
expose guinea pigs to TDI vapour. Although reaginic antibody 
was induced, the inhalation challenge with free material 
failed to elicit respiratory responses.
Based upon previous work Karol et al. (1985) proposed a 
series of experimental protocols to assess high and low 
molecular weight antigens and with regard to both immediate 
and delayed-onset pulmonary sensitivity. The protocol for 
the low molecular weight materials involved exposure for 3 hr 
per day for five days followed by exposure to a material- 
protein conjugate from day 20 onwards. This type of approach 
was used by Botham et al. (1988) for investigating low 
molecular weight materials including TMA. Although reaginic 
antibodies were induced following inhalation exposure to free 
material, respiratory responses were not elicited when 
protein conjugates were used for challenge.
From studies of occupational asthma in man, it is 
apparent that inhaled materials can induce asthma by a 
variety of mechanisms (Section 1.5). In addition to 
assessing the development of antigen-specific IgE, some 
researchers have concentrated upon examining the symptoms 
following inhalation challenge which include not only the 
respiratory responses but the development of febrile 
responses. For example, Thorne and Karol, (1989)
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demonstrated the presence of febrile responses associated 
with the development of late-onset airway responses in 
sensitised guinea pigs following repeated inhalation 
challenge.
Thus the ways in which the guinea pig can be utilised 
for the investigation of immunologically-mediated respiratory 
disease continue to be explored. However, despite the fact 
that it has been used to examine respiratory sensitivity to 
materials as diverse as the isocyanates, formaldehyde, cotton 
dust and enzyme detergents (Karol, 1986; Lee et al., 1984; 
Ellakkani et al., 1984; Thorne et al., 1986, respectively), 
as yet a test system using the guinea pig has not been 
adopted for the assessment of respiratory sensitisers by the 
regulatory authorities.
1.7.2.2. Rat models
The rat has been put forward as the preferred species for the 
risk assessment of drugs and chemicals (Section 1.7). When 
considering its potential as an experimental model for 
immunologically mediated respiratory disease, in contrast to 
the guinea pig but similar to human, the major class of 
reaginic antibody produced in the rat following sensitisation 
is IgE (Stechsculte et al., 1970). In addition, since the 
work of Sedgewick & Holt et al. (1984) indicates that strain 
variations are important in determining the development of 
IgE responses in rats to inhaled antigen, the availability of 
a variety of highly inbred strains, may allow identification 
of an appropriate model for this type of investigation.
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The rat has been used to study the various aspects of 
the pulmonary response following antigen challenge in animals 
sensitised by the intraperitoneal route. The breathing 
patterns following inhalation challenge of sensitised rats 
have been described in anaesthetised (Carswell & Oliver, 1978) 
and subsequently in conscious rats (Holme & Pietuchta, 1981). 
In more detailed studies of the pulmonary response 
Bellofiorre et al. (1987) used the rat to study changes in 
upper and lower airway resistance following antigen 
challenge, whilst Eidelman et al. (1988) demonstrated the 
development of immediate, late and dual changes in airway 
resistance following antigen challenge. More recently 
Sapienza et al. (1991) examined the relationship between 
structural changes in the airways of sensitised BN rats 
following antigen challenge and the response to methacholine. 
The rat has also been used to examine cellular changes 
(Blythe et al., 1986), and alterations in the permeability of 
the tracheal epithelium (Carswell et al., 1987) following 
inhalation challenge. Arising from the above studies the 
respiratory response of the sensitised rat has shown some 
similarities to those observed in man, and may therefore, 
provide a model for examining certain aspects of respiratory 
allergy.
With the development and use of appropriate animal 
models, it may in future be possible to predict which 
chemicals may have the potential to induce human 
immunological disease states, prior to use of such chemicals 
in industry. The value of such animal models will depend
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upon the degree to which they duplicate all or part of the 
human immunological disease.
1.8. OBJECTIVES OF RESEARCH
The primary objective of the present investigations was to 
examine the factors involved in the initiation and modulation 
of respiratory allergy, and to determine if the rat is a 
suitable model for the identification of potential 
respiratory allergens.
1.8.1 Studv design
The following studies focused upon the potential of inhaled 
xenobiotics to induce type I hypersensitivity and immediate 
respiratory responses in the rat. When considering 
respiratory allergens an ideal model should incorporate both 
induction of sensitivity and elicitation of respiratory 
responses by the inhaled route. In the past the use of 
repeated short inhalation exposures have led to the 
development of transient IgE responses in the rat, however 
through manipulation of exposure conditions, the tendency for 
the development of a state of tolerance may be overcome. The 
induction of reaginic antibody following inhalation exposure, 
together with the elicitation of respiratory responses and 
changes in lung cell population post challenge have been 
examined (Chapter 4).
Although both high and low molecular weight materials 
are capable of inducing allergic lung disease, when 
considering occupational asthma, concern lies with the 
identification of low molecular weight materials. The
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factors influencing induction of reaginic antibody and 
respiratory responses following inhalation exposure to low 
molecular weight materials are described in Chapter 5. Since 
the allergenicity of low molecular weight materials is 
generally considered to be mediated through their ability to 
bind to host proteins, hapten-protein conjugates were studied 
in order to provide information upon the allergenicity of 
these materials. In addition intraperitoneal administration 
of antigen was also examined as a means of rendering animals 
sensitive prior to inhalation challenge for the assessment of 
the ability of these materials to elicit respiratory 
responses in sensitised individuals. '
The characteristics of the aerosol used for exposure, 
the dose of antigen received, and the site of deposition 
within the lung may also influence the development of 
sensitivity. Therefore the characteristics of the aerosols 
employed for the induction of reaginic antibody were examined 
with a view to defining the type of aerosol necessary for 
sensitisation in the rat (Chapter 6).
Finally the aim of the investigations described in 
Chapter 8 was to establish a system suitable for both the 
induction of sensitivity and elicitation of respiratory 
response following inhalation challenge, which could be used 
as a routine method for assessing the ability of a variety of 
materials to induce respiratory allergy. This was examined 
with regard to a range of low molecular weight materials.
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CHAPTER 2
General materials and methods
2.1. ANIMALS
Brown Norway (BN) rats (male 6-8 wk old) obtained from Bantin 
and Kingman, (Hull, Humberside, UK) and PVG rats (male 6-8 wk 
old) obtained from Olac 1976, (Bicester, Oxon, UK) were used 
for immunisation procedures; Sprague-Dawley rats (male 6-8 wk 
old) obtained from Olac 1976 were used for analysis of 
reaginic antibody.
They were kept in ventilated, temperature controlled 
rooms. The temperature was between 19-24“C and the relative 
humidity 45-70%. Animals received a nutritionally adequate 
diet (Rat and Mouse No.l expanded) supplied by Special Diet 
Services Ltd., Witham, Essex, UK and mains tap water[which were[ 
freely available.
2.2. IMMUNISATION MATERIAL
Ovalbumin grade II (OA), bovine serum albumin grade V (BSA), 
human serum albumin Grade V (HSA), sheep serum albumin grade 
V (SSA) and penicillin G (Pen) were obtained from Sigma 
Chemical Co., Poole, Dorset, UK. Rat serum (RS) obtained 
from Sera Lab. UK, was freeze dried prior to use. The dyes 
Reactive Orange 14 (R014), Reactive Blue 4 (RB4) and Reactive 
Blue 2 (RB2) were also obtained from Sigma. The Lanasol dyes 
Blue 3R (LB3R), Red 5B (LR5B) and Yellow 4G (LY4G) were 
provided by Dr M. Topping (HSE). Since commercially 
available reactive dyes often contain traces of other 
reactive dyes as a means of providing an exact shade, samples
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of the unshaded dyes Reactive Orange 4 (R04) and Reactive 
Orange 13 (R013) were donated by ICI Dyes Division, UK.
lota-carrageenan (CGN) was used as an adjuvant at a 
concentration of 1 mg/ml in saline. It was prepared by 
heating until the solution became clear.
2.3. PREPARATION OF ANTIGEN-PROTEIN CONJUGATES
2.3.1. Dve conjugates
The methods of conjugation of dye to protein were based upon 
the method of Luczynska and Topping (1986).
2.3.1.1. Method I
To create conditions similar to those where binding to body 
protein could occur during exposure, the conjugation was 
carried out under physiological conditions. Briefly,
125 mg of dye was dissolved in 12.5 ml of phosphate buffered 
saline (PBS) and this was mixed with 500 mg of protein 
dissolved in 12.5 mis of PBS to give 5 mg of dye to 20 mg of 
protein/ml. The reaction mixture was incubated overnight at 
37“C. To obtain conjugates of varying hapten density the 
amount of dye present in the incubation mixture was reduced 
whilst the protein concentration remained constant.
After incubation the mixture was centrifuged to remove 
insoluble material prior to separation on a G25 Sephadex 
column. The protein fraction was collected and dialysed at 
4°C overnight against distilled water, concentrated using
polyethylene glycol (Average M .Wt8000 (PEG)) and freeze 
dried. This method was used for the production of OA, HSA, 
BSA and RS conjugates.
— 34 —
2.3.1.2. Method II
This method was used for the conjugation of rat serum and was 
carried out as described above but at pH 9.6 using 50 mM 
carbonate buffer.
2.3.2. Hexvl isocvanate conjugates
The conjugation method used for hexyl isocyanate was based 
upon that used by Karol et al. (1979). Briefly, 500 mg of 
either OA, BSA or RS were dissolved in 50 mis of 0.05 M boric 
acid -0.05 M KCl - 0.035 M NaOH buffer at pH 9.4. The 
solutions were brought to 0“C in an ice bath and 133 jj.1 of 
hexyl isocyanate was added to the rapidly stirred mixture.
The mixture was stirred at 0“C for 1 hour then brought to 
room temperature before the pH was adjusted to 7.4 using 1 M 
HCl. The conjugation mixtures were then dialysed at 4°C 
against PBS for 48 hours followed by distilled water for a 
further 72 hours, concentrated using PEG and freeze dried.
2.3.3. Penicillin conjugates
The conjugation of penicillin G was carried out based upon 
the method of Lee et al. (1985). Penicillin G was conjugated 
with OA, BSA or RS. The incubation mixture contained 20 mg 
protein and 40 mg penicillin/ml in 0.5 M bicarbonate buffer 
pH 10. The reaction mixtures were incubated at 37“C 
overnight then dialysed against distilled water at 4°C for 2 
days. The preparations were concentrated using PEG and 
freeze dried.
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2.4. ANALYSES OF CONJUGATES
2.4.1. Analysis of dve - protein conjugates 
Standard curves for free dye and dye protein conjugate were 
constructed and read at X max for the relevant unbound dye on 
a Cecil CE272 spectrophotometer. The wavelength was not 
substantially altered by conjugation, and assuming the 
extinction coefficient remained the same for free and unbound 
dye, the amount of dye and protein present on the conjugate 
could be calculated. The number of molecules of dye per 
protein molecule or hapten density was calculated from these 
values.
Hapten /xg dye present/molecular weight of dye
density =  —
/Ltg protein present/molecular weight of protein
2.4.2. Analysis of hexvl isocvanate and penicillin 
conjugates
The determination of degree of substitution of amine groups 
was carried out using the improved 2,4,6-trinitrobenzene- 
sulphonic acid (TNBS) method of Snyder & Sobocinski (1975). 
Dilutions of the conjugate and appropriate protein were made 
up in borate buffer pH 9.3. To 2 ml of the diluted protein 
conjugate 50 /xl of 0.3 M TNBS in borate buffer was added.
The mixture was incubated for 30 mins at room temperature and 
the optical density determined at 420 nm using a Cecil CE272 
spectrophotometer. The percentage loss of amine groups on 
the carrier protein was calculated.
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(OD of protein - OD of conjugate)
100 -   X 100
OD of protein
Analysis of the conjugates revealed a percentage loss of 
amine groups of 18, 41 and 62% for hexylisocyanate-ovalbumin, 
rat serum and bovine serum albumin respectively; and 71, 72 
and 72% for penicillin-ovalbumin, rat serum and bovine serum 
albumin respectively.
2.5. ANTIBODY ANALYSIS
2.5.1. Serum preparation
Blood samples for examination were obtained from the lateral 
tail vein. Once the sample had clotted they were released 
from the side of the tube and left for at least 2 hours for 
the clot to contract. SeraSieve (Hughs and Hughs Ltd, 
Romford, Essex, UK) was layered on top of the sample to a 
depth of approximately 6.5 mm. The samples were then 
centrifuged at 1000 g for 10 minutes, the separated serum was 
decanted off and stored at -20“C.
2.5.2. Passive cutaneous anaohvlaxis fPCA)
Naive (untreated) Sprague Dawley rats were shaved on the back 
and flanks and injected intradermally with 0.1 ml of the sera 
to be tested, the site marked and identified.
Twenty-four hours later each rat was injected 
intravenously with 0.6 ml of challenging antigen (1 mg/ml) 
together with 0.4 ml of Evans blue (2% in saline). After 20- 
30 min the animal was examined for positive responses, which 
appear as a bluing of the skin at the site of injection. To
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allow better evaluation of the response the animal was killed 
by cervical dislocation and the skin reflected. The diameter 
of extravasation of dye at the site of injection was measured 
and the area of dye extravasation (ADE) calculated. In some 
instances where no positive responses were observed the 
challenge procedure was repeated using a second antigen 
before the animal was killed and the skin examined.
2.5.3. ELISA assav
Solutions of antigens 10 jig/ml in 50 mM carbonate buffer 
pH 9.6 were bound to an ELISA plate (M129B Dynatech 
Laboratories Ltd., Billingshurst, Sussex, UK) for 3 hours at 
37“C. Excess antigen or any other material was removed by 
washing after this and each subsequent incubation using 0.5% 
tween 20; 2% BSA in PBS. The plates were then incubated with 
16 /xl/ml goat serum (Seralab, Crawley Down, Sussex, UK) in 
carbonate buffer at 37°C for 1 hour to ensure that all 
binding sites on the surface of the plate had been taken up.
A reference serum, normal rat serum and the sera to be 
examined were diluted 1/125 in PBS and titrated across the 
plate, then incubated overnight at 4°C. This was followed by 
an incubation with 10 jil/ml sheep serum (Serotec Ltd, 
Kidlington, Oxford, UK) in PBS at 37°C to prevent non­
specific binding during the subsequent 1 hour incubation with 
peroxidase-labelled sheep anti-rat IgG Fc antibody (Serotec 
Ltd, Kidlington, Oxford, UK) at room temperature in a light- 
proof chamber. The required concentration of the peroxidase- 
labelled antisera was determined for each batch used. The 
antiserum was diluted to the appropriate concentration in
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0.05% tween 20 in PBS for use. The chromogen O-phenylene 
diamine (1.08 mg/ml in distilled water) together with the 
substrate hydrogen peroxide (1 fil/ml of 20 volumes) to 
develop the colour was placed in the plate and incubated 
until the reference sera colour had fully developed (20-25 
minutes). The reaction was stopped using 0.1 M HCl and the 
optical density of each well read on a Dynatech Mini Reader 
II at 490 nm. The reference serum was included on each plate 
to allow comparison between various plates and day of assay. 
Sera from an ovalbumin and an R014-0A treated animal were 
used as the reference sera. Sera from animals treated with 
the range of dyes were all compared to the response obtained 
with the R014 reference serum.
A non-linear regression was carried out on the reference 
serum and the amount of antigen specific antibody present in 
the test samples calculated as a percentage of the reference 
serum.
2.6 BRONCHOALVEOLAR LAVAGE AND PREPARATION OF CELLS 
Animals were anaesthetised with Sagatal 0.1 ml/100 g (May and 
Baker, Dagenham, Essex, UK) , they were then exsanguinated and 
the thorax opened. The trachea was then exposed and a 
polythene cannula (pp 240 Portex Plastics Ltd, Hythe, Kent, 
UK) with a three-way tap (Baxter Healthcare Ltd., Thetford, 
Norfolk, UK) attached, inserted and secured. Two 10 ml 
syringes were attached to a three-way tap so that fluid could 
easily be introduced and removed from the lungs. The lungs 
were gently inflated with warm saline and after 10 minutes 
the fluid was withdrawn. A further aliquot of saline was
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introduced and withdrawn immediately, this was repeated until 
15 ml of saline had! been used. The lavage fluid was 
collected in plastic round bottomed universal tubes (Gibco 
Europe Ltd, Paisley, UK), centrifuged at 300 g for 20 minutes 
at 4“C the supernatant removed and the cell pellet suspended 
in 2 ml of saline. Total cell number was counted using an 
improved[Neubauer haemocytometer and the concentration 
adjusted to give 0.5 x 10® cells/ml. The diluted cell 
suspensions (100 ul) were placed in the wells of a Shandon 
cytocentrifuge and spun at 1000 rpm for 5 minutes. Slides 
were air dried and stained with either May Grunwald Geimsa or 
Toluidine blue. Differential counts of the cells present 
were determined from 1000 consecutively counted cells. The 
presence of mast cells was confirmed with the Toluidine blue 
stain.
2.7. ATMOSPHERE GENERATION
Throughout these studies various methods and conditions of 
atmosphere generation have been investigated in order to 
improve the response to inhaled antigen. All atmosphere 
generation and animal exposures were carried out within a 
fume cupboard. Clean, dry compressed air was used for 
aerosol generation and atmosphere dilution. Aerosols were 
generated using solutions of material in PBS, and were 
diluted with air before introduction into the exposure 
system. Three types of pneumatic aerosol generator were 
employed - the Gage nebuliser; the system 22 Acorn and Misty 
Ox nebulisers and the modified Liu-Lee nebuliser.
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2.7.1. Gage nebuliser
A concentric glass jet nebuliser together with a size 
selective cyclone form the Gage nebuliser (Gage, 1968). In 
this system there is recirculation of antigen which is held 
within a constant head reservoir connected to the nebuliser 
and a size-selective cyclone (Fig.2.1). Air is passed 
through the nebuliser creating a venturi effect which draws 
the antigen into the atomiser for atomisation and then into 
the size-selective cyclone. Particles greater than 7 /xm are 
removed and excess material collecting within the cyclone 
drained back in to recirculation.
2.7.2. Svstem 22 Acorn and Mistv Ox nebulisers
The Acorn and Misty Ox nebulisers supplied by Medic-Aid, 
Pagham, Sussex, UK, are constructed in plastic. As air is 
passed through the Acorn nebuliser (Fig.2.2) liquid is drawn 
up by capillary action to the concentric jets. The nebulised 
material impacts upon a baffle which allows high velocity 
aerosols to move away from the jet after initial impaction. 
The Misty Ox is used for humidifying oxygen atmospheres for 
patients. The input air supply creates a venturi effect 
across an orifice which draws material through the system for 
nébulisation. The "swirl" effect produced by the offset 
venturi and baffle system ensure the large particles remain 
in the reservoir. The amount of "oxygen" in the atmosphere 
can be regulated, and when the Misty Ox was used for aerosol 
generation it was set at the 40% level.
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Figure 2.2. Acorn nebuliser
Aerosol output
Concave baffle
Precision concentric jets
Reservoir
Feeder fins for return of 
condensed aerosol
Capillary base plate
Inlet for compressed air
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2.7.3. Modified Liu-Lee nebuliser
A modified Liu-Lee nebuliser (Liu and Lee, 1975; Leong et 
al., 1982) was lent by CDE, Porton Down, UK (Fig.2.3). An 
air pressure of 35 psi is required to drive the Liu-Lee 
nebuliser, which provides an output flow rate of 3.2 1/min 
from the nebuliser. This system uses a constant feed of 
solution for nébulisation and does not involve recirculation 
of material.
2.8. EXPOSURE SYSTEM
Aerosols generated using the various systems were passed 
through a diluter to a 16 litre glass exposure chamber with 
ports present for nose only exposure and atmosphere sampling 
(Fig.2.4). The animals were restrained in polycarbonate 
tapered tubes for nose only exposure. Where animals were 
restrained in a plethysmograph for respiratory monitoring an 
exposure chamber with larger ports was used, these animals 
received a head only exposure. Atmospheres were allowed to 
equilibrate prior to exposure. The time taken for an 
atmosphere to reach equilibrium is dependent on the size of 
the chamber and the flow of air through the system. The 
equilibration time was calculated using the equation provided 
by Silver (1946) which calculates the time taken for the 
atmosphere to reach 99% of the desired concentration.
T i m e g g  =
4.605 X volume of chamber (litres) 
Air flow (litres/minute)
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Figure 2.3. Liu Lee nebuliser
Aerosol output
Rubber bung
Diameter 
1/16"^
'O' Ring
Compressed air 35 psi
Diameter
3/8"
0.013" Diameter hole 
(No.80 drill) in 3/8" disc
Liquid fed from 
a syringe pump
Reservoir Condensed aerosol 
waste
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2.9. ATMOSPHERE ANALYSIS
2.9.1. Determination of atmospheric concentration 
Samples of atmospheres were collected using a vacuum onto 
vinyl metrical VMl filters (Gelman Sciences Inc, USA) and 
washed off the filter into a known amount of distilled water, 
For dye and dye-protein conjugates the amount of material 
present was measured directly on a Cecil CE272 
spectrophotometer at the appropriate wavelength; whereas for 
proteins and non-coloured conjugates this was determined 
using the method of Lowry et al. (1951). The concentration 
of material per litre of atmosphere was calculated
material collected 
sample time (min) x sampling rate (1/min)
2.9.2. Determination of aerosol particle size distribution 
Analysis of particle size distribution was carried out using 
an Anderson 1.4 LPM personnel particle sizing sampler 
(Schaffer Instruments, Wantage, Oxfordshire, UK) which is a 
multistage multiorifice cascade impacter (Fig.2.5). The 
atmosphere was divided according to particle size into 
particles >4.7, 4.7-3.3, 3.3-2.2 and 2.2-0.65 /xm and 
collected onto metal plates, particles <0.65 were collected 
onto a filter. Material was washed off the plates and 
filter, and analysed as above. The results for each size 
range were expressed as a percentage of the total amount of 
material collected.
The particle size distribution of some atmospheres were 
examined using the Malvern API aerosizer (Malvern Instrument
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Figure 2.5. Anderson mini sampler
Outlet to vacuum
O' ring
Screw top
I
I
m
Gasket
Filter 0.65 /im 
Stage 4 2.2-0.65 pm
Stage 3 3.3-2.2 pm
Stage 2 4.7-3.3 pm
Stage 1 4.7 pm
Outer casing
Aerosol
deposits
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Ltd, Malvern, Worcestershire, UK). In this system particles 
are measured and counted as they pass through two lazer 
beams. The results of this analysis particle size were 
expressed as the mean geometric diameter.
2.10. MONITORING OF RESPIRATORY PATTERNS
Respiration was monitored by body plethysmography using the 
system developed in Chapter 3. Briefly, animals were 
acclimatised to restraint during the week preceding 
examination. Rats were loaded into the plethysmograph and 
the system checked for leaks. Once the animals had settled 
and an even respiration had been established, recording 
commenced. Pre-exposure (control) readings were made prior 
to exposure to challenge with antigen or mediator. Changes 
in respiratory rate, tidal volume and minute volume were 
expressed as a percentage of the pre-exposure value.
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CHAPTER 3
Development of methodology for assessing respiration in rats 
following inhalation challenge
3.1. INTRODUCTION
In order to provide an animal model to determine the ability 
of materials both to induce and elicit respiratory responses 
it is necessary to assess the respiration of sensitised 
animals during inhalation challenge with specific allergen.
Many techniques for measurement of pulmonary function in 
man require the imposition of force to drive the specific 
test manoeuvres which are performed in co-operation with the 
subject. Forced expiratory volume (FEV) which is defined as 
the volume of gas exhaled, after full inspiration, being as 
rapid and complete as possible, i.e. forced, is most commonly 
used to give a measure of lung function in man. Such co­
operation is not available when assessing the lung function 
of laboratory animals and therefore various methods of 
measuring pressure and air flow change during respiration 
have been devised.
Problems encountered with the measurement of respiratory 
variables in small animals are associated with the extreme 
demands of sensitivity and signal speed required of both 
measuring systems and instrumentation. The types of 
apparatus that can be used for measuring respiratory 
responses in small animals and their performance have been 
described in detail by Mauderly (1989) and with particular 
reference to their use in pulmonary toxicology by Alarie 
(1990).
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Monitoring of spontaneous breathing in small animals can 
be used to yield indices of respiratory rate, tidal volume 
and minute volume as well as the more elaborate measures of 
pulmonary resistance and dynamic compliance. The techniques 
used for pulmonary function tests in rodents and their 
interpretation have been reviewed by Costa (1985). Some 
methods employ the use of general anaesthesia and in some 
instances include the use of muscle relaxants to inhibit 
spontaneous breathing. This type of preparation has been 
employed by Dahlback (1981) for examining the effectiveness 
of various drugs on bronchial hyper-reactivity.
The pressure drop from the intrapleural space to the 
atmospheric end of the nose or mouth is the transpulmonary 
pressure or driving force needed to move air and deform 
(inflate or deflate) the lung. Measurement of intrapleural 
pressure in conscious guinea pigs was first carried out by 
Admur and Mead (1958) using an intrapleural catheter and a 
body plethysmograph. Thus by relating volume and flow rate 
at specific points during the respiratory cycle information 
on the mechanical properties of the lung were obtained. 
Recently this approach was used by Shopp et al. (1987) to 
examine the effect of inhalation of a blowing agent, 
azodicarbonamide, used in the manufacture of expanded foam 
plastics. Measures of pulmonary resistance and dynamic 
compliance were obtained in conscious guinea pigs 
immediately, and at 24 hours after, exposure to the 
azodicarbonamide. Measurement of lung function using these 
invasive techniques has the disadvantage that investigation 
is limited to alterations that occur within a matter of hours
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or days of preparation, and does not allow long term 
sequential measurements to be made.
Repeated monitoring of respiration can be carried out in 
animals whilst anaesthetised using temporary tracheal cannula 
positioned transorally. This procedure was used by Gross et 
al. (1981) to investigate chronic effects of diesel exhaust 
and allowed evaluation of lung function for a period of over 
two years. Up to eighteen different respiratory variables 
were obtained of which only measures of expiratory reserve, 
residual volume, maximum expiratory flow at 40 and 20% of 
vital capacity and the forced expiratory volume in 0.1 
seconds were found to change significantly due to exposure.
Examination of spontaneous breathing in restrained 
unanaesthetised,animals can be carried out using body 
plethysmography, where the volume of air displaced by the 
expansion and contraction of thoracic cavity during breathing 
is measured. Spontaneous breathing in unrestrained animals 
can be carried out using a whole body plethysmography in 
which the subject breaths within a closed chamber.
Respiration is detected by the pressure changes produced due 
to heating and humidification of the inspired air, therefore 
temperature and humidity in such systems have to be carefully 
controlled (Mauderly, 1989; Alarie, 1990). When constant 
ventilation is maintained the whole body plethysmography can 
be used as an exposure chamber, and measures of respiratory 
pattern, rate and tidal volume can be obtained during 
exposure (Karol, 1981). This methodology has also been 
developed further to include the additional use of a head 
chamber and slight restraint to measure inspiratory and
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expiratory air flows (Matijak-Schaper et al. 1983) and the 
examination of respiration during exercise in order to reveal 
defects not apparent during normal breathing (Alarie, 1990).
In the past decade advances have been made towards the 
development of assay systems for evaluating the adverse 
effects of inhaled materials based upon respiratory measures. 
When developing a system it is important to determine which 
particular lung function measurements are most appropriate to 
the problem being addressed, the most suitable method of 
obtaining them, and the interpretation of the observations.
One of the methods found to be of significant predictive 
value both in ranking irritation potency and in determining 
tolerable limits for occupational exposure is that of Alarie 
(1981). This test measures suppression of breathing frequency 
in'unanaesthetised mice when exposed to atmospheres of sensory 
irritants. Inhalation challenge of sensitised animals from a 
variety of species produces a rapid shallow breathing pattern 
which changes to a slow breathing pattern during severe 
responses (Alarie, 1981). Guinea pigs which have been 
sensitised immunologically to an antigen respond to 
inhalation challenge with an increase in respiratory rate, 
and may also go on to develop respiratory collapse. In order 
to provide a system for assessing these respiratory responses 
Karol (1978b) employed a respiratory index which took into 
account both the increase in breathing rate, and the time of 
onset and severity of respiratory collapse. Other 
researchers have set limits for respiratory rate as a means 
of identifying positive responses in the guinea pig. Botham 
et al. (1989), for example, expressed the respiration rate as
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a percentage of the pre-exposure respiration rate and defined 
an increase in rate above 129% as indicative of a moderate 
response and a rate below 71% indicative of a severe 
response. Assessment of the responses of sensitised rats 
following inhalation challenge may prove to be less complex 
since they are characterised by a decrease in breathing 
frequency (Carswell and Oliver, 1978; Piechuta et al., 1979).
The present studies were directed towards the 
development of a system for the detection of immediate 
respiratory responses in spontaneous breathing rats. 
Considerations which influenced the choice of system employed 
were cost, sensitivity and ease of use. The investigations 
were confined to the monitoring of breathing patterns i.e. 
respiratory rate, tidal volume and minute volume, since 
substantial tissue alteration, due to chronic challenge, is 
usually necessary before lung resistance and compliance 
change significantly (Costa, 1985).
3.2. MATERIALS AND METHODS
The plethysmograph and the sensors were fabricated out of 
perspex and were modifications of the designs of Riley and 
Conning (1988). The plethysmograph (Fig.3.1.) consisted of a 
body section with a sliding back stop, a neck section and 
head section. The position of the back stop could be altered 
to accommodate different sized animals. When the back stop 
was secured in position by a compression gland, an air tight 
seal was formed. The neck section was machined so that the 
rubber neck seals could be held in place by "O" rings. Two 
further "O" rings were fitted on the neck section so that
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when assembled an air tight seal was formed between the neck 
and body sections of the apparatus. The double neck seal 
provided a centre portion which could be filled with foam to 
ensure the seal around the animal's neck was maintained, this 
also meant that the neck seal could be less restrictive. The 
rubber for the neck seal needed to be thin and strong with a 
degree of elasticity. Latex sheet grade "s" natural 0.25 mm 
thick from Clough (Croydon) Ltd, UK, was found to be 
suitable. The size of the hole of the neck seal could be 
varied according to the size of the animal. In addition a 
thin polythene collar was placed over the head of the animal 
before fitting of the neck seal to prevent escape from the 
plethysmograph and to protect the delicate neck seal during 
monitoring. The system was modified to allow a "leaks test" 
to be carried out. The rod of the back stop was hollow and 
open to the inside of the plethysmograph, a two-way tap 
(Anachem Ltd) was placed on the end of the rod to allow the 
plethysmograph to be sealed.
The plethysmograph was designed with an open head piece 
and this enabled animals to be exposed directly to 
equilibrated atmospheres, so that comparable atmospheres 
could be used for inhalation challenge. In addition the 
problems that occur with the piping of some atmospheres to 
enclosed head chambers would also be eliminated.
The pressure sensor (Fig.3.2.) consisted of a small pot 
with an inlet port through which pressure changes within the 
plethysmograph were introduced. A tambour (neoprene 40“ soft 
20 thou, from Four D Rubber Company, Heanor, Derbyshire, UK) 
was stretched across the top of the chamber. A bar magnet
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rested on the tambour, and above this was mounted a linear 
Hall effect i.e. (integrated circuit) sensor (RS Components 
Ltd, Corby, Northants, UK Part No. 304-267). The position of 
the sensor was adjusted so that, when the tambour was 
stretched by plus 2 ml of air, the magnet sat approximately 
2 mm away from the sensor. A power source provided the 
current for the sensor which detected changes in magnetic 
flux density. These were registered as changes in voltage.
As the animal breathed the chest wall expanded and 
contracted, it was this movement that produced a change in 
volume within the plethysmograph. This resulted in a 
pressure change within the system which was registered by 
movement of the tambour, which moved the magnet towards and 
away from the linear Hall effect i.e. sensor producing 
fluctuations in magnetic flux density.
An Amstrad computer CP 1512 PC was fitted with the 
computerscope ISC-16 board and attached to a computerscope 
ISC-16 analogue-digital converter (Advanced Instruments Ltd., 
Oxford, UK). The signals from the sensor were sent to an 
analogue-digital converter and from there to the computer 
where data were stored directly onto floppy disc. The 
computerscope program was used for data acquisition, and 
programs were written for calibration of the sensors and 
analysis of the data by F. Lawrence (BIBRA, Carshalton,
Surrey, UK) . The computerscope system was set to sample data 
every 20 /xs, and was used at maximum sensitivity (200 mv) . 
Using the analysis programme breathing patterns could be 
examined, and measures of respiratory rate, tidal volume and 
minute volume calculated for chosen time periods. Repeated
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measurements for specified intervals of time could be made 
for examination of a complete trace over the period of the 
experiment. The data were stored on to disc in a form 
compatible for export in to a spreadsheet (Borlands Quattro, 
Borlands International Inc, Twyford, Berkshire, UK) for 
transformation into percentage of pre-exposure values.
Advantages of the use of the computerised system over 
that of chart recordings are storage, ease of examination and 
analysis of data. In addition animals breathe at different 
rates, which may alter during monitoring, traces can be 
expanded to inspect areas of high respiration rate which 
would otherwise be indecipherable on recorder sheets.
3.2. EXPERIMENTAL
3.2.1. Establishment of a "leaks" test
The system for checking for leaks was carried out to detect 
when a seal had not been formed by the ”0” ring between the 
neck and body sections of the plethysmograph, and the 
presence of loosely fitting or damaged neck seals. To ensure 
that the plethysmograph when assembled| wasj air tight, a 
solid neck seal was placed in the inner seal position, and 
the two-way tap on the back stop opened so that a flow of 
2 1/min could be drawn through the plethysmograph under 
negative pressure. A flow meter was attached to the 
plethysmograph outlet to the sensor; if no leaks were present 
a flow of 2 1/min into the plethysmograph would be 
registered. The system could similarly be checked for leaks 
once an animal was loaded into the plethysmograph. It was 
not possible constantly to monitor for leaks throughout
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exposure, therefore the system was checked at the end of the 
exposure period to ensure the system had remained sealed. It 
was important to establish this fact if tidal volumes were 
required.
3.3.2. Calibration and evaluation of sensors 
The sensors were calibrated from the position at which they 
were attached to the plethysmograph to allow for the effect 
of dead space in the tubing between plethysmograph and 
sensor. Using a three-way tap and a 2 ml syringe each sensor 
was calibrated from plus 2 ml to minus 2 ml of air in 0.4 ml 
increments. Stability and life span of the tambours were 
checked by repeating the calibration over a period of ten 
days. In addition, to determine if the elasticity of the 
tambour altered with work, the calibration was carried out 
after one hour of continuous work provided by an animal 
ventilator. To compare the indicated tidal volumes obtained 
from each sensor, repeated readings were taken using an 
animal ventilator for periods of one minute for each of the 
four sensors in rotation for 12 minutes. In addition, using 
another set of tambours, known volumes of air were introduced 
and withdrawn from the sensors and the values indicated by 
the sensing system compared with the actual volumes. The 
calculation of respiratory rate was similarly checked by 
splitting the signal from the sensor between the computer and 
a chart recorder and comparing the frequency indicated by the 
chart recorder and that calculated by the computer system.
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3.3.3. Effect of restraint upon respiration 
There was always the possibility that the stress of being 
restrained would lead to changes in respiration rate. Brown 
Norway rats were monitored for periods up to 40 minutes 
during exposure to atmospheres of phosphate buffered saline 
(PBS). In some instances, animals were acclimatised to 
restraint during the week preceding examination, using the 
nose only restraining tubes for periods of 20-30 minutes.
3.4. RESULTS
3.4.1. Establishment of a "leaks" test
The methods employed for determining the presence of an 
airtight system before and once the animal was loaded for 
investigation proved to be successful. It was possible to 
establish that the seals within the apparatus, and between 
the apparatus and the animal were air tight, and that they 
were still in place at the end of the period of examination. 
Thus, once the "leaks" test was in place no data were lost 
through reduction or loss of signal.
3.4.2. Calibration and evaluation of sensors
The calibration curves for the four sensors (Fig.3.3.) are a 
mean of the values obtained from five calibrations. The 
standard deviations were low, mostly between 1-2 mV, except 
for sensors 2 and 4 which gave deviations of 5 and 10 mV 
respectively at the plus 2 ml extreme. Calibrations did not 
alter after one hour of continuous work. The shape of 
calibration curve varied for each sensor; this was probably 
due to variations in tambour tension and distances between
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the magnet and the sensor. Repeated tidal volumes obtained 
using an animal ventilator are shown in Fig.3.4. Although 
the indicated tidal volume remained the same for each 
individual sensor, intersensor differences were noted in that 
sensor number three produced a curve substantially different 
from the others. Examination of tidal volumes obtained by 
the introduction of known volumes of air into the sensors 
revealed that accurate values could be obtained between 
volumes of 0.2 and 1.2 mis, and that the variation was less 
than 10% (Fig.3.5.). At volumes above 1.2 ml there was no 
longer a linear relationship between actual volume and that 
detected. However, in practice the tidal volumes obtained 
for the rat were within the linear range of the sensors.
3.4.3. Effect of restraint upon respiration 
Breathing patterns were viewed and adjustments to the 
position of the animal made to improve the signal. Only when 
all the animals had settled down and produced even 
respiratory patterns was monitoring commenced. Animals which 
had not previously been subjected to restraint had a higher 
initial respiration rate, unsettled breathing patterns and 
were more likely to struggle and break the seal resulting in 
loss or reduced signal. Acclimatisation to restraint removed 
this and reduced the time taken to produce steady breathing.
Differences between respiration rates obtained with and 
without acclimatisation are highlighted in Figure 3.6. The 
respiration of unacclimatised animals can be extremely 
irregular, and as in this example take up to 32 minutes 
before becoming settled. An extremely high pre-exposure rate
— 63 —
Figure 3.5. Range of accuracy of sensors
E
o
>
15
TJ
0.4  0.8  1.2 1.6
Syringe volume (ml)
3.2 1
2.8 -
1.6 -
1.2 -
0.8 -
0.4  -
2.0
— 64 —
g ■P
0 (0
k u
(N
>
73 (0
(U
C p
•H 0
(0 %
-P
A c
0
0
Q) u
4J CQ
(0
U 73
Q)
c 10
0 •H
•H ■P
fO
(0 g
k •H
•H t—1
0 ü
in ü
0) (d
p c
<w
0 c
(0
in
d) 73
rH g
0 (d
g
(0 73
X G)
H 10
-H
4J
• (d
VD g• •H
en rH
ü
<U ü
U (d
0
en C
•H (d
L U
(5zlU
<
ü
com
CL
- 2
- 2
_ o
- 2
■ CM
- 2
CM
_ O
aitr
m
- CM
O
o o o oo oo 8
co
LU
mû co
II
I ■
4 O
3 in N in  /  DNiHivaya lo y iN o o  %
— 65 —
can create a false impression of a reduced respiration rate 
following challenge. A gradual decrease in respiration rate 
was apparent in some acclimatised animals, as seen in this 
example. However, respiration was not observed to fall below 
80% of the pre-exposure values during the time period over 
which monitoring of inhalation challenge would take place. 
Introduction of an animal to an atmosphere produced an 
immediate rise in respiration rate which rapidly returned to 
pre-exposure levels.
3.5. DISCUSSION
The respiratory monitoring system was developed in order to 
monitor bronchoconstriction or other changes in respiration 
in rats, occurring as a result of elicitation of Type 1 
immediate hypersensitivity responses. The technique of 
measuring pressure changes in a body plethysmograph was 
employed, and included the use of a double neck seal which 
was less restrictive. When a check for leaks was 
incorporated this proved a reliable system. The performance 
of the rubber tambours used as the means of determining 
pressure changes in the sensor remained constant even after 
prolonged work. Variability between the responses obtained 
at higher tidal volumes was probably due to differences in 
tambour tension, whereas the 10% variation in accuracy was 
within the limits of the linear Hall effect i.e. sensors. 
These observations indicated that this system was suitable 
for measuring pressure changes, as it was accurate over the 
required volume range for the rat, and remained stable over 
the time period of an experiment.
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Although the sensor was calibrated, the size of animal 
being examined varied. Ideally calibration should be carried 
out when the animal is loaded into the plethysmograph, 
however with this system it was not possible, because the 
relationship between actual tidal volume and that detected 
revealed that the sensitivity of the system was reduced at 
the extreme limits of the calibration curve. Hence the 
introduction of volumes for calibration when the animal was 
present in the plethysmograph could not be adequately 
detected. When plethysmography as a technique is used to 
measure tidal volume the values obtained are usually 10% 
greater than the actual volume entering the nose (Mauderly, 
1989). In this system differences in animal size and sensor 
performance were the major contributors toward variance in 
tidal volume values, which did not allow measurement of 
absolute tidal volume. Respiratory rate between animals also 
differed making comparisons difficult. Therefore to 
eliminate all these factors respiratory measurements were 
expressed as a percentage of the pre-exposure period.
Acclimatisation was an important factor in ensuring good 
quality results. It was found that acclimatisation to 
restraint was the important factor reducing background 
movement and the period of time for the animals to settle 
down. The temperament of the rat strain being examined was 
reflected in the acclimatisation time required prior to 
monitoring. The BN strain was more compliant than the PVG 
and took less time to settle down. Studies of respiratory 
patterns of Fischer rats when confined to a nose only 
exposure system was examined by Mauderly (1986) who found
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that rate and minute volume were highest during the first
15 minutes and then declined with confinement time. In the
present system a decline in respiration rate was observed in
some animals reaching 80% of pre-exposure values, which falls
at al
well within the no response limit of 70% suggested by Botham/
(1988) for the guinea pig. It is doubtful whether further
acclimatisation prior to monitoring would eliminate this,
given the continuous decline in respiration over a 6 hr
period described by Mauderly (1986). Even using the
et al.
technique of whole body plethysmography Kar6I^( 1981) found 
that it was necessary to acclimatise guinea pigs overnight 
before accurate data could be obtained within an hour of 
challenge.
A major drawback of the computerscope system was that a
measure of respiratory rate could not be obtained prior to,
or during monitoring, neither could the breathing pattern
traces be viewed during data acquisition. Although the
breathing patterns could be viewed, a measure of rate would
have aided in determining when animals had settled down in
the plethysmograph. A display of respiratory rate and
breathing pattern during challenge would have allowed
responses to be monitored, and, in cases of severe reaction,
challenge terminated. The animals were closely observed
during exposure and this was found not to be necessary. Rats
do not appear to be prone/respiratory collapse during
respiratory hypersensitivity responses, as observed in the
pt al.
guinea pig (Atkinson, 1981; Karolf 1981).
The system measured the rate, tidal volume and allowed 
viewing of respiratory patterns, enabling identification of
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positive responses at challenge. The sensor system was 
accurate within the working range for the rat, providing a 
simple and robust system which was suitable for routine 
evaluation of respiratory responses. For more extensive 
investigation of lung function solid head pieces and the use 
of pneumotachographs could easily be introduced, but new or 
updated programming would be required.
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CHAPTER 4
Investigation of the factors influencing induction of 
reaginic antibodv production bv inhalation in the rat
4.1. INTRODUCTION
The precise conditions which predispose toward and trigger
the development of type I reagin-mediated hypersensitivity
are not wholly understood, but are related to genetic
constitution and hormonal status of the individual together
with environmental factors and the intrinsic allergenic
properties of the material concerned.
In normal circumstances IgE production is delicately
regulated so as to provide adequate protection to the
individual without resulting in damaging inflammatory
reactions. IgE regulation in both man and animals has been ^
& Marcelietti
found to be dominated by suppressive mechanisms (Katzf 1983). 
Studies of the regulation of IgE production following 
inhalation exposure to allergen in mice (Fox and siraganian,
1981; Holt et al., 1981) and rats (Sedgwick and Holt, 1984) 
have also demonstrated the development of suppression of the 
IgE response.
In order to establish an animal model for IgE mediated 
respiratory sensitivity the normal tendency for a state of 
tolerance to be produced in response to inhaled antigen has 
to be overcome. The activity of the immune system is 
dynamic, with surges and declines in antibody synthesis and 
cell proliferation, therefore timing of exposure and 
challenge are of crucial importance in determining the
I (r
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outcome of the immune response. The choice of experimental 
design can also influence the interpretation of results 
obtained, the importance of which was illustrated by Karol 
(1986) when considering how and when to test for sensitivity. 
Two groups of guinea pigs had been exposed by inhalation to 
the same concentration of toluene diisocyante (TDI) and were 
comparable with regard to both pulmonary sensitivity and 
presence of TDI-specific reaginic antibodies. However 
challenging by patch testing either eight or 24 days after 
exposure altered the perception of the results, and to 
different conclusions as to whether the sensitisation 
procedure lead to contact sensitisation. Hence, great care 
must be taken determining the experimental conditions.
Although there are no natural models for the atopic 
state, there exist high IgE responder strains of rats and 
mice. The work of Murphy et al. (1974) who investigated 
reagin synthesis in inbred strains of rats revealed that the
1 Brown Norway (BN) rat was a high IgE responder strain. In
I
I addition, Abadie and Prouvost-Danlon (1980) demonstrated that
i
I the IgE response of BN rats to ovalbumin could be repeatedly
II boosted. The BN rat has also been used to investigate the 
mechanism(s) involved in the regulation of the immune 
response to inhaled materials (Sedgwick and Holt, 1984; Holt 
et al., 1985) and more recently for the investigation of the 
late respiratory responses (Eidelman et al., 1988).
I Formation of reaginic antibody is known to be dependent upon 
the dose of allergen received, with the use of repeated 
injections of low doses of allergen being most favourable 
(Tada, 1972). Similarly repeated exposure to small
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quantities of allergen, ovalbumin, via the respiratory route 
have also been found to be conducive to the formation of 
reaginic antibody (Atkinson, 1981; Sedgwick and Holt, 1984). 
Therefore in these studies it was decided to use the BN
strain of rat and repeated short exposures of antigen.
Since production of IgE antibody in rodents is regulated 
toward tolerance (Katz, 1983) it may be necessary to 
manipulate the immune response to provide the optimum 
condition for reaginic antibody formation. The use of 
adjuvant is a well known tool for the immunologist to enhance 
immune responsiveness either in antibody production or cell- 
mediated immunity. The toxicologist is also familiar with 
the use of adjuvants in the field of contact sensitivity, 
where they are routinely used to increase the number of 
responders or enhance the detection of weak sensitisers.
The list of materials that have adjuvant properties is 
diverse as is their mode of action. It has been postulated 
that certain adjuvants stimulate the production of cellular
factors that direct the immune response toward either IgG or 
IgE production in response to antigen (Ishizaka, 1983). 
Aluminium hydroxide gel and B. pertussis vaccine are known to 
be effective adjuvants for the IgE response, whereas Freunds 
complete adjuvant is effective for the IgG isotype but not 
IgE. Previous work (Nicklin et al. 1985) has shown that the 
sulphated polygalactan carrageenan could act as an adjuvant
for reaginic antibody production, in the PVG rat following 
intraperitoneally administered ovalbumin, and also promote 
secondary responses. Therefore in the current work it was 
decided to investigate the potential of carrageenan to
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influence reaginic antibody production following inhalation 
exposure together with the factor of time of administration
in relation to antigen exposure.
During the initial experiments a high molecular weight 
material which would act as a "complete" antigen was 
required. Ovalbumin was chosen as the test material because 
of its routine use as an experimental allergen and the fact 
that it has been reported as a cause of respiratory allergy 
in the work place (Smith et al., 1987). In addition, unlike 
materials such as the proteolytic enzymes used in the 
detergent and food processing industries it does not possess 
inherent biological activities which might affect 
sensitisation or non-specifically trigger respiratory 
responses.
In man bronchoprovocation tests are used as a means of 
identifying the causative agent in cases of occupational 
asthma. The mechanisms which produce the respiratory 
responses vary from IgE-mediated hypersensitivity induced by, 
for example, green coffee beans to the direct irritant effect 
of sulphur dioxide, whilst some agents such as cotton dust 
produce bronchoconstriction by directly stimulating the 
release of mast cell mediators (Millman, 1988). The present 
study is directed towards a model for Type I immediate 
hypersensitivity, therefore it is important to correlate the 
antibody status to the respiratory symptoms. Alterations in 
respiratory patterns in response to inhaled antigen in 
actively sensitised rats have been reported measured in 
anaesthetised (Carswell and Oliver, 1978) and subsequently in 
conscious rats (Holme and Pietuchta, 1981). More recently
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immediate and late changes in lung resistance have been 
detected in BN rats following antigen challenge (Eidelman et 
al., 1988).
The release of mediators during immediate 
hypersensitivity responses are responsible not only for the 
respiratory symptoms but also the ensuing inflammation which 
is a feature of asthma (Djukanovic et al., 1990). The 
technique of bronchoalveolar lavage samples the epithelial 
surface and is used both in man and experimental animals as a 
tool to assess lung injury, as well as providing a means of 
obtaining cells and fluids for in vitro studies. The 
cellular changes following inhalation challenge will be 
examined using this technique.
In these studies it was decided to investigate the 
potential both to induce and elicit responses via inhalation. 
Experiments were carried out in order to define the exposure 
conditions under which sensitisation via the inhaled route 
could be established, but without inducing a state of 
tolerance.
4.2. EXPERIMENTAL
4.2.1. Induction of reaginic antibodv bv inhalation exposure 
Groups of BN rats were pretreated with either saline or 1 mg 
carrageenan i.p. 7 days prior to nose only exposure to 
atmospheres of 1 and 10 ^g/1 ovalbumin. The animals were 
exposed for 7 minutes on days 0, 7 and 14. The atmospheres 
were generated from 0.1 and 1.0% solutions of ovalbumin in 
PBS using a Gage nebuliser at a flow rate of 8 1/min through 
the atomiser, and 10 1/min of diluting air (Section 2.7.1.).
— 74 —
Serum samples were obtained two days after the second 
exposure and subsequently at weekly intervals (Section
2.5.1.). They were assessed for the presence of anti­
ovalbumin reaginic and IgG antibodies by passive cutaneous 
anaphylaxis ((PCA) Section 2.5.2.) and ELISA assay (Section 
2.5.3.) respectively. When the reaginic response showed a 
decline, the animals were given a further 7 minute exposure 
to ovalbumin in order to induce a secondary response.
4.2.2. Influence of rat strain and adjuvant administration 
on induction of reaginic antibodv bv inhalation exposure 
Using similar exposure conditions as those described above, 
PVG and BN rats were compared for their capacity to produce 
IgE antibody after inhalation exposure and their ability to 
express respiratory responses. Rats were treated with either 
500 ug or 1 mg of carrageenan i.p. 7 days prior to exposure, 
or 500 ug carrageenan i.p. 14 and 7 days prior to exposure to 
atmospheres of 10 jttg/l ovalbumin generated using the Gage 
nebuliser (as above). Animals were bled at weekly intervals 
from day 9 onwards, and their serum assessed for the presence 
of reaginic antibody. Respiratory responses were monitored 
on day 46 following inhalation challenge.
In order to ascertain the nature of the respiratory 
responses observed, PCA-positive rats which had already shown 
respiratory responses (see Chapter 7) were challenged with 
atmospheres of the drug methacholine generated from a 25 or 
50 mg/ml solution using the Liu-Lee nebuliser (Section
2.7.3.). In addition, to establish if the timing and amount 
of carrageenan received could be manipulated to improve the
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number of responders, further groups of 3 to 4 rats were 
treated with 1 mg of carrageenan which was administered prior 
to, or on the same day as inhalation exposure (see Table 
4.4.) .
4.2.3. Examination of the cellular changes occurring 
following inhalation challenge
To examine the cellular response occurring in the lung after 
an immediate respiratory response, bronchoalveolar lavage was 
carried out on sensitised animals after inhalation challenge. 
Brown Norway and PVG rats were injected i.p. with either 
saline or 10 /xg of ovalbumin together with 1 mg of 
carrageenan. They were bled on day 21 and the sera examined 
for the presence of reaginic antibody. Animals were divided 
into groups and respiration monitored during inhalation 
challenge with aerosols of ovalbumin generated from 1% (OA) 
solutions in PBS using the Liu-Lee nebuliser. Bronchoalveolar 
lavage was then carried out at either 1, 2 or 3 hr post 
challenge (Section 2.6.). The lavage cell population was 
counted and differential counts performed. Changes in the 
population of cells within the lung after an immediate 
response to inhaled ovalbumin, may well be superimposed upon 
a generalised response to inhaled particulate. This was 
taken into consideration when the results were examined, the 
effect of sensitisation and time of lavage were analysed 
using a 2 x 3 factorial analysis of variance (Snedicor & 
Cochran, 1967a). Where either of the main effects 
(sensitization or time of lavage) or their interaction was 
significant then this was investigated further using the
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Least Significant Difference test (Snedicor & Cochran,
1967b).
4.3. RESULTS
4.3.1. Induction of reaginic antibody by inhalation exposure 
Frôiü the sixteen animals exposed to’^ atmospheres of either i or 
10 ug/1 ovalbumin in the absence of carrageenan, only four 
developed transient reaginic antibody by day 16 (Table 4.1).
Table 4.1. Induction of reaginic antibodies in Brown Norway rats exposed 
to atmospheres of ovalbumin on days 0, 7 and 14#
OA
(/^ g/1) CGN
Animal
number
ADE mm^
9 16 23 30 37* 44 51 58** 65 72 days
1 ng/l 1.1 0 / 314 \ 50 0 0 0 0 0 0 0
1.2 0 1 113 j 0 0 0 0 0 0 0 0
1.3 0 V sq/ 0 0 0 0 0 0 0 0
1.4 0 V -Q 0 0 0 0 0 0 0 0
10 iug/1 — 1.13 0 0 0 0 0 0 0 0 0
1.14 0 ri54/ 0 0 0 0 0 0 0 0
1.15 0 0 0 0 0 0 0 0 0
• 1.16 0 0 0 0 0 0 0 0 0 0
1 fjg/1 + 1.9 227 201 95 133 113 iTol)227 113 201 227
1.10 0 0 0 0 0 ^0 0 0 0 0
1.11 0 0 0 0 0 0 0 0 0 0
1.12 177 227 314 227 154 177 491 201 255 255
10 ^ug/l + 1.21 314 346 346 201 79 201 284 201 346 227
1.22 0 133 0 0 0 0 0 0 0 0
1.23 0 227 154 201 78 284 573 95 255 255
1.24 707 452 416 346 491 573 573 380 707 416
# = Exposure period 7 minutes; * = Boosted day 42; ** = Boosted day 63
However, the reaginic antibody response in the five out of 
the eight animals pretreated with carrageenan prior to 
exposure to atmospheres of either 1 or 10 ug/1 ovalbumin was 
more sustained and could be detected from day 9 onwards.
These responses had begun to decline in most animals by day 
37, and subsequent inhalation exposure on day 42 succeeded in
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increasing the PCA response. In the group receiving 1 /xg/1 
ovalbumin the PCA response had continued to decrease even 
after this boost exposure and in some animals was 0 on day 
44, however, by day 51 the reaginic antibody response had 
reappeared. The PCA response in animals receiving 10 Mg/1 
ovalbumin on day 42 was raised by day 44. When the PCA 
response was observed to have reached its peak and begun to 
decline, further exposure to ovalbumin served to increase the 
PCA level.
Interestingly, antigen-specific IgG responses were 
present in all animals exposed to atmospheres of ovalbumin 
regardless of carrageenan pretreatment (Table 4.2) indicating 
the development of an immune rather than an allergenic 
response as determined by the presence of reaginic antibody.
Table 4.2. Induction of IgG antibodies in Brown Norway rats exposed to 
atmospheres of ovalbumin on days 0, 7 and 14#
OA
(M9/1) CGN
Animal
number
Percentage of anti-ovalbumin reference serum
9 16 23 30 37* 44 51 58** 65 72 days
1 fig/I 1.1 0 0 7 22 11 30 42 16 29 38
1.2 0 0 2 24 8 27 NT 18 21 36
1.3 0 0 1 26 11 17 52 30 29 26
1.4 0 0 7 8 2 3 11 11 11 23
10 fig/1 — 1.13 0 0 13 30 44 13 NT 38 31 51
1.14 0 2 20 32 22 16 87 80 38 64
1.15 0 2 18 47 36 20 59 59 22 98
1.16 0 2 13 41 23 30 96 69 NT 46
1 fig/1 + 1.9 0 2 13 16 2 7 48 34 41 66
1.10 0 0 7 9 5 8 47 22 15 57
1.11 0 0 8 3 3 5 21 7 28 26
1.12 0 2 14 3 3 5 27 23 32 37
10 fig/1 + 1.21 2 7 17 18 7 13 188 135 67 165
1.22 0 4 17 11 9 11 52 55 26 62
1.23 0 2 28 26 13 14 52 36 70 92
1.24 10 17 65 136 44 34 114 81 105 110
# = Exposure period 7 minutes; *
NT = not tested
= boosted day 42; ** = boosted day 53
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In general terms the IgG response followed a similar pattern 
to that of the reaginic response. However it appeared to 
develop more slowly than the reaginic response, appearing a 
little earlier in the carrageenan pretreated group exposed to 
10 M9/1 ovalbumin.
4.3.2. Influence of rat strain and adjuvant administration 
o^f I
on induction^reaginic antibodv bv inhalation exposure
The effects of differing carrageenan pretreatments are shown
in Table 4.3. Administration of carrageenan either one day
Table 4.3. Effect of time and distribution of the carrageenan fCGNt dose 
on the induction of a reaginic antibodv response to inhaled 
ovalbumin
CGN Ovalbumin Number of animals
responding on day
Total Received Received
received jig on day Route on day 9 23 30
1000 0 IP 0 2/2 2/2 2/2
1000 0 INH 0, 7, 21 0/3 0/3 0/3
1000 0, 7, 14 INK 0, 7, 21 1/4 1/4 1/4
1000 -1 INH 0, 7, 21 0/4 0/4 0/4
500 -7 INH 0, 7, 21 0/4 0/4 0/4
1000 -7 INH 0 0/3 0/3 0/3
1000 -7 INH 0, 7 0/3 2/3 0/3
1000 -7 INH 0, 7, 21 2/4 4/4 3/4
1000 -14, -7 INH 0, 7, 21 3/4 4/4 2/4
IP = Intraperitoneal injection 10 fig ovalbumin 
INK = Inhalation exposure 7 minutes
prior to, or immediately before inhalation exposure (day 0) 
failed to induce reaginic antibody production, whilst 
administration immediately prior to each exposure produced a 
limited response in one out of the four animals examined. 
Pretreatment with 500ug carrageenan 14 and 7 days prior to
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exposure produced responses that were as good as those 
observed following treatment with 1 mg carrageenan 7 days 
prior to exposure. When the 7 day carrageenan pretreatment 
was reduced from 1 mg to 500 fig reaginic antibody was not 
produced.
Experiments which incorporated the variation of 
carrageenan treatment with the use of PVG rats revealed that 
under conditions where the BN reacted to inhaled OA the PVG 
failed to do so (Table 4.4). Inhalation responses were 
characterised by periodic notching within the breathing 
patterns (Fig.4.1). Only those animals from the groups 
pretreated with 1 mg of carrageenan that were PCA-positive 
developed respiratory responses. The respiration results 
could be expressed graphically as a percentage of the pre­
exposure period for respiration rate, tidal volume and minute 
volume. A typical response is shown in Figure 4.2. At the 
start of exposure to ovalbumin the respiration rate increased 
to 140% of the pre-exposure period then rapidly fell to less 
than 60% and gradually returned to normal once the exposure 
ceased. Apart from a small rise in tidal volume at the start 
of exposure tidal volume was unaffected. As might be 
expected the PVG rats which did not produce reaginic antibody 
also failed to develop respiratory responses. From the 
twelve animals challenged with methacholine which had 
previously demonstrated respiratory sensitivity only two 
produced the characteristic periodic breathing pattern 
(Fig.4.3).
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Figure 4.1. Respiration responses obtained during inhalation 
challenge of ovalbumin sensitive Brown Norway rats
An.No.
5.1
Pre­
exposure
exposure
5.5
exposure
5.11
exposure
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Figure 4.2. Graphical representation of respiratory 
responses obtained from a sensitised Brown Norway rat 
exposed to specific allergen
OVALBUMIN CHALLENGE
1 6 0
1 4 0  -
L U
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20 -
EXPOSURE
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Figure 4.3. Inhalation challenge of a sensitised rat 
(Animal No. 43.44) with methacholine
Methacholine atmosphere generated from a 50 mg/ml 
solution using the Liu-Lee nebuliser
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4.3.3. Examination of the cellular changes occurring 
following inhalation challenge
Examination of the bronchoalveolar lavage cell population 
after immediate respiratory responses revealed marked 
differences between the BN and PVG rat strain, despite the 
fact that all animals with reaginic antibody developed 
respiratory responses at challenge. The differential counts 
were converted into absolute counts for each cell type 
present and are shown together with the total cell numbers in 
Tables 4.5 and 4.6 for PVG and BN rats respectively. The 
total number of cells recovered at lavage from PVG rats was 
less than that from BN rats. However, the major difference 
was the presence of eosinophils in the BN rat lung. The 
effect of challenge in sensitised PVG rats did not produce 
any cellular changes.
In the BN however, there was a marked alteration in the 
lavage cell population after inhalation challenge. The 
effect of sensitisation, time of examination and their 
interaction on the lavage cell population were subject to 
statistical evaluation. Inhalation of atmospheres of 
ovalbumin did not alter cell population in control 
(unsensitised) rats, whereas inhalation challenge of 
sensitised rats (Table 4.7) produced a significant rise in 
the total number of cells recovered. The populations of 
multinucleate, macrophage and mast cells were increased. The 
time period between inhalation and lavage influenced the 
total number of cells recovered and produced changes in all 
cell populations except that of eosinophils (Table 4.8).
There were no differences between cell number and type
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Table 4.7. Examination of the effect of sensitisation on 
bronchoalveolar lavage cell population after inhalation 
challenge in the Brown Norway rat
Cell type Treatment
Mean cell _ 
number x 10 Sensitised
Total cell Control 3.84 *
Sensitised 5.28
Multinucleate Control 0.0617 **
Sensitised 0.1178
Macrophage Control 3.55 *
Sensitised 4.81
Mast cells Control 0.0000 ***
Sensitised 0.0037
= P<0.05; ** = P<0.01; *** = P<0.001
Table 4.8. Examination of the effect of time of lavage after 
inhalation challenge in the Brown Norway rat
Cell type Time of lavage
Mean cell , 
number x 10
Time of lavage
2 hr 3 hr
Total cells 1 hr 3.64 * NS
2 hr 6.56 - **
3 hr 3.91 -
Multinucleate 1 hr 0.0576 * * NS
2 hr 0.1414 - *
3 hr 0.0870 -
Macrophage 1 hr 3.41 * * * NS
2 hr 5.83 - **
3 hr 3.69 -
Lymphocyte 1 hr 0.077 * NS
2 hr 0.392 - *
3 hr 0.102 -
Neutrophil 1 hr 0.070 NS NS
2 hr 0.144 - *
3 hr 0.026 - -
Mast cell 1 hr 0.0006 *** NS
2 hr 0.0060 - ***
3 hr 0.0000
* = P <0.05; ** = P <0.01; *** = P <0.001; NS = Not significant
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recovered and 1 and 3 hours, but the neutrophil 2 hr 
population differed from that obtained at 3 hours post 
challenge. When the interaction between sensitisation and 
time of lavage was examined (Table 4.9) it was confirmed 
there was a significant increase in the lavage cell 
population at 2 hours post challenge in sensitised rats. The 
macrophage was the main cell type present in the lavage, and 
although there was an increase in the mast cell population 
they were a small proportion of the cells recovered.
4.4. DISCUSSION
Using repeated short inhalation exposure it was possible to 
induce a transient reaginic antibody response. This was 
consistent with the observations of Sedgwick and Holt (1984) 
that repeated inhalation exposure of BN rats produced 
transient IgE responses followed by systemic tolerance. The 
use of carrageenan as an adjuvant served to induce a 
sustained response and prevent the development of tolerance. 
Administration of at least 1 mg of carrageenan with ovalbumin 
was required to induce reagin production and the optimum time 
for administration was found to be 7 to 14 days prior to 
inhalation exposure.
The presence of reaginic antibody was related to 
the elicitation of respiratory responses. The breathing 
patterns observed were similar to those described by Holme 
and Piechuta (1981) in conscious animals and which they 
classified as apnoea. Challenge of PCA positive animals 
previously exhibiting respiratory symptoms with the drug 
methacholine produced a similar periodic notching of the
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breathing pattern in a limited number of animals. This suggests 
that the periodic breathing pattern is related to constriction 
of smooth muscle.
Immediate respiratory responses obtained at inhalation 
challenge of parenterally sensitised rats were followed by 
increases in the bronchoalveolar lavage cell population in the 
BN strain alone, which was due to a transient influx of 
macrophages. This occurred despite the fact that both strains 
of rat developed antigen-mediated immediate respiratory 
responses consistent with their antibody status. The rapid 
onset of respiratory symptoms in sensitised animals was due to 
reagin-mediated degranulation of mast cells (Friedman and 
Kaliner, 1987). Although highly significant, the number of mast 
cells counted was low compared to other cell types, and their 
presence in PVG and control BN populations may not have been 
detected. Increased levels of mast cells have also been 
detected in fibreoptic biopsy specimens from asthmatics by 
Lozewicz et al. (1988) and the number of mast cells present has 
been shown to be correlated to the severity of the disease 
(Flint et ai., 1985). The absence of mast cells 3 hr post 
challenge may have been due to degranulation.
The major difference between BN and PVG bronchoalveolar 
lavage cell population in control animals was the presence of 
the eosinophil in the BN strain. Peripheral blood and sputum
jeosinophilia'often accompany both allergic and non-allergic 
asthma (Djukanovic et ai., 1990), yet in this series of 
experiments the eosinophil population remained constant. 
DeMonchy et ai. (1985) examined bronchoalveolar lavage samples 
from asthmatics with immediate responses and those with dual
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responses within 2-3 hr of antigen challenge and demonstrated 
that the presence of eosinophils was a feature of the late phase 
response. Similarly Metzger et al. (1987) demonstrated the 
presence of eosinophils, neutrophils and helper T cells in 
bronchoalveolar lavage samples 48 hr post challenge. The late 
response in Sprague Dawley rats has been shown to be 
characterised by the presence of neutrophils (Blythe et al.,
1986), whereas in the guinea pig, which under normal conditions 
can have up to 12% eosinophils present in lavage samples 
(Warheit 1989) , the late response is characterised by an 
eosinophil infiltrate (Gulbenkin et al., 1990). It would be of 
interest, therefore, to determine if the late phase cellular 
response of the BN rat, which also has a population of lung 
eosinophils, is characterised by either a neutrophilic or 
eosinophilic infiltrate. Studies by Eidelman et al. (1988) 
using anaesthetised BN rats have demonstrated changes in lung 
resistance occurring during the late response, thus it may also 
be possible to correlate the cellular changes observed with the 
onset of late respiratory responses in the spontaneously 
breathing conscious animal.
The lymphocyte population was also increased at the 2 hr 
time point and it is open to speculation as to whether these 
were activated T cells secreting lymphokines that were 
responsible for attracting the macrophages into the lung lumen 
and ensuring they remained at the site of inflammation. Both 
eosinophil and the macrophage express low affinity IgE receptors 
on their surface, and are therefore available to participate in 
the IgE mediated responses and may play a role in the initiation 
of the cellular changes observed. Activation of macrophages
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from asthmatic patients has been demonstrated after in vitro 
culture with antigen (Tonnel et al., 1983). In addition 
macrophage products include a factor chemotactic for eosinophils 
as has been described previously (Gosset et al., 1984).
Although the PVG rat is capable of producing good reaginic 
responses to antigen administration by the intraperitoneal 
route, this was not so after inhalation exposure. Neither were 
any cellular changes initiated after inhalation responses. The 
BN, therefore, proved to be the most appropriate strain for 
examining respiratory allergy.
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CHAPTER 5
Investigation of the factors influencing the induction of 
reaginic antibodv to low molecular weight materials bv 
inhalation
5.1. INTRODUCTION
The use of low molecular weight materials in industry has 
been shown to lead to the development respiratory allergy in 
certain individuals. The problem of assessing the potential 
allergenicity of this type of material is associated with the 
fact that to be recognised by the immune system they need to 
be presented conjugated to protein as haptens. In its 
strictest sense the term hapten can be taken to designate any 
substance which does not induce an immune response, but when 
presented as a conjugate with an appropriate carrier can be 
recognised as immunogenic.
Model systems for examining the conditions for inducing 
sensitivity in vivo have indicated the importance of the 
formation of hapten-carrier complexes. Murdock and Pepys 
(1984) using a rat model for examining the allergenicity of 
platinum salts failed to detect IgE antibody after 
immunisation with free salts. However, when administered 
conjugated to an ovalbumin carrier, together with the 
adjuvant Bordetella pertussis, platinum-specific IgE 
responses could be elicited.
Using the inhalation exposure conditions employed in 
Chapter 4 experiments were carried out to determine if
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reaginic responses could be induced by inhalation exposure 
against selected low molecular weight materials bound to 
protein. One of the range of reactive dyes examined in 
Chapter 7, reactive orange 14, was selected for these 
experiments because it had been reported as being highly 
allergenic (Howe, 1986). Similarly penicillin was included 
for examination because this class of compounds has been 
identified as a cause of occupational asthma during 
manufacture (Davies, et al., 1974).
An allergic response directed against the hapten portion 
of a conjugate can be elicited using the free hapten for 
challenge. However, the use of hapten-protein conjugates as 
target antigens for the measurement of serum hapten-specific 
antibody has been found to provide a more accurate system of 
assessment. Luczynska and Topping (1986) developed a RAST 
test for the detection of IgE directed against the reactive 
dyes. They found that the use of free dye did not correlate 
well with workers symptoms, but did reflect the level of 
total IgE present in exposed and unexposed individuals, 
whereas the use of dye-HSA conjugates was found to detect 
dye-specific IgE in only those individuals with symptoms 
associated with dye exposure.
The form of the hapten-protein conjugate is also an
important factor in determining whether antigen-specific
et al.
antibodies can be detected. Karol''(1978a) demonstrated the 
presence of antigen-specific IgE antibody in serum from 
toluene diisocyanate (TDI) sensitive workers by using a
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p-tolyl-monoisocyanate-protein antigen, and since has 
demonstrated reactivity to other forms of tolyl- 
monoisocyanate conjugates (KaroT, 1980). Banks et al.
(1981) subsequently examined the use of tolyl-monoisocyanate- 
protein conjugate as a means of detecting anti-TDI antibody 
but did not find any evidence for the presence of antigen- 
specific IgE in serum from TDI exposed patients. The problem 
of detecting these antibodies was further investigated by Jin 
and Karol (1989) in guinea pigs exposed to TDI. The 
detection of IgE antibody responses was found to be dependent 
upon the composition of the challenge antigen, in that the 
highest titres of antigen-specific antibody were obtained 
using hapten conjugates with a high TDI density. This 
observation may explain some of the differences in the 
results obtained during the investigations of IgE antibody 
profiles in individuals exposed to TDI. Such results confirm 
the importance of the factors of hapten density and conjugate 
quality in the detection of hapten-specific antibody.
The type of protein used as a carrier also plays an
important role in determining the allergenicity of conjugates
used in experimental systems. The antibody response to the
hapten di-nitrophenol (DNP) in mice and guinea pigs has been
shown to be dependent upon the carrier protein employed 
et al.
(Leskowitz( 1972). It would appear that the more foreign 
(immunogenic) a carrier protein is to the species being used, 
the higher the hapten antibody response is likely to be.
When materials bind to protein they may alter the
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response to both the carrier protein and the hapten portion 
of the conjugate. In addition to enhancing immune 
recognition, formation of hapten-conjugates or modification 
of proteins can also alter the specificity of the response as 
well as reducing allergenicity. There is evidence that 
modification of proteins by either méthylation, acétylation 
or succinylation can reduce the humoral antibody response 
against native determinants and induce antibody responses 
against new antigenic determinants on these modified 
molecules (Shirrmacher and Wigzel, 1974).
Conjugation with a non-proteinaceous carrier can inhibit 
antibody responses to that material. Modification of 
ovalbumin with polyethylene glycol has been found to reduce 
its allergenicity, with regard to induction of primary 
responses and secondary responses in pre-sensitised animals 
(Sehon, 1983). Similarly Wei et al. (1986) showed that the 
binding of trimellitic anhydride to polyvinyl alcohol 
suppressed the induction of both the primary and secondary 
anti-hapten responses in pre-sensitised animals.
The formation of hapten-protein conjugates in vivo may 
occur with various elements within the respiratory 
epithelium. The most likely candidate available for binding 
is serum albumin which is a normal constituent of lung 
secretions and comprises 30% of the total protein recovered 
from lung lavage fluid (Young and Reynolds, 1984). Sarlo and 
Clark (1989) observed that antibodies to self protein were 
present in the sera from TDI-exposed guinea pigs, and
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suggested that low molecular weight materials acting as 
haptens could induce an immune response to self protein. As 
a non-mammalian protein, ovalbumin should provide a good 
carrier protein for the low molecular weight materials to be 
examined, however, the use of self protein (rat serum) or 
human serum albumin may provide a more appropriate carrier 
for this type of work. The efficiency of various protein 
carriers and the importance of hapten density on the 
induction of IgE responses was examined, after both 
inhalation and parenteral exposure, with a view to enhancing 
the anti-hapten response and reducing the carrier response.
Alterations in the permeability of the respiratory
mucosal barrier may also influence the development of
sensitivity. Increased permeability of the gastrointestinal
mucosa following oral antigen challenge of sensitised mice
has been shown to increase the uptake of unrelated or
, et al.
bystander antigen into the circulation (Kleinman/l989). 
Similarly, in the lung, other antigens may gain access across 
the respiratory epithelium during specifically induced 
allergic responses. In this way, hypersensitivity to a 
particular inhaled material may lead to the ingress of 
unrelated antigens and the establishment of allergy to an 
expanding repertoire of respiratory allergens.
Increases in transepithelial transport of horseradish 
peroxidase have been found to occur after antigen induced 
bronchoconstriction (Boucher et al., 1978) and histamine or 
methacholine challenge in the guinea pig (Boucher et al..
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1977). Penetration of the intracellular spaces of the 
tracheal epithelium by the marker lanthanum was found to 
correlate directly to the respiratory responses elicited 
during challenge of DNP sensitised rats (Carswell et al.
1987). These observations would suggest that the potent 
mediators released during allergic responses were responsible 
for changes in respiratory epithelial permeability.
Therefore, pre-exposure to carrier antigen alone prior 
to exposure to hapten-protein conjugate was examined as a 
means of inducing changes in respiratory mucosal permeability 
during responses to the carrier, that may allow better 
recognition of the hapten.
5.2. EXPERIMENTAL
5.2.1. Use of free material to induce reaginic antibodv 
production bv inhalation
The possibility of using dye alone directly for induction of 
sensitivity was examined using a regimen similar to that 
employed by Karol et al. (1985). Aerosols were generated 
from either 0.01% R014 in PBS using the Gage nebuliser 
(section 2.7.1) at a flow rate of 8 1/min with 10 1/min air 
dilution, or from 1% R014 in PBS using the Liu-Lee nebuliser 
(section 2.7.3) with 12 1/min air dilution. Groups of four 
animals were pre-treated with 1 mg carrageenan i.p. 7 days 
prior to inhalation exposure on 5 consecutive days for either 
1 hour using atmospheres generated using the Gage nebuliser 
or for 3 0 minutes using atmospheres generated using the
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Liu-Lee nebuliser. A further five exposures were given from 
days 21 to 25. Animals were bled at weekly intervals and the 
sera assessed for the presence of reaginic antibody (section 
2.5.2) as shown in Table 5.1.
Table 5.1. Protocol for induction of reaginic antibodv 
bv inhalation using free R014
1 mg CGN 
Animal received 
number on day
Aerosol generation Exposure
Nebuliser R014 conc. Duration on days
8.9-12 -7 
46.17-20 -7
Gage
Liu-Lee
0.01%
1.0%
60 min 
30 min
0-5,21-25
0-5,21-25
5.2.2. Use of haoten-protein conjugates to induce reaainic 
antibodv bv inhalation exposure
Sixteen animals were pretreated with 1 mg carrageenan i.p.
7 days prior to exposure to atmospheres generated from 1% 
solutions of Pen-OA in PBS using the Gage nebuliser at a flow 
rate of 8 1/min with 10 1/min diluting air. Animals were 
exposed for 7 minutes on days 0, 7 and 14 and were boosted on 
day 35. The animals were bled at weekly intervals starting 
at day 9 and the sera assessed for the presence of either 
hapten-specific (Pen) using BSA-conjugates or carrier- 
specific (OA) reaginic antibody.
Similarly eight animals were pretreated with 500 /xg 
carrageenan i.p. 14 and 7 days prior to exposure to
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atmospheres of R014-0A generated from a 1% solution in PBS 
using a Gage nebuliser (as above). They were exposed on days 
0, 7 and 14 and boosted on day 42 with R014-BSA. Animals 
were bled weekly from day 9 onwards and the sera assessed for 
the presence of hapten-specific antibody using R014-BSA and 
after the boost exposure R014-HSA.
Six animals were treated parenterally with 10 /xg R014- 
OA together with 1 mg carrageenan to produce reaginic 
antibody. When the animals were PCA positive they were 
challenged by inhalation using aerosols of either R014 or 
R014-BSA (generated from 0.01% and 1.0% solutions in PBS 
respectively using the Gage nebuliser as above) and the 
respiratory responses monitored by whole body 
plethysmography.
5.2.3. Examination of the effect of haoten densitv. carrier 
protein and atmospheric concentration on induction of anti- 
R014 reaginic antibody following inhalation exposure 
In order to optimise the response against the hapten rather 
than the carrier, the effects of altering the amount of 
material received by the animal, and the hapten density of 
the conjugate were both investigated.
Groups of 4 animals were pretreated with 1 mg 
carrageenan i.p. 7 days prior to exposure to atmospheres of 
R014-HSA conjugates with hapten densities of 2:1, 4:1 or 
11:1. The atmospheres were generated using a Gage nebuliser 
at a flow rate of 10 1/min and 8 1/min diluting air using
- 101 -
solutions of either 0.01, 0.1 or 1.0% conjugate in PBS. 
Animals were exposed on day 0, 7 and 14, bled on day 9 and 
subsequently at weekly intervals and the serum assessed for 
the presence of hapten-specific reaginic antibody. In the 
event that no reaginic responses were induced the animals 
were challenged via the intraperitoneal route to determine if 
a state of tolerance had been induced during the inhalation 
exposure.
The use of rat serum (RS) and sheep serum albumin (SSA) 
as carrier proteins for inhalation exposure was assessed. 
Atmospheres were generated (as above) using 1% solutions of 
R014-carrageenan in PBS and administered on days 0, 7 and 14 
to animals pretreated with carrageenan i.p. 7 days prior to 
exposure.
Sixteen animals were pretreated with 1 mg carrageenan 
i.p. 7 days prior to exposure to atmospheres generated from 
1% solutions of Pen-RS in PBS using the Gage nebuliser at a 
flow rate of 8 1/min with 10 1/min diluting air. Animals 
were exposed for 7 minutes/day on days 0, 7 and 14 and were 
boosted on day 35. They were bled at weekly intervals 
starting at day 9 and the sera assessed for the presence of 
hapten-specific (Pen) antibody.
5.2.4. Effect of hapten densitv and carrier protein on the 
induction of hapten-specific reaginic antibodv bv the 
intraperitoneal route
The impact of hapten density was examined by
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intraperitoneal exposure using 10 ug of R014-0A conjugate at 
hapten densities of 2:1, 4:1, 8:1, 10:1 and 16:1 administered 
together with 1 mg carrageenan. The animals were bled at 
weekly intervals and the serum assessed for the presence of 
anti-R014 reaginic antibody. The allergenicity of R014-HSA 
conjugates with hapten densities of 2:1, 4:1 and 11:1 was 
also examined after intraperitoneal administration with 
carrageenan as was the allergenicity of the RB4-0A 5:1 and 
2:1 conjugates.
In addition the effectiveness of rat serum as a carrier 
protein was examined after intraperitoneal administration 
using conjugates produced at pH 9.6 and 10 as well as under 
physiological conditions. In some instances animals received 
a second injection of conjugate and carrageenan on day 14.
5.2.5. Examination of the effect of ore-exoosure to carrier 
proteins on the induction of anti~R014 reaginic antibodv bv 
inhalation
Groups of 4 animals were pretreated with 500 /zg carrageenan 
i.p. either on day -7 and 0 or days -14 and -7 prior to 
exposure to atmospheres of either the OA or HSA carrier 
protein on days 0 and 7. They were then exposed to 
atmospheres of either R014-0A (hapten density 16:1) or R014- 
HSA (hapten density 18:1) using the Gage nebuliser at a flow 
rate of 10 1/min and 8 1/min diluting air on days 14, 21 and 
28. All these atmospheres were generated from 1% solutions 
in PBS except for groups receiving aerosols of the hapten-
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protein conjugates alone which were generated from either 1 
or 0.1% solutions as shown in Table 5.2.
Table 5.2. Protocol (1) for investigating the effect of 
pre-exposure to carrier proteins on the induction 
of reaoinic antibodv bv inhalation
Animal
numbers
CGN* received 
on days
Inhalation exposure
Carrier 
Day 0 and 7
Conjugate 
Day 14, 21 and 28
14.1-4 -7 and 0 OA 1% R014-0A 1%
14.5-8 - R014-0A 1%
14.9-12 - R014-0A 0.1%
14.13-16 HSA 1% R014-HSA 1%
14.17-20 - R014-HSA 1%
14.21-24 - R014-HSA 0.1%
14.25-28 -14 and -7 OA 1% R014-0A 1%
14.29-32 - R014-0A 1%
14.33-36 - R014-0A 0.1%
14.37-40 HSA 1% R014-HSA 1%
14.41-44 - R014-HSA 1%
14.45-48 — R014-HSA 0.1%
* Total received 1 mg i.p.
To determine whether further administration of 
carrageenan was necessary before exposure to the hapten- 
protein conjugate. Groups of 4 animals were pretreated with 
1 mg carrageenan i.p. 7 days prior to exposure to atmospheres 
generated (as above) from 1% solutions of carrier protein 
(OA) in PBS on days 0, 7 and 14. Groups of animals received 
a second carrageenan treatment on either day 21 or 37, which 
was followed by three weekly exposures to atmospheres 
generated from 1% solutions of R014-0A as shown in Table 5.3.
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Table 5.3. Protocol (2) for investigating the effect 
of pre-exposure to carrier proteins on the induction 
of reaginic antibodv bv inhalation
Animal
numbers
1 mg CGN 
received 
on days
Inhalation iexposure
Carrier protein 
OA 1% CGN
Conjugate 
R014-0A 1%
15.1-4 -7 0,7,14 21 28,35,42
15.5-8 -7 0,7,14 - 28,35,42
15.9-12 -7 0,7,14 35 42,49,56
15.13-16 -7 0,7,14 - 42,49,56
5.3. RESULTS
5.3.1. Use of free material to induce reaainic antibodv 
production bv inhalation
Exposure to free R014 by inhalation failed to induce reaginic 
antibody formation at the atmospheric concentrations of 
0.2 /xg/1 and 7.0 /xg/1 produced using the Gage and Liu-Lee 
nebulisers respectively.
5.3.2. Use of hapten protein conjugates to induce reaainic 
antibodv production bv inhalation exposure
Several of the animals exposed to Pen-OA produced reaginic 
antibody (Table 5.4). The penicillin-specific response was 
detected in 3/16 animals on day 9 and 5/16 on day 16 whilst 
the carrier response was only present in 7/16 animals on
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day 9. The animal that expressed only an anti-penicillin 
response was the one animal that subsequently went on to 
produce a secondary response after challenge with Pen-OA 
which could be detected on days 37 and 44. The development
of the carrier response in this animal was delayed appearing
on day 44.
Following the results obtained from exposure to Pen-OA 
it was felt that sustained anti-hapten responses might be 
obtained if carrageenan was administered 14 and 7 days prior
to exposure to aerosols of the R014-0A conjugate. Again the
number of responders was low, 3/8, and these animals produced 
antibody against both R014 and the carrier (Table 5.5). 
However, it was only the carrier response which was 
sustained, at so high a level that for induction of secondary 
anti-R014 responses a different conjugate, R014-BSA, was 
used. The hapten response was boosted in two of the animals 
and was present on day 44 and 51. In addition to the 
ovalbumin carrier response, anti-BSA antibodies could be 
detected 9 days after the R014-BSA exposure.
It was intended that animals responding were to be 
divided into groups for inhalation challenge with either Pen- 
BSA or free Pen. However, there were insufficient responders 
to carry out this part of the experiment.
Inhalation challenge of animals sensitised with R014- 
OA by the intraperitoneal route with either R014 or R014-BSA 
produced the characteristic "notching" breathing pattern.
Only those animals that were PCA positive responded (Table
5.6). The percentage change in respiratory rate is shown in 
Figure 5.1. An approximate 50% decrease in respiratory rate
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Table 5.6. Inhalation challenge of Brown Norway rats treated 
with reactive oranoe-ovalbumin bv intraperitoneal 
administration using either dve alone or protein conjugates
Animal
number
ADE mm^ 
day 21
Day 21 inhalation 
challenge
ADE mm^ 
day 37
Day 38 inhalation 
challenge
Antigen Response Antigen Response
11.1 0 R014 -ve 0 —  —
11.2 154 R014 +ve 227 R014-RS i+ve
11.3 ± R014 -ve 177 R014-RS +ve
11.4 0 R014-BSA -ve 0 —  —
11.5 ± R014-BSA -ve 0 — —
11.6 255 R014-BSA +ve 0 - —
- = not challenged
-ve = negative response
+ve = positive response, periodic notching in breathing pattern observed
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Figure 5.1. Percentage change in respiration rate obtained 
in R014-0A sensitised Brown Norway challenged with 
either R014 or R014-BSA conjugate
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was observed for both the R014 and R014-BSA challenge. The 
maximum reduction in respiratory rate obtained in animals 
challenged using free dye was reached 2 minutes later than 
that produced using the R014 conjugate. Examination of the 
sera after the challenge showed that only animals challenged 
with R014 continued to produce reaginic antibody.
5.3.3. Examination of the effect of hapten densitv. carrier 
protein and atmosphere concentration on induction of reaginic 
antibodv bv inhalation
Use of HSA as the carrier protein did not induce a reaginic 
response when administered via the inhaled route using 
conjugates with a variety of hapten densities and 
concentrations of solutions for atmosphere generation. 
Injection of conjugates to determine the state of tolerance 
revealed that at lower hapten densities responses were induced 
only against the carrier whereas at the higher density of 11:1 
both carrier- and hapten-specific antibodies could be detected 
in animals previously exposed to atmospheres generated from 
0.01 and 0.1% solutions, indicating that inhalation exposure 
in these animals had not induced a state of tolerance (Table
5.7).
Presentation of R014 conjugated to either RS, SSA or HSA, 
or Penicillin conjugated to RS failed to induce reaginic 
antibody formation.
- Ill -
Table 5.7. Examination of the ability of Brown Norway rats 
exposed to atmospheres of R014-HSA at various hapten 
densities to respond to i.p. challenge with R014-HSA
Hapten density
Concentrât ion 
solution
i.p. exposure 
14
10 /jg
21 days
R014-BSA HSA R014-BSA HSA
2.1 0.1% 0/4 0/4 0/4 1/4
0.1% 0/4 3/4 0/4 2/4
1.0% 0/4 0/4 0/4 0/4
4.1. 0.01% 0/4 2/4 0/4 3/4
0.1% 0/4 2/4 0/4 3/4
1.0% 0/4 0/4 0/4 0/4
11.1 0.01% 3/4 3/4 0/4 1/4
0.1% 3/4 3/4 0/4 3/4
1.0% 0/4 0/4 0/4 3/4
Table 5.8. Range of hapten densities produced under varying
conjugation conditions
Hapten density dye : protein
fjg Dye/20 mg of protein ml of PBS in conjugate mixture
Dye Protein 5000 3125 2500 1562 1000 500 50
R014 OA
OA
OA
16.28:1
13.27:1
12.27:1
9.50:1 8.46:1 5.10:1 - 1.60:1
R014 HSA
HSA
HSA
20.28:1
19.64:1
18.25:1
10.80:1 4.81:1 2.11:1 0.25:1
RB4 OA 4.48:1 2.25:1 “ — — “
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5.3.4. Effect of hapten densitv and carrier protein on the 
induction of hapten specific antibodv bv the intraperitoneal 
route
The hapten densities of conjugates produced with a view to 
providing a range of hapten densities are shown in Table 5.8. 
There was some small variation between the levels of hapten 
density produced under the same conditions. There was a 
linear relationship between the concentration of dye in the 
incubation mixture and the amount of dye present on the 
conjugate.
Parenteral administration of R014-0A at various hapten 
densities showed that, even at hapten densities as low as 2:1, 
hapten specific reaginic antibody could be induced 
(Table 5.9). There was a direct relationship between hapten
Table 5.9. Reaginic antibodv responses in BN rats treated with 
reactive orange 14 ovalbumin conjugate at various hapten densities
Number of PCA positive animals
Hapten density 14 21 28 35 42 56 64 (
2:1 4/4 4/4 3/4 2/4 1/4 1/4 1/4
5:1 2/4 2/4 2/4 2/4 2/4 2/4 1/4
8:1 4/4 4/4 4/4 4/4 3/4 3/4 3/4
10:1 4/4 4/4 3/4 3/4 3/4 3/4 3/4
16:1 4/4 4/4 4/4 4/4 4/4 4/4 4/4
density and duration of the response. Conjugates of RB4-0A at 
hapten densities of 5:1 and 2:1 induced reaginic responses in
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Table 5.10. Effect of carrier protein on the development of 
hapten-specific reaginic antibodv
10 /vg antigen 
i.p. Hapten density
Number of animals responding
14 21 28 days
R014-HSA <1:1 0/3 0/3 0/3
R014-HSA 2:1 0/3 0/3 0/3
R014-HSA 4:1 0/3 0/3 0/3
R014-HSA 11:1 0/3 1/3 0/3
R014-HSA 18:1 1/3 1/3 1/3
R014-HSA x2 18:1 2/3 2/3 2/3
R014-SSA NC 0/3 1/3 1/3
R014-RS NC 0/3 0/3 0/4
R014-RS x2 NC 0/3 0/3 0/4
R014-RS (9.6) NC 0/4 0/4 0/4
R04-RS (9.6)x2 NC 0/4 2/4 0/4
Pen-RS (10.0) NC 0/3 0/3 0/3
Pen-RS (10.0)x2 NC 0/3 3/3 3/3
R014-0A 16:1 3/3 3/3 3/3
x2 = i.p. injection on days 0 and 14
Values in brackets indicate pH at which conjugation carried out. 
NC = Hapten density not calculated but conjugation carried out at 
5 mg Dye/20 mg protein/ml.
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3/4 and 4/4 animals respectively. Similar examination of 
SSA,HSA and RS (Table 5.10) showed that these proteins did not 
act as efficient carrier proteins. Sheep serum albumin 
produced an anti-hapten response in 1/3 from day 21 onwards 
and HSA in 1/3 from day 14. A second injection of R014-HSA 
with carrageenan on day 14 served to increase the responders 
to2/3. Rat serum conjugates produced under physiological 
conditions failed to induce anti-R014 reaginic antibody even 
after a second administration on day 14. However, when rat 
serum conjugates produced at pH 9.6 were used, two treatments 
of conjugate together with carrageenan were required to induce 
reaginic antibody which could be detected on day 21. Rat 
serum treated at pH 9.6 did not elicit a positive PCA response 
when used for challenge.
5.3.5. Examination of the effect of pre-exoosure to carrier 
proteins on the induction of anti-R014 reaainic antibodv by 
inhalation
The effect of two exposures of HSA or OA carrier proteins 
prior to the hapten-conjugate produced an initial anti­
ovalbumin response in one animal (No.14.28) on days 16 and 30, 
the area of dye extravation (ADE) measured being 255 and 
277 mm^ respectively, but no anti-R014 response. Increasing 
exposure to carrier to three treatments and the inclusion of a 
second carrageenan treatment prior to exposure to the 
conjugate also failed further to enhance the number of 
responders or produce an anti-hapten response. Anti-ovalbumin 
responses were detected in animals 15.5 on day 9 (ADE ±), 15.3 
on day 16 (ADE 177 mm^) and 15.2 on day 23 (ADE 380 mm^) .
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5.4. DISCUSSION
Factors influencing the induction of reaginic antibody 
following inhalation exposure were examined with a view i  to 
determining the optimal exposure conditions for investigating 
the allergenicity low molecular weight materials.
The failure of free R014 to induce reaginic antibody 
production following inhalation exposure may have been related 
to the exposure regimen used or the amount of antigen 
received. However, the requirement for material to be 
presented associated with protein was also apparent from 
experiments described later in Chapter 7 where it was found 
that R014 was not recognised as allergenic unless protein 
bound. It was possible to induce both primary and secondary 
anti-hapten reaginic antibodies following inhalation exposure 
to either penicillin or R014 conjugated to an ovalbumin 
carrier, but the number of responders was low.
Although very few animals became sensitised by the 
inhalation route, the ability of R014 to elicit respiratory 
responses during inhalation challenge was established using 
parenterally sensitised animals. Respiratory symptoms were 
elicited using both free R014 and the R014-BSA conjugate. 
Similarly, respiratory symptoms could be elicited using 
penicillin, as described later in Section 7.2.2. When free 
R014 was used for challenge, development of the response was 
delayed suggesting that binding to respiratory proteins in 
vivo was taking place before the response could be elicited. 
The use of proteins other than ovalbumin as carrier proteins 
RS-Pen, R014-RS, R014-HSA and R014-SSA did not prove 
successful. Similarly in experiments examining the effect of
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hapten density and dose received, exposure to R014-HSA 
conjugates did not induce anti-hapten or -carrier reaginic 
antibodies. However, parenteral challenge demonstrated that 
inhalation exposure had not produced systemic tolerance in all 
animals. At the higher hapten density (11:1) parenteral 
challenge induced hapten-specific antibodies indicating that 
use of lower hapten densities either did not provide enough 
material for recognition or that a state of tolerance had been 
induced.
When carrier proteins other than ovalbumin were examined 
following intraperitoneal administration limited anti-hapten 
responses were produced. R014-RS conjugates prepared using 
physiological conditions failed to induce reaginic antibody.
It was found that it was possible to form conjugates between 
penicillin and rat serum proteins that were recognised as 
allergenic, however this required conjugation to be 
carried out at pH 10. In addition two treatments of Pen-RS 
conjugate were required to induce an anti-penicillin response. 
Thus when R014-RS conjugation was carried out at pH 9.6 and 
two treatments of the conjugate administered reaginic 
responses could be obtained. This would indicate that for 
materials bound to self protein to be recognised as foreign 
they must produce significant alterations in the protein 
structure.
Parenteral administration of R014-0A at various hapten 
densities revealed that even at hapten densities as low as 
2:1, hapten specific responses could be obtained, although the 
responses were less sustained. Thus the failure of inhalation 
exposure to R014-HSA conjugates to induce reaginic antibody
-  117 -
may in part be related to the efficiency of the HSA as a 
carrier protein, and to the requirement for a high hapten 
density conjugate when exposing via the inhalation route.
When examining the effect of pre-exposure to carrier
proteins on induction of reaginic antibody following
inhalation exposure the number of anti-carrier responses were
not as expected from the results obtained using ovalbumin
(Section 4.3.1.). R014-0A or Pen-OA (Section 5.3.2.). The
concept that sensitisation to a hapten portion of a conjugate
might occur during an allergic response directed against the
carrier could not therefore be adequately investigated.
Exposure to carrier protein by intraperitoneal exposure would
have ensured the initial sensitivity required to test this
hypothesis. With regard to the initial carrier response prior
intraperitoneal exposure to carrier protein can under certain
conditions, depending on the dose level used, result in
reduced levels of antibody formed against both the carrier and
et al.
the hapten (Leskowitzf 1972). It seems unlikely that this 
occurred in these experiments as exposure to R014-HSA under 
similar conditions was shown not to produce systemic 
tolerance.
In experiments 5.3.3. onwards a different Gage nebuliser 
was in use, and although the conditions of atmosphere 
generation produced the same venturi flow of air (1 1/min) 
across the tip of the atomiser and similar atmospheric 
concentrations (approximately 10 ug/1) the reaginic response 
was poor. This would suggest that induction of respiratory 
sensitivity was not solely dependent upon atmospheric 
concentration and the dose received, but also other
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characteristics such as particle size. Further investigations 
into the role of particle size on the induction of respiratory 
sensitisation are described in Chapter 6.
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CHAPTER 6
Assessment of conditions of atmosphere generation on 
induction of reaainic antibodv bv the inhaled route
6.1. INTRODUCTION
It is now clear that many factors affect the course of an 
immune response against inhaled antigen. These include the 
amount of antigen received, the hapten density of the 
material, and perhaps most important the physical 
characteristics of the atmosphere. The interaction between 
these various factors will dictate the outcome of exposure 
with respect to the development of tolerance or 
sensitisation.
Throughout these studies atmospheres have been generated 
as aerosols. These consist of a system of finely divided 
liquid droplets or solid particles in gaseous suspension, 
the particles being sufficiently small to remain airborne for 
some period of time, so that the atmosphere is relatively 
stable.
Atmospheric concentration together with particle size 
distribution, determine not only the dose of material 
received but also the site at which deposition occurs within 
the lung (Payne, 1989). A major determinant influencing 
pulmonary deposition of inhaled aerosols is the aerodynamic 
properties of the constituent particles. In general, 
particles with a diameter greater than 10 /xm will be trapped 
in the nasopharyngeal region and main bronchi (Hatch and 
Gross, 1964) , particles between 10 and 5 /xm achieve varying
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degrees of penetration of the bronchial tree, with the 
smallest likely to impact on the terminal bronchioles 
(Conning & Riley, 1988) . Particles less than 1-5 /xm in 
diameter are capable of reaching the alveoli, and up to 70% 
of particles 2 /xm in size may be retained within the lung 
(Hatch and Gross, 1964). A large proportion of particles, 
less than 0.5 /xm, are generally exhaled.
The amount of inhaled material deposited in the 
respiratory tract will differ considerably due to factors 
such as airway geometry, mode of breathing (nose or mouth) 
and the metabolism of the subject (Snipes, 1989). In animal 
studies the exact amount of test material administered by 
either injection, oral intubation or topical application is 
known, and in the case of feeding studies, the actual dose 
level can be easily calculated. During inhalation exposure, 
however, it cannot be assumed that animals of the same 
species or strain receive identical doses when breathing the 
same aerosol (McMahon, 1977). Although it is generally 
recognised that not all individuals in a group of animals 
exposed will receive exactly the same dose, the assumption is 
made that all of the experimental subjects receive the same 
(average) dose (Snipes, 1989).
Exposure to a given aerosol concentration does not, 
therefore, adequately define the dose delivered, nor does it 
specify the anatomical distribution of that dose. The 
concept of aerodynamic diameter is often used to predict the 
likely particle deposition pattern within the lung. 
Radiolabelled aerosols of a known particle size have been 
used as a means of providing models of lung deposition in
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both man (Svartengren, et al., 1987), and experimental 
animals (Rabbe, 1977). Most animals are primarily nose 
breathers, which may as a consequence affect pulmonary 
penetration of aerosol particles due to nasopharyngeal 
deposition. Thus only a small proportion of an inhaled dose 
may reach the lungs. This is further compounded by the fact 
that the amount of material deposited in the lungs is 
influenced by particle size rather than particle number 
(Payne, 1989). This occurs because most aerosols consist of 
spherical particles (Swift, 1980) and since the volume of a 
sphere increases with the cube of its diameter, the largest 
particles in an aerosol will contain most of the antigen mass 
(Payne, 1989).
The biological effects of inhaled particles depend not 
only upon the site at which they initially come into contact 
with the airway epithelial surfaces, but the rate and route 
by which they are physically removed from the respiratory 
tract. The inhalation of materials such as anaesthetics or 
irritants which reduce frequency and depth of respiration 
will influence not only the magnitude of the dose received 
but also its distribution within the lung (Alarie, 1966; 
Sweeny at ai., 1983; Leith, 1984).
Deposition of material within the lung depends upon 
differences in ventilation per gram body weight (McMahon, 
1977). At rest and during aerobic exercise the relationship 
between aerobic metabolism varies with body mass to the power 
3/4 (Leith, 1984). Consequently smaller animals with a 
relatively higher pulmonary ventilation will inhale larger 
amounts of aerosol per unit of body mass than larger animals
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during the same exposure period (McMahon, 1977; Snipes,
1989). This difference in ventilation of the respiratory 
tract is an important consideration as the dose received will 
differ between various species exposed to the same aerosol. 
This also has implications with regard to extrapolating the 
findings of animal studies involving inhalation exposure to 
the human situation.
The behaviour of aerosols within the respiratory tract 
and the methods by which the body deals with inhaled 
particles is a complex interaction between physical and 
biological mechanisms. The characteristics of the aerosol in 
which the antigen is presented may be a critical factor in 
determining immune recognition and the form the immune 
response takes.
The following studies therefore were carried out to 
investigate various aspects of atmosphere generation with a 
view to defining the conditions necessary for induction of 
reaginic antibody by inhalation exposure. The performance of 
several atmosphere generating systems was examined with 
regard to the atmospheric concentration together with 
particle size distribution of the aerosols produced.
6.2. EXPERIMENTAL
6.2.1. Comparison of the performance of four aerosol 
generating svstems
Atmospheres generated using the Gage, Acorn, Misty Ox and 
Liu-Lee nebulisers were compared (Sections 2.7.1.; 2.7.2 and
2.7.3. respectively). The effect of altering the air flow 
used for aerosol generation and atmosphere dilution were
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examined with regard to particle size distribution and 
atmospheric concentration. Particle size distribution of 
atmospheres generated by the Gage, Acorn and Misty Ox 
nebulisers was examined using the Anderson mini sampler 
(Section 2.9.1.) whilst that of the Liu-Lee nebuliser was 
assessed using the Malvern API aerosizer (Section 2.9.2.). A 
range of concentrations of either R014, R014-0A or ovalbumin 
in PBS were used for aerosol generation; for the Liu-Lee 
nebuliser, which runs at a constant 35 psi, the concentration 
of PBS was increased to vary the particle size of the 
aerosols produced.
6.2.2. Examination of the abilitv of atmospheres produced 
using the various generating svstems to induce reaainic 
antibodv
6.2.2.1. Gage nebuliser
The performance of the Gage nebuliser (Section 2.7.1.) was 
examined using atmospheres generated from 1% ovalbumin and 
Pen-OA in PBS which had previously proved successful. The 
nebuliser output flow rate of 10 1/min with a dilution of air 
at 8 1/min was used. Animals were pretreated i.p. with 
either 500 /xg carrageenan 7 and 14 days, or 1 mg carrageenan 
7 days prior to inhalation exposure on days 0, 7 and 14.
They were bled on day 9 and then at weekly intervals, and 
sera assessed for the presence of reaginic antibody (Sections
2.5.1. and 2.5.2.). The respiration of selected groups was 
monitored by plethysmography during exposure on day 14 and 
also during the boost exposure on day 28.
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6.2.2.2. Acorn nebuliser and Misty Ox
Using the Acorn nebuliser (Section 2.7.2.) at an output flow 
of 10 1/min with no air dilution, groups of 4 animals treated 
with 1 mg carrageenan i.p. 7 days prior to inhalation 
exposure, were exposed to atmospheres generated from 1% 
solutions of either OA or R014-0A (hapten density 8:1 or 
16:1) or RB4-0A (hapten density 2:1 or 4:1) in PBS on days 0, 
7 and 14. The animals were bled on days 9, 16 and 30 and the 
serum assessed for the presence of anti-hapten and anti­
carrier reaginic antibody. On day 21, animals were 
challenged by inhalation with either free dye alone or dye- 
BSA conjugate and respiration was monitored by whole body 
plethysmography for respiratory changes as shown on Table
6.1. A group of animals was also exposed to ovalbumin 
atmospheres generated from a 1% solution using the Misty Ox 
nebuliser at an input flow rate of 8 1/min and a dilution of 
10 1/min.
Table 6.1. Protocol for examining the potential of 
atmospheres generated using the Acorn nebuliser to 
induce reaginic antibodv production
Animal
numbers Antigen
Hapten
density
Inhalation challenge 
Antigen
27.1-4 OA - OA
27.5-8 R014-0A 8:1 R014
27.9-12 R014-OA 8:1 R014-BSA
27.13-16 R014-0A 16:1 R014
27.17-20 R014-0A 16:1 R014-BSA
27.21-24 RB4-0A 2:1 RB4
27.25-28 RB4-0A 2:1 RB4-BSA
27.29-32 RB4-0A 4:1 RB4
27.33-36 RB4-0A 4:1 RB4-BSA
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6.2.2.3. Liu-Lee nebuliser
Groups of 4 animals pretreated with 1 mg carrageenan i.p. 7 
days prior to exposure exposed to atmospheres generated using 
the Liu-Lee nebuliser (Section 2.7.3.). The dilution rate 
used was either 12 or 6 1/min and solutions of either 1 or 2% 
ovalbumin were dissolved in either 0.15, 1.5 or 3.0 M PBS to 
provide atmospheres with differing particle sizes. Animals 
were exposed on days 0, 7 and 14 and received a boost 
exposure on day 35. They were bled on day 9 and subsequently 
at weekly intervals. The sera were then assessed for the 
presence of anti-ovalbumin reaginic and IgG antibodies. They 
were challenged by inhalation on days 44 to 45 and 
respiration monitored.
Examination of hapten-proteins conjugates using the 
Liu-Lee nebuliser was carried out using aerosols generated 
from 1% material dissolved in either 0.15 or 3.0 M PBS with 
dilution rates of 12 or 6 1/min respectively. Animals were 
treated with 1 mg carrageenan i.p. 7 days prior to inhalation 
exposure to atmospheres of either R014-0A (hapten density 
13:1) or hexylisocyanate-ovalbumin conjugate (HIC-OA) on days 
0, 7 and 14 and boosted on day 35. Animals were bled at 
weekly intervals from day 9 onwards and the sera assessed for 
the presence of anti-hapten and -carrier antibodies. The 
animals were challenged on days 44 to 45 using either free 
material BSA in 0.15 M PBS by inhalation and respiration 
monitored as shown on Table 6.2.
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Table 6.2. Protocol for examining the potential of 
atmospheres generated using the Liu-Lee nebuliser 
to induce hapten-specific antibody production
Aerosol Challenge antigen
Animal
numbers
1%
Antigen
PBS
Strength
Diln.
1/min PCA Inhalation
46.1-4 R014-OA 0.15 M 12 OA
R014-BSA
R014
46.5-8 R014-0A 3.0 M 6 OA
R014-BSA
R014
46.9-12 HIC-OA 0.15 M 12 OA
HIC-BSA
HIC-BSA
46.13-16 HIC-OA 3.0 M 6 OA
HIC-BSA
HIC-BSA
6.3. RESULTS
6.3.1. Comparison of the performance of four generating 
systems
The results for particle size analysis of aerosols generated 
from 1% ovalbumin in PBS for the various generation systems 
are shown in Table 6.3. The original Gage nebuliser provided 
a range of particle sizes from >4.7 to <0.65 /xm, 95% being
3.3 /xm and smaller, with an atmospheric concentration of
10 /xg/1. The second Gage nebuliser , however, !
whilst producing a similar atmospheric concentration 
(8 /xg/1), did not produce particles above 2.2 /xm in size.
The Misty Ox nebuliser produced an atmospheric particle size 
up to 3.3 /xm with an atmospheric concentration of 12 /xg/1. 
The Acorn nebuliser produced an atmosphere with particles 
present from >4.7 to <0.65 /xm, with an atmospheric
I"-'
concentration of 53 /xg/1.
The effects of alteration of the Acorn nebuliser output
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Table 6.3. Effect of generation system used on the particle size 
distribution of atmospheres generated using 1% ovalbumin in PBS
PSD (%)
Atmospheric
concentration
pg/iGeneration system >4.7
Particle 
>3.3 >2.
size /im 
2 >0.65 <0.65
Gage nebuliser l®'® 5 10 21 36 29 10
Gage nebuliser 2*'^ 0 0 0 29 70 8
Misty Ox nebuliser*'^ 0 0 10 53 36 12
Acorn nebuliser*^'® 14 21 51 11 3 53
Input air flow: a = 8 
e = 0 1/min
and b = 6 1/min; diluting airflow c = 10, d = 8 and
Table 6.4. Effect of nebuliser output flow rate on the particle size
distribution and concentrations of atmospheres Generated from
0.1% reactive oranae 14 in PBS
PSD (%)
Atmospheric
concentration
pg/1
Output flow rate 
1/min >4.7
Particle size /vm 
>3.3 >2.2 >0.65 <0.65
4 1 2 35 50 12 3.5
6 10 16 22 41 11 12.4
10 4 6 18 49 23 20.5
Generation conditions:- Nebuliser output flow rate as shown with no 
dilution.
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flow rate were examined using atmospheres generated from 0.1% 
R014 in PBS are shown in Table 6.4. An increase in flow rate 
from 4 to 10 1/min produced increases in the atmospheric 
concentration from 3.5 to 20.5 /xg/1.
In addition to atmospheric concentration, output flow 
rate influenced atmosphere particle size distribution, which 
was reduced at the higher flow rates probably due to particle 
fragmentation. The influence of the concentration of 
material used for generation is shown in Table 6.5.
Increasing concentrations of R014 from 0.01 to 0.2% produced 
a linear increase in atmospheric concentrations, and the 
particle size was reduced at lower R014 concentrations. 
Further, increasing the concentration of R014 to 1% produced 
a slight increase in atmospheric concentration but the 
atmospheric particle size began to decrease. The effect of 
increasing air dilution was to reduce the particle size as 
seen with atmospheres of 0.1% R014 generated using an output 
of 6 1/min with either 10 1/min or no air dilution (Tables
6.4 and 6.5 respectively).
The type of material being examined also influenced 
atmosphere characteristics (Table 6.6). Using 0.1% solutions 
of either free dye, carrier protein or dye-conjugates all 
materials produced particles from >4.7 to <0.65 /xm in size, 
however, with ovalbumin, R014-0A (hapten density 8:1) and 
R014 (hapten density 16:1) more particles were present in the 
larger size ranges than for free dye. There also appeared to 
be an inverse relationship between atmospheric concentration 
and molecular weight of the material examined. The 
conjugation of increasing amounts of dye to the ovalbumin
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Table 6.5. Effect of concentration of material used for 
generation on the particle size distribution and 
concentration of atmospheres generated using an Acorn 
nebuliser and solutions of reactive orange 14 in PBS
PSD (%)
Atmospheric
concentration
pg/iR014 concentration >4.7
Particle 
>3.3 >2.2
size fum 
>0.65 <0.65
1% 3 5 17 39 36 17.8
0.2% 13 17 27 35 9 14.5
0.1% 1 12 41 29 16 6.0
0.01% 0 4 29 45 22 0.5
Generation conditions: 
with 10 1/min air.
Nebuliser output flow rate of 6 1/min and dilution
Table 6.6. Effect of material used on atmosphere particle size
distribution using an Acorn nebuliser
PSD (%)
Material 
0.1% in PBS
Hapten
density >4.7
Particle size [um 
>3.3 >2.2 >0.65 <0.65
concentrât ion
pg/1
R014 - 4 6 18 49 23 20.5
OA - 25 28 26 19 3 15.9
R014-0A 8:1 27 22 21 17 13 10.5
R014-0A 16:1 21 20 24 22 12 8.0
Generation conditions: Nebuliser output of 10 1/min with no dilution.
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molecules served to reduce atmospheric concentration showing 
that even subtle changes in hapten density can effect 
atmosphere characteristics. Atmospheres produced by the 
Acorn nebuliser were as liquid droplets on the plates of the 
Anderson mini sampler, whereas the Gage and Misty Ox 
nebulisers produced a powdery deposit. I
The effect of ovalbumin concentration and PBS strength 
on particle size distribution of aerosols generated using the 
Liu-Lee nebuliser was determined using the Malvern API 
aerosizer. The results are shown in Table 6.7 and are 
expressed as the geometric mean diameter of the particles 
present in the aerosols. As previously observed, increased 
diluting air flow reduced atmosphere particle size, 
conversely increasing either the ovalbumin concentration or 
PBS strength increased the particle size. Atmospheric 
concentrations produced by using a dilution rate of 12 1/min 
were 4-6 and 5-8 /xg/1 using solutions of 1 and 2% ovalbumin 
respectively, whereas at a dilution rate of 6 1/min 
concentrations of 7-9 and 8-12 /xg/1 were obtained using 
solutions of 1 and 2% ovalbumin respectively.
6.3.2. Examination of the densitv of atmospheres produced 
using the various generating svstems to induce reaainic 
antibody
6.3.2.1. Gage nebuliser
In further studies examining the inhalation of atmospheres 
produced using the Gage nebuliser, exposure to atmospheres of 
ovalbumin and Pen-OA failed to induce reaginic antibody as 
detected by PCA (Table 6.8). However, monitoring of selected
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Table 6.7. Geometric mean diameters of particles in aerosols 
generated under various conditions using the Liu-Lee nebuliser
OA Concn PBS conc.
Geometric mean diameter ± GSD
12 1/min* 6 1/min*
1%
1%
1%
0.15 M 
1.5 M 
3.0 M
1.25 ± 1.96 
2.49 ± 2.73 
4.08 ± 2.53
1.95 ± 2.29 
3.80 ± 2.63 
NT
2%
2%
0.15 M
1.5 M
2.38 ± 2.90
3.67 ± 2.64
2.93 ± 3.00 
3.95 ± 2.55
* Flow of diluting air.
NT = Not tested.
Measured using a Malvern API aerosizer.
Table 6.8. Reaginic and respiratorv responses in carrageenan 
pretreated BN rats exposed to atmospheres of ovalbumin 
and Pen-OA using a Gage nebuliser^
Number of animals responding on day
Antigen Concn.
received 
on day
9
PCA
14
RM
16
PCA
23
PCA
28
RM
30
PCA
OA 0.1% -7 0/4 NT 0/4 0/4 NT 0/4
OA 1.0% -7 0/4 2/4 0/4 0/4 0/4 0/4
Pen-OA 0.1% -7 0/4 NT 0/4* 0/4 NT 0/4*
Pen-OA 0.1% -14,-7 0/4 NT 0/4* 0/4 0/4 0/4*
Pen-OA 1.0% -7 0/4 NT 0/4* 0/4 NT 0/4*
Pen-OA 1.0% -14,-7 0/4 3/4 0/4* 0/4 3/4 0/4*
Gage nebuliser : generation conditions of output flow 10 1/min with 
8 1/min dilution.
NT = Not tested
* PCA result for Pen-BSA challenge and ovalbumin challenge.
** Total received 1 mg
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groups during the exposure on day 14 revealed the 
characteristic alterations in breathing pattern (Fig.6.1).
The Misty Ox nebuliser failed to induce reaginic antibody.
6.3.2.2. Acorn nebuliser
Atmospheres generated from either ovalbumin, R014-0A or 
RB4-0A using the Acorn system failed to induce any anti­
hapten responses and only produced a single anti-carrier 
response in an RB4-0A treated animal (No.27.31 area of dye 
extravasation (ADE) = 314 mm^. Respiratory responses were 
not observed after inhalation challenge with either the free 
dye or BSA-conjugate.
6.3.2.3. Liu-Lee nebuliser
PCA responses of rats exposed to atmospheres generated using 
the Liu-Lee nebuliser with an air dilution of either 12 or 6 
1/min are shown in Tables 6.9 and 6.10 respectively. At a 
dilution of 12 1/min atmospheres generated from all the 
combinations of ovalbumin concentration and PBS strength 
succeeded in inducing reaginic antibody in at least one 
animal from each group. At 6 1/min PCA responses could be 
detected in animals receiving 1% ovalbumin in 3.0 M PBS and 
after the boost exposure in one animal receiving 1% ovalbumin 
in 0.15 M PBS. The responses were not all as long lived as 
those observed in the experiment described in Chapter 4. The 
boost exposure, in addition to boosting the PCA response in 
some animals, also produced detectable levels of antibody in 
those which had been negative previously. Respiratory 
responses could be elicited in those animals with, or which
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Table 6.9. Reaainic antibody and inhalation responses in 
carrageenan pretreated Brown Norway rats exposed to 
ovalbumin atmospheres generated using the Liu-Lee Nebuliser 
and diluted at 12 1/minute on days 0, 7 and 14
OA Concn. PBS conc.
Animal
No.
Day (
ADE mm^ 
of sample
Inhalation
Challenge9 16 23 30* 37 44
1% 0.15 M 36.61 0 / '314 ^ 9 5 154 154 0 +
36.62 0 I 201 J 0 0 0 0 -36.63 0visi-/  0 0 0 0 -36.64 0 0 0 0 0
1% 1.5 M 36.65 0 50 0 0 0 0 —
36.66 0 201 0 0 0 0 -
36.67 0 0 95 ± 95 201 +
36.68 0 0 0 0 0 0 -
1% 3.0 M 36.69 0 0 0 0 0 0 —
36.70 0 177 0 0 0 0 -
36.71 0 0 0 0 0 0 -
36.72 0 0 0 0 0 0 -
2% 0.15 M 42.5 0 79 113 177 0 201 +
42.6 0 0 0 0 0 346 +
42.7 0 0 0 0 0 0 -
42.8 0 0 0 0 0 0 —
2% 1.5 M 36.73 0 0 0 0 0 0 —
36.74 0 201 154 0 0 0 -
36.75 0 0 0 0 0 0 -
36.76 0 0 0 0 79 0 —
= No response
= Positive response; periodic notching in breathing pattern observed. 
= Boosted day 35
= Blueing at site of injection not measurable.
— 13 5 —
Table 6.10. Reaginic antibody and inhalation responses in 
carrageenan pretreated Brown Norway rats exposed to atmospheres of 
ovalbumin generated using the Liu-Lee Nebuliser and 
diluted at 6 1/minute on days 0, 7 and 14
OA
Concn. PBS Conc.
Animal
No.
Day
ADE mm^ 
of sample
Inhalation
Challenge9 16 23 30* 37 44
1% 0.15 M 42.1 0 0 0 0 0 0 —
42.2 0 0 0 0 0 0 -
42.3 0 0 0 0 0 0 -
42.4 0 0 0 0 0 24 +
1% 1.5 M 42.9 0 0 0 0 0 0 -
42.10 0 0 0 0 0 0 -
42.11 0 0 0 0 0 0 -
42.12 0 0 0 0 0 0 —
1% 3.0 M 42.17 0 0 0 0 0 ± +
42.18 0 0 0 0 284 314 +
42.19 0 0 0 0 0 0 -
42.20 0 314 227 177 0 ± —
2% 1.5 M 42.13 0 0 0 0 0 0 —
42.14 0 0 0 0 0 0 -
42.15 0 0 0 0 0 0 -
42.16 0 0 0 0 0 0 —
2% 3.0 M 42.21 0 0 0 0 0 0 —
42.22 0 0 0 0 0 0 -
42.23 0 0 0 0 0 0 -
42.24 0 0 0 0 0 0 —
= No response
= Positive response; periodic notching in breathing pattern observed. 
= Boosted day 35
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Table 6.11. IgG antibody response in carrageenan pretreated 
Brown Norway rats exposed to ovalbumin atmospheres generated 
using the Liu-Lee nebuliser
Ovalbumin PBS Conc.
Diln.
1/min
Animal
No.
% Anti-ovalbumin reference serum 
day of sample
9 16 23 30* 37 44
1% 0.15 M 12 36.61 0 0 5 7 26 89
36.62 0 1 3 2 13 101
36.63 0 0 3 6 9 64
36.64 0 0 0 2 0 9
2% 0.15 M 12 42.5 0 0 6 11 19 88
42.6 0 0 4 5 12 108
42.7 0 2 17 7 25 81
42.8 0 0 8 6 12 87
1% 3.0 M 6 42.17 0 0 16 6 10 71
42.18 0 0 24 24 43 141
42.19 0 1 29 14 7 10
42.20 0 0 5 19 6 28
2% 3.0 M 6 42.13 0 0 6 5 8 139
42.14 0 5 14 14 17 125
42.15 0 0 17 5 11 48
42.16 0 0 14 2 15 48
* = Boosted day 35
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had recently produced reaginic antibody. Examination of the 
IgG responses from selected groups (Table 6.11) showed that 
the IgG response was present, whether or not a reaginic 
response was induced. The IgG responses were increased after 
the boost exposure. Again, the IgG antibody response 
appeared later than the reaginic antibody. Using the Liu- 
Lee nebuliser, aerosol of the hapten-protein conjugates R014- 
OA and RB4-0A failed to induce either anti-hapten or -carrier 
reaginic antibody nor were any respiratory responses 
observed.
6.4. DISCUSSION
During examination of certain elements of atmosphere 
generation and their influence on induction of reaginic 
antibody production, certain factors were identified as 
important in determining the particle size distribution of an 
atmosphere.
Flow rate of compressed air used to drive the nebuliser 
was found to have a direct effect on atmospheric 
concentration, because it determined the amount of material 
drawn through the apparatus during nébulisation. Reduction 
of particle size at higher flow rates was probably due to 
fragmentation during nébulisation. The alteration of 
particle size distribution associated with flow rate used for 
aerosol generation has also been observed by Clay at al.
(1983) when examining several nebulisers including the Acorn.
In general, investigators interested in particle size 
distribution have analysed the output of various nebulisers 
immediately the aerosol was generated, before any other
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alterations could take place. For inhalation purposes, 
however, the atmosphere must be sampled within the breathing 
zone of the exposed animals. Addition of air after 
nébulisation is used to provide a homogeneous atmosphere 
within the exposure chamber and is classically used as a 
means of reducing atmospheric concentration. In these 
studies addition of diluting air was observed to reduce 
particle size which was probably due to increased drying of 
particles.
Concentration of material used for nébulisation was also 
found to have a major influence on atmospheric concentration 
at levels below 1%, where there appeared to be a linear 
relationship between concentration used and the atmospheric 
concentration achieved. Any alteration in the concentration 
of solution used for nébulisation had a marked effect on 
particle size distribution regardless of the apparatus used. 
Conversely Clay et al, (1983) using solutions of the 
bronchodilator terbutaline found that the concentration used 
for nébulisation had little effect on particle distribution. 
This difference may be due to the type of material and 
concentration levels selected. The protein solutions used in 
these studies will possess different physical properties such 
as surface tension and viscosity, and these are most probably 
responsible for the variation in particle size distribution 
(Swift, 1980). As might be expected, the use of different 
types of material for aerosol generation resulted in changes 
in particle size distribution. Using the Acorn nebuliser it 
would appear that atmospheric concentration is dependent upon 
the hapten density of the material being examined, since the
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addition of hapten to protein carrier was observed to reduce 
atmospheric concentration. This was not evident with 
aerosols obtained using the Liu-Lee nebuliser where 
atmospheric concentrations of 7 ng/1 were obtained using 1% 
R014 (Section 5.3.1.) and 1% R014-0A (Section 6.2.2.3.) for 
generation. The effect of the physical properties of 
material on aerosol generation was overcome by the use of 
constant infusion of material into the Liu-Lee nebuliser. 
Altering the PBS concentration of solutions for use in the 
Liu-Lee nebuliser produced the required shift in particle 
size distribution, but did not appreciably alter atmospheric 
concentration. These findings are consistent with the 
observations of Davis and Bubb (1978) which indicate that 
chemical composition of aerosol droplets and the 
concentration of salts within them influence particle size 
distribution.
All these observations indicated that any small change 
in conditions of aerosol generation could markedly alter the 
character of the atmosphere generated. When assessing the 
ability of allergen aerosols produced by the various 
generating systems to induce reaginic antibody production, 
conditions were selected in order to produce aerosols with a 
similar concentration and/or particle size distribution as 
that produced by the original Gage nebuliser.
Although the exposure of animals to atmospheres of OA 
and Pen-OA using the Gage nebuliser did not produce enough 
antibody to elicit a PCA response, monitoring of animals 
during the induction phase revealed that sufficient cell- 
bound antibody was present to elicit respiratory response
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(Table 6.8.). Similarly Church (1975) observed respiratory 
responses before the presence of circulating reaginic 
antibody could be detected. Therefore, in this instance, 
respiratory challenge would appear to be a more sensitive 
indicator of the present of low levels of IgE. This occurred 
because the PCA assay measures only excess circulating 
antibody, whereas it was the cell-bound antibody that was 
responsible for mast cell degranulation and subsequent 
respiratory responses. The respiratory response of animals 
exposed to aerosols of 1% ovalbumin was transient in nature, 
similar to the transient reaginic responses observed using 
the Liu-Lee (Section 6.3.7.) and the Gage nebuliser (Section
4.3.1.) which could not be re-elicited upon subsequent 
exposure. However, in animals exposed to aerosols of 1% Pen- 
OA respiratory responses could still be elicited on day 28, 
indicating that low level IgE production was being 
maintained. This situation may bear similarities to those 
instances in man where a Type I hypersensitivity response is 
thought to be involved in respiratory responses, yet antigen 
specific IgE cannot be demonstrated.
The performance of the aerosols generated using the 
Acorn nebuliser, with regard to induction of reaginic 
antibody, was poor. It was noted that deposits of material 
on the stages of the Anderson were liquid, indicating that 
atmospheres consisted of droplets of material rather than dry 
particles. One reason put forward for poor bioavailability 
of inhaled drug aerosols has been the potential increase in 
particle size through condensation growth immediately after 
inspiration (Gonda and Byron, 1978). Thus aerosols produced
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by the Acorn nebuliser which would not be subjected to 
condensation growth would have different sites of deposition 
within the respiratory tract compared to those produced by 
either the Gage or Liu-Lee nebulisers. Therefore even when 
using aerosols with a defined particle size, the hygroscopic 
nature of the particles will alter the theoretical site of 
deposition.
The fact that both reaginic antibody production and 
respiratory responses could be induced in the rat after 
inhalation exposure was confirmed using the Liu-Lee 
nebuliser. Variability in the onset and persistence of 
reaginic antibody production together with the development of 
secondary responses, indicate that although the conditions of 
atmosphere generation and inhalation exposure were suitable 
for inducing reaginic antibody, they are not at present 
sufficiently reliable for evaluation purposes. Generation 
conditions selected as likely to be favourable for induction 
of anti-hapten reaginic antibody proved unsuccessful. The 
failure of the conjugates R014 and HIC-OA (which were known 
to be allergenic Chapter 7), to induce either an anti-carrier 
or hapten response may reflect subtle alterations in particle 
size distribution. Therefore, not only does each atmosphere 
generation system need to be characterised to define the 
generation conditions required to provide the optimum 
atmospheric concentration and particle size distribution for 
induction of reaginic antibody production, adjustments will 
be required for each new material examined.
In the past Gage nebulisers have been used to generate 
aerosols of paraquat (Gage, 1968) and of toluene
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diisocyanate-guinea pig serum conjugates for inhalation 
challenge (Botham et al., 1988) The advantage of using glass 
is that material does not absorb onto its surface, which may 
be an important consideration when examining the use of free 
material for inhalation challenge. However, each Gage 
nebuliser is "hand-made", producing inherent variability 
which was reflected in the shift in particle size 
distribution and ability to induce reaginic antibody 
production. The Acorn nebuliser, designed for producing 
therapeutic aerosols, had the advantage that, as moulded, the 
performance of each unit should be similar. However, the 
aerosols produced proved unsuitable for the purpose of 
inducing sensitivity. In systems that involve recirculation 
of material for nébulisation (Gage and Acorn nebulisers), 
changes in atmosphere characteristics can occur due to 
concentration of solution through evaporation during 
nébulisation. This problem is overcome in the Liu-Lee 
nebuliser by constant infusion of material into the 
nebuliser.
The Anderson mini sampler although suitable for sampling 
atmospheres at the generation flow rate produced by the 
systems used, had limitations related to the time delay 
between sampling and obtaining results. It is important to 
have the facility for continuous monitoring of atmospheres so 
that the exact conditions of exposure are known. Ideally had 
equipment such as the Malvern API aerosizer been routinely 
available, closer monitoring of aerosol particle size 
distribution could have been carried out during exposure, and 
characterisation of the performance of any new nebuliser more
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readily assessed.
Examination of the conditions of atmosphere generation 
has revealed several factors which could alter or subtly 
influence aerosol particle size and atmospheric 
concentration. This was found to be of critical importance 
for sensitisation by inhalation. The complex interaction 
between site of deposition and dose of allergen received, 
that provide the conditions for induction of sensitivity 
remain to be established. Fortunately the atmospheric 
characteristics required to elicit a respiratory response do 
not appear to be so critical, since atmospheres produced by 
the Gage, Acorn (Section 7.3.2.) and the Liu-Lee nebuliser 
have been shown to be capable of eliciting responses.
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CHAPTER 7
Assessment of the potential alleraenicitv of various low 
molecular weight materials
7.1. INTRODUCTION
Throughout the previous chapters it has become apparent that 
to provide a test system for allergenicity in which type I 
hypersensitivity reactions are induced by inhalation, the 
atmosphere characteristics, and in particular the particle 
size distribution, have to fall within certain defined 
limits. This is an important consideration in the 
development of a model which can in turn be validated by 
inter-laboratory studies. However, as the atmosphere 
characteristics required for elicitation of respiratory 
responses do not appear to be as critical as for induction, 
sensitisation by routes other than inhalation followed by 
inhalation challenge may provide a means of identifying 
respiratory allergens.
In previous studies (Sections 3.1 and 3.4) 
intraperitoneal administration of antigen together with the 
adjuvant carrageenan has facilitated the production of 
hapten-specific reaginic antibody in the Brown Norway rat. 
Sensitisation by this route has been employed by many 
researchers to render animals sensitive prior to the 
investigation of various aspects of respiratory allergy. For 
example, bronchial hyper-reactivity (Dahlback, 1981), 
inflammatory changes (Blythe et al., 1986) and pulmonary 
function (Bellofiore et al., 1987).
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In order to provide a general model for allergenicity 
rather than to concentrate upon a single material, it was 
decided to examine a range of low molecular weight materials 
both with regard to their ability to induce reaginic antibody 
following intraperitoneal administration, and their capacity 
to elicit respiratory responses following inhalation 
challenge.
The allergenicity of the materials to be examined may 
depend, in part, upon their ability to bind to carrier 
protein. Although the immunogenicity of the carrier protein 
employed plays an important role in the recognition of the 
hapten, when dealing with the more potent allergens the use 
of a highly immunogenic carrier such as ovalbumin may not be 
essential. Therefore, materials were presented conjugated to 
either rat serum (self protein) or ovalbumin as a means of 
providing further information their intrinsic allergenic 
potential.
Antibiotics and isocyanates are amongst the fourteen 
types of material prescribed under the 1975 Social Security 
Act (DHSS, 1986) as causes of occupational asthma. A 
subsequent review of sensitising agents by the Industrial 
Injuries Advisory Council in accordance with Section 14Id of 
the Social Security Act, 1975 (DHSS, 1990) added a further 
nine materials to the list which included the reactive dyes. 
Therefore, the materials selected for examination included an 
industrial chemical, hexyl isocyanate, the drug penicillin G 
and a range of reactive dyes.
Reactive dyes were introduced in the early 1950's and 
occupational asthma among workers handling these materials
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was first reported by Alanko et al. (1978). Stern (1985), in 
addition to demonstrating sensitivity to the dye Levafix 
yellow E-2RA in two dye house workers, also reported the 
death of a worker related to exposure to reactive dyes. A 
subsequent survey of dye house workers in the UK showed that 
5% of the workforce had work-related respiratory symptoms to 
the dyes they were handling (Docker, 1986) . Specific 
sensitisation has been demonstrated for a number of dyes, and 
studies where reactive dyes have been identified as 
responsible for individual cases for occupational asthma 
through induction of symptoms during bronchoprovocation 
and/or presence of dye-specific IgE antibodies are listed in 
Table 7.1.
The reactive dyes are, as their name implies, highly 
reactive chemicals designed to bind to proteinaceous fabric 
fibres. Consequently, they have been shown to react with 
body peptides and proteins, including glutathione, 
haemoglobin and lysozyme, at physiological pH and temperature 
(Shore et al., 1968). Assuming that the potential to bind to 
body proteins is related to the allergenicity of low 
molecular weight chemicals, the reactive dyes provide an 
ideal model for investigation in the proposed test system.
In addition, they exist in sufficient number to provide a 
range of structurally related materials with which the 
relationship between structure and allergenicity can be 
explored. The reactive dyes consist of two distinct 
portions, the reactive group that binds to the fabric and the 
chromophore portion, that produces the colour. The range of 
the reactive groups employed by the major dye manufacturers
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Table 7.1. Reactive dves which have been identified as causing 
occupational asthma
Colour index 
classification Reference
Test
system
Commercial
name
Black
Reactive black 5 Wass et al. 1990 (s) Remazol black B
Blue
Reactive blue 114 Alanko et al. 1978 (s,b) Drimaren billiant 
blue K-BL
Orange
Reactive orange 12 Kalas & Rostokova 1980 (s,b) Ostazine golden 
yellow HR
Reactive orange 13 Kalas & Rostokova 1980 (s,b) Ostazine orange 2HR
Reactive orange 14 Howe 1986 (s) Procion yellow MX4R
Reactive orange 37 Kalas & Rostokova 1980 (s,b) Procion brown P-GR
Reactive orange 67 Hagmar et al. 1986 (s) Levafix Gold Gleb 
E-3GA
Reactive orange 86 Luczynska & Topping 1986 (s) Procion yellow MX3R
Red
Reactive red 2 Luczynski & Topping 1986 (s) Procion red MX5B
Reactive red 5 Luczynski & Topping 1986 (s) Procion red MXG
Reactive red 66 Topping et al. 1989 (s) Lanasol red 5B
Reactive red 123 Estlander et al. 1988 (s,b) Drimaren scarlet 
K-2G
Yellow
Reactive yellow 25 Alanko et al. 1978 (s,b) Drimaren brilliant 
yellow K-3GL
Reactive yellow 39 Topping et al. 1989 (s) Lanasol Yellow 2G
Reactive yellow 106 Alanko et al. 1978 (s,b) Levafix brilliant 
yellow E36
Mixtures
Reactive dyes 
Unclassified #
Docker et al. 1987 (s) 42 dyes tested
Black Park et al. 1989 (s,b) Black GR
Orange Estlander et al. 1988 (s,b) Remazol Gold Gleb 
RNL
Orange Park et al. 1989 (s,b) Orange GR
Red Alanko et al. 1978 (s,b) Cibacron billiant 
scarlet 3D
Red Park et al. 1989 (s,b) Red BBN
Yellow Stern 1985 (s,b) Levafix yellow 
E-2RA
Yellow Park 1989 (s,b) Yellow GR
# = Dye either renamed, withdrawn or not entered into the Society of Dyers 
and Colourists' Colours Index.
s = serological examination; b = bronchoprovocation test.
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are given by Rys and Zollinger (1975). The characteristics 
of the dyes selected for examination are shown in Table 7.2. 
Certain of these dyes show structural similarities and the 
possibility that there may be cross-reactivity between these 
materials once an immune response has been induced was 
investigated.
Table 7.2. Characteristics of dves examined
Dye Code Chemical class Reactive system
Molecular
weight
Reactive Orange 14 R014 Azo Dichlorotriazine 447
Reactive Orange 4 R04 Azo Dichlorotriazine 746
Reactive Orange 13 R013 Azo Monochlorotriazine 725
Reactive Blue 4 RB4 Anthraquinone Dichlorotriazine 637
Reactive Blue 2 RB2 Anthraqu inone Monochlorotriazine 774
Lanasol Blue 3R LB3R Anthraquinone a-acrylobromide 789*
Lanasol Red 5B LR5B Azo a-acrylobromide 629*
Lanasol Yellow 4G LY4G Azo a-acrylobromide 699*
* Structure not available to author.
The concept of relating molecular structure and
biological activity of a material as a means of forming a 
predictive approach for hazard assessment is a fundamental 
aspect of toxicological investigations. The approaches 
available to the researcher and how they can be applied to 
the field of toxicology have been discussed by Golberg 
(1983). Recently the use of structure activity relationships 
as an approach for identifying low molecular weight 
I substances likely to cause occupational asthma has been 
I discussed by Agius et al. (1991). In these studies computer
/
graphic molecular modelling techniques were employed to 
examine the molecular structure of/ two o)f the reactive dyes
to determine if there was a relationship between their
molecular structure and allergenicity. Previously this type
of technique has been applied to predicting the structure of 
the melatonin receptor binding site, and as a potential model 
for predicting chemical carcinogenicity (Lewis et al., 1989a, 
1989b).
7.2. EXPERIMENTAL
7.2.1. Comparison of allerqenicitv of three reactive dves 
Initially the three reactive dyes Reactive orange 14 (R014), 
Reactive blue 4 (RB4) and Reactive blue 2 (RB2) were chosen 
for examination due to certain similarities in their 
structure (Fig.7.1). R014 and RB4 are dichlorotriazine dyes
whereas RB2 is a monochlorotriazine dye, whilst RB4 and RB2 
share the same anthraquinone structure. Groups of three 
animals were injected i.p. with 10 ug of either free dye or 
dye conjugated to ovalbumin (Section 2.3.1.1.), which was 
administered in either 1 ml of saline or carrageenan (1 mg/ml 
in saline). The animals were bled at weekly intervals 
(Section 2.5.1.) and sera assessed for the presence of 
reaginic antibody by passive cutaneous anaphylaxis ((PCA) 
Section 2.5.2.) using either free dye, dye-bovine serum 
albumin or ovalbumin (carrier protein) for challenge. The 
effect of free R014 administered together with carrageenan 
was also examined at dose levels of 100 and 500 ug/animal.
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7.2.2. Assessment of the alleraenicitv of a range of low 
molecular weight materials
The following immunisation regime was designed to investigate 
the allergenicity of chemicals conjugated to either rat serum 
(RS) or ovalbumin (OA) under various conditions for the 
induction of reaginic antibody. The allergenicity of RS 
conjugates made at alkaline pH (Section 2.3.1.2) was 
determined using two intraperitoneal injections of 10 ng 
conjugate together with 1 mg carrageenan given on days 0 and 
14. For OA conjugates made under physiological conditions 
(2.3.1.1), a single injection of conjugate with or without 
carrageenan was administered. When the reaginic response had 
developed, animals were challenged via the inhalation route 
using either 1% solutions of the BSA conjugate or 0.1% free 
material in PBS and monitored by plethysmography for 
respiratory responses aerosols were produced using either the 
Acorn or Liu-Lee nebulisers. Using this regimen in addition 
to R014, RB4 and RB2 further reactive dyes were examined; 
these were the unshaded dyes R04 and R013 which are dichloro- 
and monochloro-triazine dyes respectively (Fig.7.1), and 
three Lanasol dyes, Lanasol blue 3R (LB3R), Lanasol red 5B 
(LR5B) and Lanasol yellow 4G (LY4G) which contain the 
acrylobromide group. The dye RB2 differs from R014 and RB4 
in that it requires a high temperature during dyeing, 
therefore the allergenicity of this dye was also examined 
after conjugation with ovalbumin at 60°C. The presence of 
dye-specific IgG antibody (Section 2.5.3.) was determined 
using the day 21 serum sample from animals treated with each 
of the eight dyes examined.
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Figure 7.1. Structures of the reactive dyes
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Penicillin (Pen) and hexyl conjugate isocyanate (HIC) 
were also examined using this regimen, but for the HIC 
inhalation challenge with free material, a solution of 
20 ug/ml in PBS was used. The potential of the PVG strain of 
rat as a model animal for assessing allergenicity of 
materials presented via the intraperitoneal route followed by 
inhalation challenge was also examined using Pen and HIC 
conjugates.
7.2.3. Examination of cross-reactivitv between the reactive 
dves
Cross-reactivity between the dyes R014, R04 and R013 was 
examined with regard to elicitation of the PCA response and 
respiratory responses upon challenge by inhalation. Rats 
were injected i.p. with either 10 ug R014-0A, R04-0A or R013- 
OA together with 1 mg carrageenan. Animals were bled at 
weekly intervals and the sera assessed for anti-dye reaginic 
antibody. A subsequent PCA assay was performed in three 
Sprague Dawley rats, which were injected intradermally with a 
"pooled serum sample" from within each group, and at PCA 
challenge the rats were injected with either R014-BSA, R04- 
BSA or R013-BSA. For inhalation challenge one animal from 
each treatment group was selected and challenged using one of 
the above dye-BSA conjugates.
A similar examination of cross-reactivity between the 
anthraquinone dyes RB4, RB2 and LB3R was carried out.
Animals were injected i.p. with 10 /xg of either RB4-0A or 
LB3R-0A together with 1 mg carrageenan. They were bled at 
weekly intervals and the serum assessed for the presence of
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anti-dye reaginic antibody. As sufficient responders to RB2 
could not be guaranteed, assessment of the specificity of the 
anti-RB2 response was limited to the PCA assay. A "pooled 
serum sample" from within each group, and an aliquot of the 
day 14 serum sample from the RB2-0A treated animal (No.
40.55) were each injected into three Sprague Dawley rats. At 
PCA challenge the rats were injected with either RB2-BSA, 
RB4-BSA or LB3R-BSA. Animals sensitised with RB4-0A received 
either free RB2, RB2-BSA or LB3R-BSA at inhalation challenge, 
whilst those sensitised with LB3R-0A received either free 
RB2, RB2-BSA or RB4-BSA.
7.2.4. Examination of the relationship between dve structure 
and alleraenicitv using computer graphic molecular modelling 
techniques
To examine further the relationship of structure to 
allergenicity, computer graphic molecular modelling 
techniques were employed. Two dyes were selected for 
examination, these were the non-shaded dyes R04 and R013
which differed in their allergenic potency (Section 7.3.2.) 
and in their structure by a single group (Fig.7.1.). The 
molecular modelling was carried out by Dr D.F.V. Lewis of the 
Molecular Graphics Unit at Surrey University. Based upon 
calculations of electrostatic potential energy two approaches 
of analysis were employed. Firstly, the surface 
electrostatic potential energy of each molecule was colour 
coded. This was carried out using the SYBYL program (Evans 
and Sutherland Computers Ltd, Salt Lake, Utah, USA) which was 
run on an Evans and Sutherland PS 390 computer. The
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relationship between surface charge and volume of the R04 and
R013 molecules was determined and presented as van der Waals 
dot surface. Secondly, the molecules were analysed to give 
values of the electrostatic potential energy using the COSMIC 
program (Smith, Kline and French, Welwyn Garden, UK) which 
was run on a Sigmex 6130 computer. In this analysis the 
surface charge in a given area was colour coded, the colour 
varying depending on the position related to the plane of the 
molecule. Data from both these systems were analysed using a 
Microvax II mini computer.
7.3. RESULTS
7.3.1. Comparison of the alleraenicitv of three reactive 
dyes
Initial examination of the dyes R014, RB4 and RB2 both alone 
and conjugated to protein administered with and without 
carrageenan showed that free dye did not induce reaginic 
antibody (Table 7.3). Increasing the level of R014 
administered from 10 ug to either 100 or 500 ug/ml did not 
stimulate reagin production. Using the OA conjugates only 
the R014-0A produced a transient reaginic antibody response 
in the absence of carrageenan, however, this could only be 
detected using the R014-BSA conjugate for challenge. When 
administered together with carrageenan both R014-0A and RB4- 
OA conjugates produced sustained reaginic responses which 
could be detected using free dye or BSA-conjugate for PCA 
challenge. The RB2-0A conjugate on the other hand failed to 
induce any anti-hapten reaginic antibody, but like the other
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Table 7.3. Comparison of reaginic antibody responses induced by R014, 
RB4 and RB2 administered either as free dve or conjugated to ovalbumin 
administered with and without carrageenan
Antigen
CGN 
1 mg
Number of (animals responding
Day 14 Day 21 Day 42
D C P D C P D C P
R014 - 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
R014 + 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
R014-OA - 0/3 2/3 3/3 0/3 0/3 3/3 0/3 0/3 1/2
R014-0A + 3/3 3/3 3/3 3/3 3/3 3/3 2/3 2/3 2/2
RB4 - 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
RB4 + 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
RB4-OA - 0/3 0/3 2/3 0/3 0/3 2/3 0/3 0/3 2/3
RB4-OA + 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3
RB2 - 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
RB2 + 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
RB2-0A - 0/3 0/3 2/3 0/3 0/3 2/3 0/3 0/3 1/3
RB2-0A + 0/3 0/3 3/3 0/3 0/3 3/3 0/3 0/3 3/3
PCA challenge - D = dye alone; C = dye-BSA conjugate; 
P = protein carrier-ovalbumin
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dye conjugates, it produced an anti-carrier response even in 
the absence of carrageenan.
7.3.2. Assessment of the alleraenicitv of a range of low 
molecular weight materials
Using the conditions most favourable for reagin production, 
reaginic antibody responses from animals treated with either 
chemical or chemical conjugated to either RS or OA are shown 
in the following tables Table 7.4 for R014; Table 7.5 for 
R04; Table 7.6 for R013; Table 7.7 for RB4; Table 7.8 for 
RB2; Table 7.9 for LB3R; Table 7.10 for LR5B; Table 7.11 for 
LY4G; Table 7.12 for HIC and Table 7.13 for Pen.
Using the treatment conditions most favourable for 
reagin production, ovalbumin conjugates administered with 
carrageenan, all chemicals except RB2-0A induced production 
of reaginic antibody. However, when the conjugate of RB2-0A 
was produced at 60°C, a transient response was observed in 
one animal only on day 14. The R014-0A, R04-0A, LB3R-0A, 
LR5B-0A, LY4G-0A, Pen-OA and HIC-OA conjugates also induced 
production of reaginic antibody in the absence of 
carrageenan. In general these responses were transient. The 
R013-0A and RB4-0A conjugates in the absence of carrageenan 
were negative.
Responses obtained using RS conjugates administered with 
carrageenan were more variable in that R013-RS, R04-RS and 
LB3R-RS conjugates failed to induce reaginic antibody, whilst 
transient responses were induced by the R014-RS, RB4-RS and 
LR5B-RS conjugates. LY4G-RS, Pen-RS and HIC-RS conjugates 
produced good responses, which in the case of HIC-RS was
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Table 7.4. Reaginic antibody responses induced bv intraperitoneal
administration of reactive orange 14 conjugated to either
rat serum or ovalbumin
Animal
Treatment
BN
2
ADE mm
number Protein conjugate CGN 14 21 28 days
34.33 R014-RS + 0 95 0
34.34 0 0 0
34.35 0 255 0
34.36 0 0 0
9.7 R014-OA 132 0 0
9.8 132 0 0
9.9 0 0 0
9.10 R014-0A + 283 452 490
9.11 314 490 346
24.1 227 154 201
24.2 117 177 284
44.1 201 227 314
44.2 227 255 380
Table 7.5. Reaginic antibody responses induced bv intraperitoneal
administration reactive orange 4 coniugated to either
rat serum or ovalbumin
BN
Treatment ADE mm^
Animal number Protein conjugate CGN 14 21 28 days
43.21 R04-RS + 0 0 0
43.22 0 0 0
43.23 0 0 0
43.24 0 0 0
40.43 R04-OA 0 0 0
40.44 314 0 0
40.45 255 284 255
31.13 R04-0A + 314 154 NT
31.14 346 380 NT
31.15 255 255 NT
31.16 255 314 NT
39.19 0 0 0
39.20 255 201 227
39.21 255 255 201
NT = Not tested
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Table 7.6. Reaginic antibody responses induced bv intraperitoneal
administration of reactive orange 13 coniugated to either
rat serum or ovalbumin
BN
Animal number
Treatment ADE mm^
Protein conjugate CGN 14 21 28 days
43.25 R013-RS + 0 0 0
43.26 0 0 0
43.27 0 0 0
43.28 0 0 0
40.40 R013-OA 0 0 0
40.41 0 0 0
40.42 0 0 0
31.17 R013-OA + 201 284 NT
31.18 0 0 NT
31.19 0 0 NT
31.20 380 416 NT
39.16 0 0 0
39.17 314 346 0
39.18 26 113 0
NT = Not tested
Table 7.7. Reaginic antibody responses induced bv intraperitoneal
administration of reactive! blue 4 coniugated to either rat
serum or ovalbumin
BN
Treatment 2ADE mm
Animal number Protein conjugate CGN 14 21 28 35 days
43.29 RB4-RS + 0 0 419 0
43.30 0 0 0 0
43.31 0 0 0 0
43.32 0 0 0 0
9.31 RB4-0A 0 0 0 NT
9.32 0 0 0 NT
9.33 0 0 0 NT
31.21 RB4-0A + 201 177 NT NT
31.22 177 255 NT NT
31.23 0 0 NT NT
31.24 64 177 NT NT
39.10 190 201 177 NT
39.11 177 177 201 NT
39.12 284 255 314 NT
NT = Not tested
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Table 7.8. Reaginic antibody responses induced bv intraperitoneal
administration of reactive blue 2 coniugated to either rat
serum or ovalbumin
BN
Animal number
Treatment 2ADE mm
Protein conjugate CGN 14 21 28 days
9.19 RB2-OA 0 0 0
9.20 0 0 0
9.21 0 0 0
9.22 RB2-0A + 0 0 0
9.23 0 0 0
9.24 0 0 0
39.13 0 0 0
39.14 0 0 0
39.15 0 0 0
40.55 RB2-0A + 0 0 0
40.55 60°C conjugation 0 0 0
40.55 255 0 0
Table 7.9. Reaginic antibody responses induced bv intraperitoneal
administration of Lanasol blue 3R coniugated to either
rat serum or ovalbumin
BN
Treatment 2ADE mm
Animal number Protein conjugate CGN 14 21 28 days
37.24 LB3R-RS + 0 0 0
37.25 0 0 0
37.26 0 0 0
37.27 0 0 0
40.31 LB3R-0A 201 177 113
40.32 255 0 0
40.33 314 0 0
37.21 LB3R-OA + 491 227 346
37.22 416 227 380
37.23 0 0 0
39.1 284 227 227
39.2 0 0 0
39.3 314 346 177
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Table 7.10. Reaginic antibody responses induced bv intraperitoneal
administration of Lanasol red 5B coniugated to either
rat serum or ovalbumin
Animal number
Treatment
BN 
ADE mm^
Protein conjugate CGN 14 21 28 days
37.31 LR5B - RS + 0 0 0
37.32 0 0 0
37.33 0 0 0
37.34 0 79 0
40.34 LR5B - OA 346 255 201
40.35 177 0 0
40.36 0 0 0
37.28 LR5B - OA + 255 380 284
37.29 255 314 227
37.30 227 225 255
39.4 416 314 284
39.5 284 416 154
39.6 319 452 346
Table 7.11. Reaginic antibody responses induced bv intraperitoneal
administration of Lanasol yellow 4G coniugated to either
rat serum or ovalbumin
BN
Treatment ADE mm^
Animal number Protein conjugate CGN 14 21 28 days
37.38 LY4G-RS + 0 0 0
37.39 0 201 346
37.40 0 0 0
37.41 0 201 380
40.37 LY4G-0A 314 255 0
40.38 284 255 0
40.39 201 0 0
37.35 LY4G-OA + 0 0 0
37.36 314 491 616
37.37 452 531 707
39.7 346 284 314
39.8 346 284 255
39.9 416 380 416
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Table 7.12. Reaginic antibody responses induced bv intraperitoneal 
administration of hexvl isocyanate coniugated to either 
rat serum or ovalbumin
PVG
Treatment
2
ADE mm
Animal number Protein conjugate CGN 14 21 28 days
45.7 HIC-RS + 154 284 284
45.8 154 177 255
45.9 0 255 255
45.4 HIC-OA 0 0 0
45.5 0 0 0
45.6 0 0 0
45.10 HIC-OA + 60 154 284
45.11 201 314 314
45.12 154 314 314
BN
Treatment 2ADE mm
Animal number Protein conjugate CGN 14 21 28 days
43.37 HIC-RS + 113 227 154
43.38 201 201 133
43.39 255 255 386
43.40 177 314 113
43.33 HIC-OA 154 64 0
43.34 0 0 0
43.45 201 113 154
43.36 177 79 177
43.41 HIC-OA + 314 255 285
43.42 346 314 255
43.43 346 314 154
43.44 314 416 346
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Table 7.13. Reaginic antibody responses induced bv intraperitoneal 
administration of penicillin G coniugated to either 
rat serum or ovalbumin
Animal number
Treatment
PVG 
ADE mm^
Protein conjugate CGN 14 21 28 days
47.1 Pen-RS + 0 176 113
47.2 0 176 153
47.3 0 201 132
47.10 Pen-OA _ 0 0 0
47.11 0 0 0
47.12 0 0 0
47.4 Pen-OA + 201 254 227
47.5 201 201 227
47.6 226 153 227
BN
Treatment ADE mm^
Animal number Protein conjugate CGN 14 21 28 days
47.7 Pen-RS + 0 201 227
47.8 0 572 176
47.9 0 NT 314
40.46 Pen-OA _ 95 201 133
40.47 113 177 95
40.48 154 227 133
40.51 Pen-OA + 616 491 416
40.52 346 346 380
40.53 314 380 380
40.54 416 452 380
NT = Not tested
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obtained by day 14 after a single treatment dye-specific IgG 
responses in sera from animals treated with ovalbumin 
conjugates varied from 0 to 256% of the reference serum, 
whilst those animals receiving rat serum conjugates produced 
lower levels of dye-specific IgG antibody ranging from 0 to 
37%.
Respiratory responses obtained after inhalation 
challenge with free material and material-BSA conjugates are 
shown in Table 7.14. All PCA-positive animals challenged 
with BSA conjugate produced the characteristic periodic 
notching breathing pattern. However when free material was 
employed LB3R and HIC failed to induce respiratory symptoms. 
Although free LY4G and Pen could both elicit respiratory 
responses during inhalation challenge, this did not occur in 
all PCA-positive animals.
The summary results of reaginic antibody responses and 
inhalation challenge are shown in Table 7.15. The materials 
have been ranked according to the presence and duration of 
the reaginic responses, together with the presence of 
periodic breathing patterns following inhalation challenge. 
Allergenicity of the dyes appeared to be related to the 
amount of dye bound to the carrier protein. Table 7.16 shows 
the various hapten densities produced by these dyes 
conjugated to ovalbumin and bovine serum albumin (BSA). The 
amount of material bound to BSA was greater than that for the 
OA conjugates. In general reaginic responses were not 
induced at hapten densities below that of 1.6:1. However, 
with all dyes even with RB2-0A at a density as low as 0.6:1, 
good IgG responses were present.
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Table 7.14. Respiratory responses observed after inhalation challenge 
of Brown Norway rats treated bv intraperitoneal injection of 
dve-ovalbumin with carrageenan
Sensitising
antigen
Inhalation antigen challenge
Free material BSA conjugate
R014-0A Animal-No. 11.1 11.2 11.3 11.5 11.6 28.27
ADE mm 0 154 ± ± 177 416
INH — + - - + +
R04-OA Animal-No. 39.19 39.20 39.21 28.17 28.18
ADE mm 0 227 201 0 491
INH — + + - +
R013-0A Animal-No. 41.25 14.26 41.27 28.2 28.22
ADE mm 0 0 227 0 255
INH - — + - +
RB4-0A Animal-No. 39.10 39.11 39.12 31.24 31.24 31.25
ADE mm 177 201 314 177 201 177
INH + + + + + +
RB2-OA Animal-No. 39.13 39.14 39.15
ADE mm NT NT NT 0 0 0
INH - — —
LB3R-0A Animal_No. 39.1 39.2 39.3 37.21 37.22 37.23
ADE mm 22 0 117 346 380 0
INH — — - + + —
LR5B-OA Animal_No. 39.4 39.5 39.6 37.28 37.29 37.30
ADE mm 284 154 346 284 314 314
INH + + + + + +
LY4G-OA Animal_No. 39.7 39.8 39.9 37.35 37.36 37.38
ADE mm 314 255 416 0 346 531
INH + - + - + +
Pen-OA Animal_No. 40.52 40.53 40.54 40.48 40.50 40.51
ADE mm 380 380 380 133 380 416
INH - + - + + +
HIC-OA Animal-No. 43.36 43.37 43.38 43.42 43.43 43.44
ADE mm 117 154 133 133 380 113
INH + + +
INK = Inhalation challenge
± = Bluing at site of injection not measurable
- = No response
+ = Positive response - periodic notching in breathing pattern observed
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Table 7.15. Summary of reaginic antibody and respiratory 
responses observed in Brown Norway rats treated with 
chemicals conjugated with either rat serum or ovalbumin
Antigen
RS-conjugate OA conjugate Inhalation challenge
Day 14 Day 21# -CGN +CGN Free material BSA-conj ugate
RB2 NT NT 0/3 0/6 - -
RB2 60°C NT NT NT 1/4* - —*
R013 0/4 0/4 0/3 4/7* + +
RB4 0/4 1/4^ 0/3 5/6® + +
LB3R 0/4 0/4 3/3^/® 4/6® - +
R04 0/4 0/4 2/3^/® 5/6® + +
LR5B 0/4 1/4^ 2/3^/® 6/6® + +
R014 0/4 2/4^ 2/3^ 6/6® + +
LY4G 0/4 2/4^® 3/3^ 5/6® + +
Pen 0/3 3/3^® 3/3® 3/4® + +
HIC 4/4® 4/4® 3/4*/® 4/4® - +
NT = Not tested 
- = Negative response
= Positive response, periodic notching in breathing pattern observed 
= Animals not PCA +ve at the time of challenge 
= transient response 
= sustained response
= mixture of sustained and transient responses 
= Late sustained response 
= Day 21 onwards
+
*
t
s
t/s
Ls
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Table 7.16. Comparison of the hapten densities 
produced bv various reactive dves conjugated 
with either ovalbumin or bovine serum albumin
Hapten densities dye:protein 
Conjugated protein
Dye Ovalbumin Bovine serum ovalbumin
R014 13.94 1* 19.04:1
R04 3.56 1 13.40:1
R013 1.64 1 3.30:1
RB4 4.48 1 8.95:1
RB2 0.61 1 (1.64:1)+ 2.84:1
LB3R 4.10 1 7.50:1
LR5B 4.90 1 10.80:1
LY4G 7.50 1 12.31:1
* Mean of 3 conjugates 
+ Conjugation carried out at 60°C.
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The comparison of the responsiveness of BN and PVG rat 
strains in this system using HIC and Pen conjugates showed 
that the PVG performed well when the allergen was 
administered with carrageenan (Tables 7.12 and 7.13 
respectively). However, in the absence of carrageenan, 
reaginic antibody production was not induced.
7.3.3. Examination of cross-reactivitv between the reactive 
dves
Results from the examination of cross-reactivity between 
R014, R04 and R013 are shown in Table 7.17. Using "pooled 
serum samples" for the PCA assay, positive PCA responses 
could be elicited using sera from R013-0A treated animals 
challenged with R04-BSA and similarly R013-BSA elicited a PCA 
response using sera from animals sensitised with R04.
Neither R013-BSA or R04-BSA could elicit PCA responses using 
sera from R014-0A treated animals and vice versa. Animals 
selected from each treatment group and challenged with each 
of the BSA conjugates by inhalation exhibited respiratory 
responses which followed the same pattern as those produced 
by the PCA responses.
Investigation of the cross-reactivity between the 
anthraquinone dyes RB2, RB4 and LB3R revealed that there was 
some degree of cross-reactivity between all the blue dyes 
examined (Table 7.18). Conjugates of RB2-BSA and LB3R-BSA 
were able to elicit PCA responses using sera from all 
anthraquinone dye-OA treated animals, whilst RB4-BSA was only 
able to elicit responses using sera from LB3R-0A treated 
animals. Inhalation challenge showed that RB2-BSA and
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Table 7.17. Cross-reactivitv between reactive orange 4, 13 and 14 
determined bv passive cutaneous anaphvlaxis fPCAl and 
inhalation challenge
Sensitizing
antigen
Animal
number
2
ADE mm
Challenge
antigen
ADE mm^ 
pooled Sera
Inhalation
challenge
R04-OA 28.18 491 R04-BSA 177 +
28.19 346 R013-BSA 227 +
28.20 314 R014-BSA 0
R013-0A 28.23 314 R04-BSA 255 +
28.22 255 R013-BSA 177 +
28.24 227 R014-BSA 0
R014-0A 28.25 416 R04-BSA 0
28.28 402 R013-BSA 0 -
28.27 416 R014-BSA 855 +
- = no response
+ = positive response - periodic "notching" in breathing pattern observed
Table 7.18. Cross-reactivitv between reactive Blue 2, Blue 4 and
Lanasol Blue 3R determined bv passive cutaneous
anaohvlaxis (PCA) and inhalation challenge
Sensitising Animal 2 Challenge ADE mm^ Inhalation
antigen number ADE mm antigen pooled Sera challenge
RB2-OA 60®C 40.55 255 RB4-BSA 0 NT
LB3R-BSA 133 NT
LB3R-0A 48.18 201 RB2-BSA 452 +
48.19 573 RB2 NT -
48.20 531 RB4-BSA 85 +
RB4-OA 48.21 255 RB2-BSA 380 +
48.22 284 RB2 NT -
48.23 255 LB3R-BSA 237
NT = Not tested 
- = No response
+ = Positive response
observed.
- periodic "notching" in breathing pattern
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RB4-BSA could elicit responses in LB3R-0A-treated animals, 
whereas LB3R-BSA did not elicit a response in the RB4-0A 
treated animal. The use of free RB2 for inhalation challenge 
failed to elicit respiratory responses.
7.3.4. Examination of the relationship between dve structure 
and alleraenicitv using computer graphic molecular modelling 
techniques
Examination of dye structure using the SYBYL program 
produced a picture of van der Waals dot surface which was 
colour coded by electrostatic potential energy for R04 and 
R013 as shown in Figures 7.2 and 7.3 respectively. The areas 
of high potential energy are shown in orange and those of low 
potential energy in green, and the lowest in blue. As might 
be expected these molecules were very similar, the 
chromophore presenting a higher potential energy than the 
reactive portion of the molecule.
Further analysis of electrostatic potential energy 
[for each molecule using the COSMIC program produced a more 
detailed picture as shown in Figures 7.4 and 7.5 for R04 and 
R013 respectively. The plane of the molecular structure is 
shown in white. Electrostatic potential energy can be either 
positive or negative. Those values with a low or negative 
electrostatic potential energy are referred to as minima, and 
those with a high electrostatic potential energy as maxima. 
The electrostatic potential energy minima are shown in green, 
with those above the plane of the molecule in light green and 
those below in pale yellow. The electrostatic potential 
energy maxima are shown in red, with those above the plane of
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Figure 7.2. van der Waals dot surface representation of
the R04 molecule
Figure 7.3. van der Waals dot surface representation of
the R013 molecule
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Figure 7.4. Distribution of the electrostatic potential 
energy in the R04 molecule
Q
I
e
# o
G
MINIMA MAXIMA
Code No. Colour Code No. Colour
1 2.9 Light yellow 1 170.0 Pink
2 5.8 Green 2 194.0 Red
3 — 6.2 Light green 3 846.0 Orange
4 -3.7 Light green 4 661.0 Orange
5 5.9 Light green 5 216.0 Orange
6 3.4 Light green 6 614.0 Orange
7 26.7 Light yellow 7 325.0 Pink
8 699.0 Pink
Minima : Green Maxima : Red
+Z : Light green +Z : Orange
-Z : Light yellow -Z : Pink
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Figure 7.5. Distribution of electrostatic potential energy
in the R013 molecule
et
m% yeie 0
e G
MINIMA MAXIMA
Code No. Colour Code No. Colour
1 -7.8 Light yellow 1 630.2 Pink
2 -8.8 Light yellow 2 895.2 Pink
3 4.4 Light yellow 3 997.0 Pink
4 -7.4 Light green 4 954.0 Orange
5 —6.8 Light green 5 987.0 Orange
6 5.3 Light green 6 900.0 Orange
7 2.1 Light green 7 835.0 Orange
8 23.5 Light green
Minima : Green Maxima : Red
+Z : Light green +Z : Orange
-Z ; Light yellow -Z : Pink
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the molecule in orange and those below in pink. The coded 
numbers provide a key for values of the electrostatic 
potential energy (kcal/mol) in that area of the molecule.
The circles surrounding the coded numbers do not relate to 
the size of the area over which the given electrostatic 
potential energy is to be found. Where the view of an area 
is obscured by the presence of a value above or on the plane 
of the molecule it is shown only as the coded number. The 
major difference between the two dyes was found to be in the 
area of the reactive group, where a lower potential energy 
was associated with the dichlorotriazine group of the R04; 
the areas electrostatic potential energy for the reactive 
portions of the molecules were 614, 669, 325 and 26.7 
kcal/mol for R04 compared to those of 987, 835, 900 and 23.5 
kcal/mol for R013. The differences in electrostatic 
potential energy produced by the presence of either the 
chlorine or amino group on the triazine ring extended to the 
whole molecule. There were more areas with a negative 
electrostatic potential energy within the chromophore portion 
of the R013 molecule, the energy levels being -7.8, -8.8,
-7.4 and -6.8 kcal/mol compared to -6.2 and -3.7 kcal/mol for 
the R04 chromophore.
7.4. DISCUSSION
In these studies, administration of free dye failed to induce 
reaginic antibody formation, however, once bound to a protein 
carrier it was possible to induce dye specific reaginic 
antibody. The sensitisation protocol which employed the use 
of material conjugated to either autologuous (RS) or
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heterologous (OA) carrier proteins in the presence or absence 
of carrageenan provided a differential picture of 
allergenicity. It became apparent that the choice of carrier 
protein was an important factor in determining the relative 
allergenicity of those materials examined. Within the range 
of materials examined and responses obtained the use of RS 
conjugates identified the more potent allergens such as HIC 
and Pen, whereas the use of OA conjugates was necessary for 
the detection of the weaker allergens such as R013 and RB4. 
Comparison of the ability of BN and PVG rat strains to 
produce reaginic antibody after intraperitoneal 
administration of allergen showed the BN strain to be the 
most suitable, since the PVG strain was not responsive when 
carrageenan was omitted from the treatment regime for Pen-OA 
and HIC-OA. Thus with the PVG rat strain, there is the 
possibility that materials with weak allergenicity such as 
R013 might not be identified, even in the presence of 
carrageenan.
Use of free dye for PCA challenge showed that PCA 
responses could be elicited using free R014 and RB4 for 
challenge. Binding of these dyes with serum proteins may 
have occurred in vivo thus providing a "natural" hapten- 
protein conjugate. However, the use of free dye did not 
identify all hapten-specific responses, since two animals 
treated with R014-0A without adjuvant (Section 7.3.1.) could 
only be identified using the R014-BSA conjugate for PCA 
challenge. This may reflect the amount of antibody present 
on the surface of the mast cell. Therefore, in all studies 
BSA conjugates were used for PCA challenge.
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The possibility of using self protein (RS) for 
presentation of allergen in order to provide a more realistic 
model was investigated, and RS conjugates were found to be 
useful in distinguishing between "moderate" and "strong" 
allergens, but were not effective in the identification of 
"weak" allergens. Conversely the more allergenic carrier,
OA, was found to be suitable for the identification of weak 
allergens.
The dyes, although considered to be highly reactive 
materials designed to bind to certain fibres, were relatively 
less antigenic than either Pen or HIC. However, the 
allergenicity of Pen and HIC was not examined using 
conjugates produced under physiological conditions.
_ Compounds such as toluene diisocyanate (TD3/) and(HIC are used
A V
in the plastics industry as catalysts and cross-linking
agents, and bind readily to the free amino groups on protein 
(Gillner, 1989; Scott and Roff, 1971), therefore in order to 
produce protein conjugates, the pH and temperature at which 
conjugation is carried out has to be carefully controlled t^ 
limit polymerisation and damage to the protein. In these 
studies HIC was considered the most allergenic material of 
those examined, as it was the only material to induce 
reaginic responses after a single administration of the RS 
conjugate. The use of free HIC for inhalation challenge 
failed to elicit respiratory symptoms. Similar observations 
have been made by Karol et al. (1979) when using the guinea 
pig. The reasons for this lack of response is that HIC is a 
monoisocyanate and although it can be bound by antibody on 
the surface of the mast cell, as a monovalent antigen, it
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cannot produce the cross-linking of antibody necessary to
trigger degranulation.
All dyes examined were recognised as antigenic by the 
immune system as determined by the presence of antigen- 
specific IgG. However, there appeared to be differences in 
the degree of allergenicity between the dyes. In general, 
the blue anthraquinone dyes appeared to be less antigenic 
than the red, orange and yellow azo dyes. This is in 
agreement with the observations of Topping et al. (1989) for 
the Lanasol wool dyes and Docker et al. (1987) for the cotton 
dyes which indicated that there was a lower incidence of 
workers with positive RAST tests against blue, brown and
green dyes.
Since the degree of binding of dye to carrier protein is 
a function of the reactive portion of the dye, lower hapten 
densities were produced by the monochlorotriazine dyes.
Studies into the binding the monochlorotriazine dye 
reactive red to body proteins suggested that cysteine thiol 
groups, primary amino groups of lysine, and the imidazole 
group of histidine were potential sites of binding, depending 
upon pH and the protein involved (Shore, 1968). This is 
reflected in the fact that in all cases the hapten density of 
the OA conjugates was always less than that of BSA 
conjugates. The monochlorotriazine dyes R013 and RB2 
appeared to be less allergenic and this may be related to the 
amount of protein-bound dye, for when the hapten density of 
the RB2-0A conjugate was increased by conjugation at 60°C a 
limited response could be induced. Thus it was necessary for 
a certain amount of dye to be bound to protein in order to
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induce reaginic antibody production. This factor has also 
been shown to be important in the allergenicity of penicillin 
conjugates (Lee, et al., 1985), when Pen-human serum albumin 
conjugates were found.to be more allergenic at higher hapten 
densities.
The allergenicity of the reactive dyes may not be 
totally a function of protein binding capacity, for if the 
ability to elicit respiratory responses were solely a 
function of in vivo binding one might expect all the dyes 
possessing the acrylobromide group to elicit respiratory 
responses, yet LB3R failed to do so.
The immobilisation of reactive dyes by covalent binding 
to resins has been used to provide "non-specific" affinity 
medium for the separation of proteins (Stellwagen, 1990).
Thus sites other than the reactive portion of the dye, i.e. 
the chromophore are available to bind electrostatically to 
proteins. The amount of crude protein extract bound by these 
immobilised dyes varies between 5-80% depending upon the dye 
employed, and amongst those dyes binding protein RB2 was 
found to bind the least (Stellwagen, 1990). In present 
studies, although RB2, once bound to protein (RB2-BSA) could 
elicit respiratory responses in RB4-sensitised animals, when 
conjugated to OA under physiological conditions it did not 
induce reaginic responses. Similarly free LB3R also failed 
to elicit respiratory responses, however, when conjugated to 
OA it could induce reaginic antibody production even in the 
absence of carrageenan.
Examination of the specificity of reaginic antibody 
produced by the dyes together with computer graphic molecular
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modelling of two selected dyes was carried out in order to 
determine if there was a relationship between structure and
allergenicity. Examination of antibody specificity revealed
that antibody was not directed against the reactive site of
the dye. This was indicated by the lack of cross-reactivity 
between R014 and R04 which share the same dichlorotriazine 
reactive group. In addition the degree of cross-reactivity 
between the anthraquinone dyes which possessed different 
reactive sites also indicated that reaginic antibody was 
directed against the chromophore portion of the molecule.
Relating the findings of the cross-reactivity studies to 
the computer modelling, certain similarities between the 
molecular structures of R04 and R013 and their allergenicity 
were evident. An overall picture of the dye molecules was 
presented as van der Waals dot surface using the SYBYL 
program which determined a/"best fit"/for the calculated 
surface electrostatic potential energy and volume. This 
analysis of the R04 and R013 molecules highlighted the 
similarities between the two molecules, showing that in both 
instances the reactive group possessed a lower electrostatic
potential energy than the chromophore, and as such would be 
more likely to bind to positive areas on the protein.
Analysis using the COSMIC program: provided more
detailed information on the position and level of 
electrostatic potential energy. The reactive group of the 
/ R04 molecule possessed a lower electrostatic potential energy 
than that of R013 which may account for the higher hapten 
density of the R04 conjugates.
( Ni)
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Analysis using the COSMIC program revealed areas of 
negative potential energy on the chromophore of the R013 
molecule which were not apparent from van der Waals dot 
surface, perhaps because they are hidden within the molecule. 
The more negative electrostatic potential energy levels on 
the dye molecule imply a stronger interaction between areas 
of positive electrostatic potential energy on proteins and 
vice versa. Considering the levels of low electrostatic 
potential energy associated with the chromophore of R013 
there is the possibility that once R013 is bound it is 
potentially more allergenic than R04. However, if the 
alteration of a single group on the reactive portion of the 
dye can produce these changes, then more profound changes in 
surface electrostatic potential energy are likely to occur 
once the dyes are bound to protein.
Thus the allergenicity of these dyes appears to be a        ^  ^      ^  .
complex interaction between the capacity of the reactive 
portion of the dye to bind covalently to proteins under 
physiological conditions and the potential of the chromophore 
to provide the necessary stimulus to trigger the development 
of reaginic antibody.
The way in which dyes are presented by inhalation to the 
immune system is either by in vivo binding to respiratory 
proteins or bound to respirable organic material. In these
studies the system of presenting antigen bound to OA has been 
shown to be suitable for the identification of materials with 
allergic potential. The inclusion of material bound to RS 
also provides a means of determining allergenic potency.
'hjp I Respiratory challenge with free material would identify those
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materials which could elicit reactions directly. This type 
of approach may provide the basis of a screening system for 
respiratory sensitisers.
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CHAPTER 8
General Discussion
The present studies have been directed towards the
development of a rat model for assessing the potential of low
molecular weight materials to induce Type I reaginic (IgE)
antibody-mediated respiratory allergy. A successful model
needs to address both the induction phase in which animals
are treated to induce reagin production and so rendered
"sensitive", and the elicitation phase where antigen-specific
respiratory responses are produced following inhalation
challenge. Ideally in such a model both induction of
sensitivity and elicitation of respiratory responses should
be carried out by inhalation exposure.
Immune recognition and the course of an immune response
to inhaled antigen is an extremely complex process, and the
interaction between the factors influencing the development
the
of sensitisation via the respiratory route in/present studies 
reflected this complexity. The elements of experimental 
design to be considered when developing an animal model for 
induction of sensitivity by the respiratory route are 
outlined schematically in Fig.8.1. In the rat, the immune 
response to inhaled materials has been shown normally to be 
directed toward the development of tolerance (Holt & 
McMenamin, 1989).
In addition to the genetic constitution of an 
individual, external environmental factors are also important 
in determining whether the shift toward IgE production is 
triggered and sensitivity induced. Therefore, in order to
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Figure 8.1. Possible factors influencing the induction
of respiratory allergy
Material 
(Hapten density)
Conditions of atmosphere 
generation
Particle size distribution 
atmospheric concentration
Chosen species 
(Genetic constitution)
Physiology
Number and duration 
of exposures
T
Dose received
Site and deposition
Immune recognition
Environmental
factors - - - 4 —  —  —  — - - Adj uvant
Development of tolerance Development of hypersensitivity
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provide an animal model for Type I reagin-mediated 
hypersensitivity it is a primary requirement to ensure that 
the experimental system is optimised for IgE production.
This usually requires the inclusion of an adjuvant into an 
immunisation regimen to modulate the class of antibodies 
produced. For example, the adjuvants, Freunds complete 
adjuvant and muramyl dipeptide, have been reported to reduce 
antigen-specific IgE titres (Hakamoka et al., 1974; Kishimoto 
et al., 1979 respectively), whereas the use of carrageenan 
has been shown not only to result in production of reaginic 
antibody but also to render the animals sensitive to 
secondary exposure (Nicklin et al., 1985). This effect of 
carrageenan by the i.p. route was also observed in animals 
treated with carrageenan prior to inhalation exposure, 
in which antigen-specific reaginic responses could be 
repeatedly boosted (Section 4.3.1.). This was in contrast to 
the development of tolerance described by Sedgwick and Holt
(1984) using a protocol which did not involve the use of 
adj uvant.
In the present investigations the timing of adjuvant and 
allergen administration was shown to be of primary importance 
in the induction of sensitivity. Whereas administration of 
allergen together with carrageenan proved to be an effective 
method for inducing reaginic antibody production following 
intraperitoneal administration, it was necessary to 
administer carrageenan 7 days prior to antigen exposure to 
induce sensitivity by inhalation exposure. This suggests 
that the administration of carrageenan altered immune 
responsiveness in advance of inhalation exposure to allergen.
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which in turn predisposed the immune response toward
formation of reaginic antibody.
Experimentally it has been shown that the IgE response
& Marcelletti
is highly T cell-dependent (Katz/^  1983) . Arising from 
investigations using human peripheral blood T cell clones it 
has been suggested that production and regulation of IgE 
synthesis is dependent not only on the interaction between 
cognate B and T cells but also the temporal production of the 
B cell growth factor interleukin 4 (IL-4) by primed T cells 
(Vercelli et al., 1989). IL-4 not only causes clonal 
proliferation but has also been shown to be involved in the 
switching of the antibody class produced from IgG to IgE 
(Lebman & Coffman, 1988). In an in vitro experimental mouse 
/  system it has been shown that whereas IgE production is
promoted through the action of IL-4 it is suppressed by gamma 
interferon (IFNyj (Snapper & Paul, 1987). Therefore the 
action of these cytokines is considered to be particularly 
important in both induction and regulation of IgE responses 
(Romagnani, 1990).
Administration of carrageenan has been shown to impair 
the production of IFNY, by mice stimulated with 
staphylococcal enterotoxin A (Suzuki et al., 1986). It is 
therefore possible that the activity of adjuvants such as 
carrageenan and B. pertussis that induce reaginic antibody 
production may be related to their ability to suppress IFNY 
production, thereby removing a mechanism for suppression of 
production and/or action of IL-4. This may not be their sole 
mode of action for Ishizaka and co-workers (Ishizaka, 1983; 
Ishizaka et al., 1987) have suggested that the activities of
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this type of adjuvant are mediated through the production of 
soluble IgE isotype-specific factors which bind IgE and 
regulate IgE synthesis. These mechanisms are clearly not 
necessarily mutually exclusive and it seems likely that the 
observed response represents the interaction between various 
processes operating in the regulation of the IgE response. 
Future work into ways in which adjuvants modify immune 
responsiveness should not only cast light upon the regulatory 
mechanisms involved in IgE production, but also increase the 
possibility of developing an animal model.
Whereas pre-treatment with carrageenan was found to be 
necessary for induction of reaginic antibody by inhalation 
exposure, the time interval between adjuvant administration 
and allergen exposure was less restrictive when the priming 
exposure was carried out by the intraperitoneal route. This 
may simply reflect differing levels of antigen received, or 
that the relationship between carrageenan, allergen and 
cellular elements of the immune system differ following 
intraperitoneal immunisation. The importance of the 
interaction between adjuvant and allergen has been observed 
in several experimental systems. B. pertussis toxin, an 
adjuvant which is employed for the induction of IgE antibody, 
has been shown to increase expression of low affinity IgE Fc 
receptor on mouse splenic lymphocytes (Munoz & Peacock,
1990), an activity which has been shown to be associated with 
the activity of IL-4 (Hudach et al., 1987). This increase in 
receptor expression was found to be greatest in the presence 
of both pertussis toxin and allergen (OA).
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Certain allergens such as platinum salts have been found 
to enhance non-specifically reaginic antibody formation to 
other allergens, e.g. ovalbumin (Murdock & Pepys, 1984b).
The allergen castor bean dust possesses the unusual 
characteristic that it can sensitise both atopic and non- 
atopic individuals (Thorpe et al., 1988). During 
investigation of the effect of castor bean toxin (ricin) on 
reaginic responses of rats to phospholipase A^, Diaz-Sanchez 
& Kemeny (1990) found that the levels of antigen-specific IgE 
and the helper/suppressor (CD4/CD8) ratios were markedly 
increased. They showed that these cellular changes were 
attributable to an increased sensitivity of the CD8 
suppressor cells to ricin. The findings using the above 
experimental systems together with the observations made in 
the present studies underline the complexity of the various 
interactions that may exist between adjuvant, environmental 
factors and the inherent or novel characteristics of a 
particular allergen.
The genetic constitution of the individual or 
experimental animal is a well known predisposing factor in 
determining the development of hypersensitivity reactions. 
Comparison of the performance of the BN and PVG strains of 
rat carried out at various stages during these studies, 
indicated that the selection of a suitable rat strain was a 
key consideration in determining the nature of the immune 
response observed.
The responsiveness of the two strains of rat, as 
determined by their ability to produce reaginic antibody and 
develop respiratory responses, was comparable when allergen
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was administered together with carrageenan by intraperitoneal 
injection. However, when carrageenan was omitted from the 
sensitisation regimen the PVG did not produce reaginic 
antibody, which was particularly evident when considering the 
response to the more potent allergens HIC and Pen (Chapter 
7). These observations are in accordance with those of 
Nicklin et al. (1985), who demonstrated that reagin synthesis 
in the PVG rat did not occur in the absence of carrageenan. 
Nicklin et al. (1985) also demonstrated that pre-exposure to 
carrageenan in the PVG rat would induce reaginic antibody 
I following intraperitoneal injection of ovalbumin. Yet when 
ovalbumin was administered by inhalation following pre­
exposure to carrageenan the PVG, unlike the BN, failed to 
produce reaginic antibody, suggesting that a different set of 
regulatory mechanisms were in place. This difference in 
response to inhaled allergen between the BN and PVG is 
emphasised by the fact that although respiratory responses 
could be achieved in sensitised animals from either strain, 
the cellular response following inhalation challenge differed 
markedly.
One of the reasons for the above observations may have 
been the presence of eosinophils in control BN lung lavage 
 ^ populations. The interaction of allergen with these cells 
could have provided the stimulus for the transient influx of 
macrophages observed two hours post allergen challenge 
(Section 4.3.3.). The accumulation of macrophages apparently 
occurred as a result of an antigen-specific response, and not 
as part of a reaction to the physical presence of antigen 
within the lung. As the macrophage response was not present
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in unsensitised rats this observation is considered
particularly relevant in the present context, since it is 
well established that macrophages as well as monocytes, 
lymphocytes and eosinophils have low affinity IgE receptors 
on their surface (Capron et al,, 1986; Spiegelberg, 1984) and 
are, therefore, available to participate in IgE mediated 
reactions.
Indeed the stimulation of human bronchoalveolar 
macrophages with anti-IgE antibody has shown that these 
macrophages can release a variety of inflammatory mediators, 
such as leukotriene (Rankin et al., 1982) leukotriene B^ , 
prostaglandin Fga, thromboxane Bg and the enzyme N-acetyl- 
glucosaminidase (Fuller et al., 1986). The latter enzyme has 
also been found in the bronchoalveolar fluid of asthmatic 
patients following allergen challenge (Tonnel et al., 1983). 
Furthermore prostaglandin F^a and leukotriene both have 
bronchoconstricting activity, whereas leukotriene B^ has 
potent chemotactic, chemokinetic and aggregatory properties 
for leucocytes (Henderson, 1987). Eosinophils together with 
neutrophils and helper T cells have been detected in broncho­
alveolar lavage samples associated with the late phase 
response in man (Metsger et al., 1987), whilst neutrophil 
infiltrates have been observed 24 hrs after antigen challenge 
in the rat (Blythe et al., 1986). Gosset et al. (1984) has 
demonstrated that alveolar macrophages from allergic 
asthmatics secrete a low molecular weight chemotactic factor 
for neutrophils and eosinophils after IgE-dependent 
stimulation. This suggests that the alveolar macrophage may
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play an important role in late phase responses in man.
Similar mechanisms may also be operative in the rat.
The responses of both strains of rat were similarly 
related to their ability to produce reaginic antibody 
following intraperitoneal exposure to allergen together with 
carrageenan, and to develop respiratory responses upon 
inhalation challenge. However, the two strains differed in 
the lung lavage cell populations present following inhalation 
challenge, and related to the ability to produce reaginic 
antibody following inhalation exposure. These observations 
apart from emphasising the difference in genetic constitution 
between the two strains of rat, would also suggest that 
induction of respiratory sensitivity is not just related to 
the ability to produce IgE.
Having selected an appropriate strain of experimental 
rat with a genetic predisposition to respond with the 
production of reaginic antibody, the most important factor in 
determining the outcome of inhalation exposure was found to 
be the characteristics of the aerosol used to present the 
allergen. Exposure to aerosols generated by several 
different methods produced a variety of responses which 
included no responses, good primary and secondary reaginic 
responses (Section 4.3.1.), transient reaginic responses 
(Section 6.3.2.3.) and transient respiratory responses in the 
absence of reaginic antibody (Section 6.3.2.1.); the number 
of responders and the quality of the response was dependent 
upon the aerosol used. It was apparent that the key factor 
in determining whether or not an IgE response was induced was 
the particle size distribution of the aerosol, which in turn
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determines the site of deposition and the dose retained 
within the lung. However, the type of aerosol used for 
challenge was not a critical factor in the elicitation of 
respiratory responses, indicating that "sensitised" mast 
cells were present either throughout the respiratory tract or 
at the sites of deposition. When free material was used for 
challenge, the onset of respiratory symptoms was delayed 
slightly, which may be indicative of the formation of 
conjugates in vivo. A similar observation was made by 
Mullins et al. (1983) when using free material for challenge.
Another factor which clearly affected allergenicity was 
hapten density, in that the amount of dye bound to the 
carrier protein in vitro correlated with the allergenicity of 
the conjugates in vivo. Furthermore, the hapten density 
produced depended on the carrier protein employed, since a 
consistently greater amount of dye bound to BSA than to OA, 
suggesting differing levels of available binding sites on the 
two proteins.
Mullins et al. (1983) exposed guinea pigs by inhalation 
to conjugates of isocyanatoethyl methacrylate and found that 
the development of respiratory symptoms was related to the 
hapten density of the conjugates used. In present studies at 
ratios below 1.6:1 reaginic antibody production was not 
triggered. If the level of hapten density of conjugates 
formed in vivo is directly related to the level of exposure, 
low levels of exposure would lead to the formation of 
conjugates with a hapten density insufficient to elicit a 
response, whereas higher levels of exposure may lead to the 
formation of conjugates with a sufficiently high hapten
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density to trigger the development of sensitivity. This 
hypothesis is supported by the work of Karol et al. (1983) 
who showed that the induction of reaginic antibody using free 
TDI was dose dependent. Although exposure to low levels of 
material may be insufficient to induce sensitivity, such 
exposure may still represent a hazard through elicitation of 
respiratory responses.
The ability to bind to protein is not, in itself, the 
only factor determining the allergenicity of a material. It 
is a commonly held view that covalent binding is required for 
allergenicity, a fact borne out by the observation that the 
food colour tartrazine, which is structurally similar to R014 
but lacking the reactive dichlorotriazine group, can only 
induce reaginic antibody when bound covalently to protein 
using carbodiamide (Nicklin & Miller, 1985). Wass and Belin,
(1990) proposed a test system for evaluating the potential of 
materials to induce occupational asthma on the basis of their 
ability to bind to a lysine-containing peptide. A range of 
over 40 chemicals was tested in this system, the level of 
binding being assessed by high performance liquid 
chromatography following incubation for 10 minutes at neutral 
pH and 37°C. Materials such as the isocyanates and acid 
anhydrides were positive in this system, but the reactive 
dyes which are known respiratory sensitisers were not 
identified using this procedure.
In the present studies computer graphic molecular 
modelling was explored as a means of providing information 
for use in the identification of respiratory allergens. The 
computer graphic modelling of the R04 and R013 dyes revealed
- 192 -
how subtle changes in molecular structure produced marked 
alterations in the surface charge of the molecule. These 
changes apparently correlated with the differences in 
allergenicity observed for these dyes, as determined by their 
ability to induce reaginic antibody production. Although it 
was not possible to model all eight dyes some degree of 
understanding as to the potential of this approach as a means 
of detecting configurations associated with allergenic 
potential has been obtained.
Examination of molecular structure and surface electro­
static potential energy of a material once bound to protein, 
would indicate not only the way in which the material is 
presented to the immune system, but also whether any changes 
in the configuration of the protein are involved. This would 
provide the most likely pattern of electrostatic potential 
energy for the allergen, and reveal whether any major changes 
in surface charge or conformation occur within the protein 
molecule as a result of this binding. Zeiss et al. (1980) 
have suggested that the antibody response to TMA is directed 
against new antigenic determinants which arise from the 
coupling of TMA with respiratory tract proteins, whilst TDI 
has been shown to induce conformational changes in serum 
proteins following inhalation exposure (Kochman, 1990). 
Comparison of these materials with other reactive chemicals 
used in industry, which are not associated with respiratory 
allergy, may provide further information on whether 
particular molecular configurations are associated with a 
respiratory allergen. Meanwhile, following further analysis 
of the range of reactive dyes examined in these studies, the
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allergenicity of other dyestuffs could be predicted and the 
hypotheses tested in an experimental animal system.
Although further and more detailed evaluation of this 
technique is clearly required, this type of computer-based 
assay system may prove to be of benefit as a screening method 
for potential allergens, especially during the developmental 
stages of new chemicals, identifying those molecular 
configurations which should be avoided. Such an approach, 
however, cannot replace the requirement for ultimate 
assessment of chemicals in animal systems.
Induction of sensitivity by inhalation exposure to free 
material in guinea pig models has yielded some encouraging 
results with potent sensitisers. However, this system has 
not been exploited as a means of providing a screening 
programme for respiratory allergens. Therefore, one of the 
principal aims of this study was to produce a regimen 
suitable for inducing Type I hypersensitivity in the rat via 
the respiratory route. Most of the protocols used for 
examination of low molecular weight materials by inhalation 
exposure are based upon a regimen proposed by Karol et al.
(1985), which involves the exposure of guinea pigs to free 
material for 3 hr/day for 5 days. However, there have been 
some problems experienced using this type of system related 
to elicitation of respiratory responses following challenge 
using either free material (Karol et al., 1980) or protein 
conjugates (Botham et al. 1988).
Using a similar regimen, sensitisation of rats to free 
R014 was attempted using atmospheric concentrations of either 
0.2 or 7 ^g/1; this however proved unsuccessful. Amongst the
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factors that may have influenced sensitisation to free R014 
was the relatively low dose levels used, since Botham et al. 
(1988) induced antigen-specific reaginic antibodies in guinea 
pigs exposed to procion yellow MX4R (PYMX4 (synonymous with 
R014)) at a dose level of 100 mg/M^. Exposure at these 
higher dose levels, may result in direct damage to the 
respiratory epithelium. Nevertheless in the present studies 
anti-R014 antibodies were not induced following 
intraperitoneal exposure to free dye either (section 7.3.1).
Although not consistent, it was possible to induce 
hapten-specific reaginic antibody responses against Pen and 
R014 by the inhalation route when these materials were 
conjugated to OA (Section 7.3.2.). This required very 
specific conditions, and further analysis of the aerosols 
produced by the Liu-Lee nebuliser using equipment such as the 
Malvern API aerosizer, which allows precise particle 
analysis, may provide the necessary information for 
generating aerosols for sensitisation.
Mullins et al. (1983) used ovalbumin conjugates for 
sensitisation by inhalation and challenged with free 
material. This type of approach proved unsatisfactory, and 
hapten-specific antibody was more reliably induced following 
intraperitoneal exposure. Following intraperitoneal 
sensitisation with hapten-protein conjugates, elicitation of 
respiratory responses was possible using either material-BSA 
conjugates or free material for inhalation challenge.
Over the years there has been considerable debate as to 
the most appropriate means of sensitisation and challenge. 
Recently there has been a move towards employing the dermal
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route of exposure for induction of sensitivity to assess 
respiratory allergens. Botham et al. (1989) used this
approach to compare the responses between a respiratory
sensitiser (TMA) and a contact sensitiser (2,4- 
dinitrochlorobenzene), and noted that only the respiratory 
sensitiser induced hapten-specific reaginic antibody.
Dearman and Kimber (1991) went on to compare the class of
antibody induced by either TMA or oxazolone (a contact
sensitiser) in mice sensitised by topical application. Again
the production of IgE was associated with the respiratory 
sensitiser. Therefore they suggested that this approach may 
have applications in specifically identifying respiratory 
allergens. In present studies, allergen was administered to 
rats via the intraperitoneal route and the presence of 
antigen-specific IgE antibody determined using the PCA assay 
which is a functional assay of the ability of that antibody 
to bind to mast cells and trigger degranulation.
The definition of what constitutes a state of 
"sensitisation" can vary from the elicitation of respiratory 
responses following antigen challenge (De Ceaurriz et al., 
1987) to the presence of antigen-specific reaginic antibody 
or, in the case of the guinea pig, development of skin 
reactions (Mullins et al. 1983). There are inherent 
difficulties in the interpretation of results associated with 
the use of respiration rate alone as an indication of 
elicitation of respiratory responses in sensitised animals, 
as this does not indicate the mechanism involved in these 
responses. Such responses can be mediated by
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antibody/antigen reactions or in some cases be antibody 
independent.
Guinea pig respiratory responses are usually
characterised by an initial rise in respiration rate followed
by a fall in respiration rate and in severe cases respiratory
collapse, hence the use of a respiratory index for evaluation
iet a X
of results (Karol',(1978b)L Even in the rat where a decrease 
in respiration rate is associated with a positive respiratory 
response, in some instances these responses may be obscured 
by a sustained gradual decline in respiration rate occurring 
during the monitoring period (Section 3.4.3.). In the 
present studies this difficulty was avoided by only 
considering as positive, animals which developed the 
characteristic periodic notching breathing pattern following 
inhalation challenge.
In addition, some materials may produce alterations in 
respiration rate due to mechanisms other than IgE-mediated 
responses. The isocyanates, for instance, are a group of 
materials with widely differing chemical reactivities. Apart 
from immunologically mediated effects, some have been shown 
to act directly as pulmonary or sensory irritants (Karol,
1986). It has also been suggested that the respiratory 
symptoms may be mediated through the cellular adrenergic 
receptors, causing impairment of the production of cyclic AMP 
which is operative in the maintenance of bronchial tone 
(Butcher, 1982). Therefore the inclusion of appropriate 
controls is required to ensure that challenge with free 
material does not non-specifically elicit the periodic 
breathing pattern.
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In addition to the development of a regimen for 
sensitisation by respiratory exposure, a parallel aim was to 
produce a system whereby differential allergenicity of a 
spectrum of test materials could be assessed. A treatment 
regimen of intraperitoneal administration was devised whereby 
material was conjugated to carrier proteins of differing 
immunogenicity, and administered to a high IgE responder 
strain of rat, in conjunction with carrageenan to facilitate 
isotype switching and reaginic antibody production. 
Measurement of antigen-specific IgE antibody indicated 
whether the antigen had been recognised by the immune system. 
Determination of the presence of this type of antibody 
although providing general information on allergenicity did 
not indicate if this was specifically related to respiratory 
sensitisation. Therefore, inhalation challenge of sensitised 
animals was used to determine the potential of the material 
to elicit respiratory responses. Challenge with a material- 
BSA conjugate provided information as to recognition of the 
allergen once protein bound, whereas challenge with free 
material revealed the potential of the material to form 
conjugates with host protein in vivo and elicit respiratory 
responses.
Using this regimen differences in allergenic potential 
were observed between the materials examined. Administration 
of materials conjugated to the more efficient carrier protein 
(OA) together with carrageenan was used to ensure reaginic 
responses were produced especially against materials that 
were considered to be "weak" allergens. As it has been found 
to be relatively difficult to induce reaginic antibody using
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material conjugated to rat serum, these conjugates were 
employed for the identification of those materials with a 
"strong" sensitising potential. The omission of carrageenan 
from the regimen was used in order to compare a range of 
materials where detection of subtle differences in 
allergenicity between "moderate" and "strong" sensitisers was 
required.
The hapten densities of dye conjugates produced as a 
result of a set regimen, enabled the allergenic 
characteristics of the dyes to be compared. However, in 
those instances where, because of the extreme reactivity of 
the test material the production of conjugates needs to be
carefully controlled, the level of percentage loss of amine 
groups on the carrier protein should fall within certain 
limits. This would ensure that sufficient material is bound 
for immune recognition without resulting in damage to the 
carrier protein. Such an approach would allow the 
allergenicity of highly reactive materials to be compared.
Although it would seem unlikely that a material 
producing low hapten density conjugates in vitro would easily 
form conjugates in vivo with host proteins, it is important 
to determine if free material can elicit respiratory 
responses. Therefore, initially for material-conjugates with 
low hapten densities which do not induce reaginic antibody 
formation, it may be necessary to manipulate the conjugation 
conditions to increase the hapten density, so that the 
ability of free material to elicit respiratory responses can 
be assessed. This may be a particularly important fact to 
establish when considering the potential cross-reactivity
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between certain materials within the work place, for example, 
between the anthraquinone dyes.
Based upon the findings of this work, a testing regimen 
for assessing the allergenicity of materials and their 
ability to induce respiratory hypersensitivity responses has 
been developed as outlined in Figure 8.2. The model was 
developed with regard to low molecular weight materials, but 
could also be applied to high molecular weight materials, 
such as enzymes or novel proteins. An unsensitised (control) 
group would be included so that non-specific activity of free 
material on respiratory patterns could be assessed.
In general the development and use of a model for 
potential inhaled allergens using inhalation as the route of 
administration has proved problematical. A clearer 
understanding of the atmospheric conditions for sensitisation 
by inhalation is required before this approach can be used 
for routine evaluation of materials. Meanwhile induction of 
reaginic antibody by intraperitoneal administration of 
material-protein conjugates, followed by inhalation challenge 
with free material would provide a simple method of 
identifying potential respiratory allergens. Such an assay 
system could provide information on allergenicity of 
potential respiratory sensitisers or form part of a panel of 
tests used to determine allergenicity of materials in the 
occupational environment.
Thus present studies have established a possible rat
model for assessing the potential of materials to induce 
Type I reagin-mediated respiratory hypersensitivity.
However, to evaluate and explore fully the potential of this
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particular model, certain aspects of these studies require 
further investigation.
In order to validate the proposed system for assessing 
I respiratory allergens it will be necessary to examine a wider
spectrum of materials, and define a format for interpretation
of the results. Should such investigations prove successful, 
inter-laboratory studies would need to be initiated before 
the assay system would be recognised by the various 
regulatory authorities. Eventually an animal model based 
upon the system proposed may be used to identify materials 
that are likely to be respiratory sensitisers. However, such 
a system may have an immediate application with regard to 
determining whether materials introduced into industrial 
processes as replacements for those recognised as a cause of 
occupational asthma, represent less of a hazard. In 
addition, examination of the atmospheric concentration 
required to elicit respiratory responses in sensitised 
animals might prove to be of value in determining threshold 
limit values for the industrial situation.
In the course of these studies into the factors involved 
in the induction and elicitation of respiratory allergy, it 
became apparent that the rat may prove a useful experimental 
model for the study of various aspects of the development and 
treatment of Type 1 respiratory allergy.
It has been suggested that the increase in reported 
cases of asthma in industrialised areas may be related to 
increased levels of atmospheric pollutants (Bates & Baker- 
Anderson, 1987) . An example of an environmental ubiquitous 
pollutant is nitrogen dioxide, a noxious gas that is present
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in cigarette smoke, vehicle exhaust and industrial burning of 
hydrocarbons. Amongst its actions it increases permeability 
of the respiratory epithelium, which may in turn influence 
access of antigen to the immune system. Long term exposure 
(up to 9 months) to concentrations of 30 ppm NOg in the 
hamster has revealed focal areas of damage to the tight
junction of the epithelial cells of the bronchioles and 
alveoli (Gordon et al., 1986). In addition increases in 
transepithelial transport of horseradish peroxidase have been 
observed in guinea pigs following exposure to 15 ppm NOg for 
two days (Ranga et al., 1980). This poses the question as to 
whether exposure to atmospheric pollutants producing these
types of lesions increases the likelihood of respiratory 
sensitisation. If in the future the conditions for induction 
of Type 1 hypersensitivity by inhalation exposure could be 
defined so that a given percentage of the population 
responded, then the impact of atmospheric pollutants on the 
modulation of sensitisation could be elucidated.
The potential of the rat system for assessing the action 
of drugs developed for treatment of asthma is one of the 
areas that could be investigated. Animals can be rendered 
sensitive to a given material by intraperitoneal treatment 
and the capacity of prophylactic drugs to inhibit the 
development of an asthmatic response as well as the capacity 
of drugs to limit a response once triggered can be assessed 
following inhalation challenge. This type of approach has 
been employed in the anaesthetised rat by Dahlback when 
investigating bronchial hyper-reactivity (1981). One class 
of drugs employed in the treatment of asthma is directed
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against preventing mast cell degranulation and release of
potent inflammatory mediators. Mast cells from different 
species, and even from diverse tissues within a given animal 
have been found to be functionally heterogeneous (Pearce, 
1986). Therefore in order to provide an appropriate system 
to evaluate the action of these drugs in man, their effect on 
anti-IgE-stimulated mast cells acquired from human broncho- 
alveolar lavage has been examined (Pearce et al., 1989). 
However, the mast cell is not the only cell involved in the 
asthmatic response and a system whereby animals are^ 
sensitised and challenged by inhalation would provide a 
valuable model. Even with the present limitation of the 
number of responders available using the current Liu-Lee 
nébulisation system, it would be possible to provide a 
sufficient number of PCA-positive animals following 
inhalation exposure. Such an approach may provide a more 
appropriate model to follow the activities of prophylactic 
drugs, since different routes of exposure may produce subtle 
differences in lung cell populations present and their 
activities.
The nature of events that lead to the development of the 
chronic inflammation associated with respiratory allergy 
involving the development of an IgE antibody response to
inhaled materials are not wholly understood. Although 
examination of the pulmonary cell populations present in 
asthmatic subjects provides valuable information on the 
inflammation present, it does not reveal the role of the 
various cell types in the initiation of this inflammation.
In addition, the cellular infiltration observed in asthmatic
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patients following antigen challenge reflects the development 
of a well established response. Investigation of the events 
leading to the development of this inflammation in an animal 
model may reveal valuable information in this area. Firstly 
it is important to ascertain whether the late phase cellular 
response observed in the rat after inhalation challenge 
follows the same pattern as that reported in man (Demonchy at 
ai., 1985; Metzger at ai., 1987; Fabbri, 1987) and if so 
whether it is also accompanied by respiratory symptoms. 
Repeated challenge of sensitised animals may produce the 
inflammatory conditions associated with asthma.
Identification of the cell types present in the
I infiltrate and their state of activation together with the 
I inflammatory mediators that these cells can release, may 
I provide information as to the mechanisms involved in the 
I development of this inflammation. Similarly, examination of 
lavage cell populations during the induction phase of
II sensitisation would provide information on the initial
cellular reactions involved in the induction of sensitivity, 
and so determine the contribution of the cells present to the
development of sensitivity.
The primary aim of this research was to develop a rat 
model for the identification of potential respiratory 
allergens: The assay system developed during these
investigations (Chapter 8) would provide the basis of a 
screening programme for such materials. Further comparison 
between the responses of BN and PVG rats following exposure to 
inhaled antigen should provide an insight into the mechanisms 
involved in the development of respiratory sensitivity.
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